0001493152-26-028882 | S-4 | XBRL Viewer | BIO Green MED Solution INC

Print Document

Schedule of Summary of Consolidated Net Loss (Details) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2026	Mar. 31, 2025	Dec. 31, 2025	Dec. 31, 2024
Segment Reporting [Line Items]
Revenues	$ 778		$ 747	$ 43
Cost of sales	635		609
Research and development			848	6,655
Total operating expenses	1,024	4,214	9,174	12,047
Operating loss	(246)	(4,214)	(8,427)	(12,004)
Total other income (expense), net	79	8	5,436	10
Loss before taxes	(167)	(4,206)	(2,991)	(11,994)
Income tax benefit / (charge)	(30)		(7)	782
Net loss	$ (197)	$ (81)	(2,998)	(11,212)
Single Reportable Segment [Member]
Segment Reporting [Line Items]
Revenues			747	43
Cost of sales			609
Research and development			848	6,655
General and administrative			7,717	5,392
Total operating expenses			9,174	12,047
Operating loss			(8,427)	(12,004)
Total other income (expense), net			5,436	10
Loss before taxes			(2,991)	(11,994)
Income tax benefit / (charge)			(7)	782
Net loss			$ (2,998)	$ (11,212)

Accounts Receivables (Details Narrative) - USD ($)	3 Months Ended	12 Months Ended
Accounts Receivables (Details Narrative) - USD ($)	Mar. 31, 2026	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Product Information [Line Items]
Provision for doubtful debt		$ 539,441
Allowance for doubtful debt description	the rate of 10% against balances greater than 120-149 days, 25% against balances greater than 150-179 days, 35% against balances greater than 180-364 days, and 50% against balances greater than 365 days	the rate of 10% against balances greater than 120-149 days, 25% against balances greater than 150-179 days, 35% against balances greater than 180-364 days, and 50% against balances greater than 365 days.
Allowance for doubtful debt	$ 286,000	$ 447,000
Future NRG Sdn. Bhd. [Member]
Product Information [Line Items]
Allowance for doubtful debt		$ 312,455	$ 251,199	$ 213,421
Accounts Receivable [Member] \| Customer Concentration Risk [Member] \| Major Customer [Member] \| Future NRG Sdn. Bhd. [Member]
Product Information [Line Items]
Concentration risk percentage		75.72%	86.35%
Accounts Receivable [Member] \| Customer Concentration Risk [Member] \| One Customer [Member] \| Future NRG Sdn. Bhd. [Member]
Product Information [Line Items]
Concentration risk percentage	75.70%	75.70%

Schedule of Accounts Payable and Accrued Liabilities (Details) - Future NRG Sdn. Bhd. [Member] - USD ($)	Mar. 31, 2026	Dec. 31, 2025	Dec. 31, 2024
Trade payables	$ 20,123	$ 3,768	$ 24,355
Accrual for material litigation		405,565	368,004
Deposit received from customer	14,829	14,774	24,578
Transportation fee payables		33,740	30,615
Total	477,406	5,113,187	3,440,900
Non-trade payables and other creditors	35,509
Accrual for legal proceedings — AHT litigation (Note 13)	406,945
Total accounts payable and accrued liabilities	$ 477,406	5,113,187	3,440,900
Holding Company [Member]
Amount due to companies		4,655,340	2,154,420
Related Company [Member]
Amount due to companies			$ 838,928

Cash and Cash Equivalents (Tables)

3 Months Ended

12 Months Ended

Mar. 31, 2026

Dec. 31, 2025

Schedule of Cash of Discontinued Operations

The following is a summary of cash and cash equivalents at December 31, 2025 and 2024 (in thousands):

Summary of Cash and Cash Equivalents

	2025		2024
	December 31,
	2025		2024
Cash	$	3,505	$	93
Cash equivalents		—		3,044
Total cash and cash equivalents	$	3,505	$	3,137

Future NRG Sdn. Bhd. [Member]

Schedule of Cash of Discontinued Operations

	Mar 31, 2026 (USD)
Cash at bank — continuing operations		9,649
Cash — discontinued operations (within held-for-sale)		—
Total consolidated cash		9,649

Cash of continuing operations comprises demand deposits placed with regulated financial institutions in Malaysia. Cash of discontinued operations is presented within assets held for sale (see Note 4).

	Note	2025		2024
		(USD)		(USD)
Cash — continuing operations			202,716		268,780
Cash — discontinued operations			3,135,050		1,701,167
Consolidated cash per cash flow statement			3,337,766		1,969,947

Schedule of Earnings Per Share, Basic and Diluted (Details) - shares	3 Months Ended		12 Months Ended
	Mar. 31, 2026	Mar. 31, 2025	Dec. 31, 2025	Dec. 31, 2024
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total shares excluded from calculation	28,009	748,218	28,111,000	117,842,000
Share-Based Payment Arrangement, Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total shares excluded from calculation	24,827	25,253	24,921,000	494,000
Restricted Stock Units (RSUs) [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total shares excluded from calculation	2	136
Series A Preferred Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total shares excluded from calculation	2	2
Series D Preferred Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total shares excluded from calculation		162,588
Series E Preferred Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total shares excluded from calculation		458,333
Common Stock Warrants [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total shares excluded from calculation	3,178	101,906

Schedule of Deferred Tax Assets (Details) - USD ($) $ in Thousands	Dec. 31, 2025	Dec. 31, 2024
Income Tax Disclosure [Abstract]
Net operating loss and tax credit carryforwards	$ 3,203	$ 59,417
Depreciation, amortization and impairment of property and equipment		39
Stock options	907	250
Research and development credits
Right of use asset	(3)	(1)
Lease liability	3	1
Other		114
Total deferred tax assets	4,110	59,820
Valuation allowance for deferred tax assets	(4,110)	(59,820)
Net deferred tax assets

Consolidated Statements of Stockholders' Equity (Deficit) - USD ($)	Preferred Stock [Member]	Common Stock [Member]	Common Stock [Member] Future NRG Sdn. Bhd. [Member]	Additional Paid-in Capital [Member]	AOCI Attributable to Parent [Member]	AOCI Attributable to Parent [Member] Future NRG Sdn. Bhd. [Member]	Retained Earnings [Member]	Retained Earnings [Member] Future NRG Sdn. Bhd. [Member]	Total	Future NRG Sdn. Bhd. [Member]
Balance at Dec. 31, 2023			$ 6,100,218	$ 429,797,000	$ (908,000)		$ (428,282,000)	$ (5,135,598)	$ 607,000	$ 964,620
Balance, shares at Dec. 31, 2023	454,537	4,412
Issue costs on issuance of common stock, preferred stock and associated warrants on underwritten offering, net of expenses		$ 0		6,209,000					6,209,000
Issue of common stock, preferred stock and associated warrants on underwritten offering, net of expenses, shares		2,944
Conversion of series B Preferred stock
Conversion of series B Preferred stock, shares	(119,000)	165
Conversion of series 6% Convertible Exchangeable Preferred
Conversion of series 6% Convertible Exchangeable, shares	(200,000)
Warrant Exercises		$ 0		1,613,000					1,613,000
Warrant Exercises, shares		29,391
Stock-based compensation				592,000					592,000
Unrealized foreign exchange on intercompany loans					(2,899,000)				(2,899,000)
Foreign currency translation					2,916,000	24,679			2,916,000	24,679
Net income (loss)							(11,212,000)	797,686	(11,212,000)	797,686
Balance at Dec. 31, 2024			6,100,218	438,211,000	(891,000)	24,679	(439,494,000)	(4,337,912)	(2,174,000)	1,786,985
Balance, shares at Dec. 31, 2024	135,537	36,913
Issue costs on issuance of common stock, preferred stock and associated warrants on underwritten offering, net of expenses				(248,000)					(248,000)
Stock-based compensation				1,666,000					1,666,000
Unrealized foreign exchange on intercompany loans					(2,380,000)				(2,380,000)
Foreign currency translation					2,385,000				2,385,000
Net income (loss)							(81,000)		(81,000)
Issue of common stock on Securities Purchase Agreement
Issue of common stock on Securities Purchase Agreement, shares		758
Series C Preferred stock conversions	$ (1,000)			1,000
Series C Preferred stock conversions, shares	(1,000,000)	11,042
Series D Preferred stock conversions	$ (2,000)	$ 1,000		1,000
Series D Preferred stock conversions, shares	(1,745,262)	799,912
Exercise of Pre-Funded Warrants
Exercise of Pre-Funded Warrants, shares		15,277
Issue of Series C preferred stock in Securities Purchase Agreement	$ 1,000			999,000					1,000,000
Issue of Series C preferred stock in Securities Purchase Agreement, shares	1,000,000
Issue of Series D preferred stock in Securities Purchase Agreement	$ 2,000			1,892,000					1,894,000
Issue of Series D preferred stock in Securities Purchase Agreement, shares	2,100,000
Issue of Series E preferred stock in Securities Purchase Agreement	$ 1,000			999,000					1,000,000
Issue of Series E preferred stock in Securities Purchase Agreement, shares	1,000,000
Deconsolidation of wholly-owned foreign operation					886,000		(886,000)
Balance at Mar. 31, 2025	$ 1,000	$ 1,000		443,521,000			(440,461,000)		3,062,000
Balance, shares at Mar. 31, 2025	1,490,275	863,902
Balance at Dec. 31, 2024			6,100,218	438,211,000	(891,000)	24,679	(439,494,000)	(4,337,912)	(2,174,000)	1,786,985
Balance, shares at Dec. 31, 2024	135,537	36,913
Stock-based compensation				2,334,000					2,334,000
Stock-based compensation, shares		500,178
Unrealized foreign exchange on intercompany loans					(2,380,000)				(2,380,000)
Foreign currency translation					2,346,000	182,395			2,346,000	182,395
Net income (loss)							(2,998,000)	2,490,410	(2,998,000)	2,490,410
Expenses related to Securities Purchase Agreement In Private Placement				(344,000)					(344,000)
Issue of common stock on Securities Purchase Agreement		$ 0		(125,000)					(125,000)
Issue of common stock on Securities Purchase Agreement, shares		1,698
Issue of common stock on share exchange agreement to purchase Fitters Sdn. Bhd		$ 1,000		4,449,000					4,450,000
Issue of common stock on share exchange agreement to purchase Fitters Sdn. Bhd, shares		699,158
Exercise of Pre-Funded & Common Warrants		$ 0							0
Exercise of Pre-Funded & Common Warrants, shares		113,479
Payment made under the Warrant Exchange Amendment				(1,100,000)					(1,100,000)
Issue of common stock on warrant exchange agreement		$ 2,000		11,033,000			(11,033,000)		2,000
Issue of common stock on Warrant Exchange Agreements, shares		1,962,000
Preferred stock dividends				(61,000)					(61,000)
Issue of Series C preferred stock	$ 1,000			999,000					1,000,000
Issue of Series C preferred stock, shares	1,000,000
Series C Preferred stock conversions	$ (1,000)	$ 0		1,000
Series C Preferred stock conversions, shares	(1,000,000)	11,042
Issue of Series D preferred stock	$ 2,000			1,892,000					1,894,000
Issue of Series D preferred stock, shares	2,100,000
Series D Preferred stock conversions	$ (2,000)	$ 1,000		1,000
Series D Preferred stock conversions, shares	(2,100,000)	962,500
Issue of Series E preferred stock	$ 1,000			999,000					1,000,000
Issue of Series E preferred stock, shares	1,000,000
Series E Preferred stock conversions	$ (1,000)	$ 0		1,000
Series E Preferred stock conversions, shares	(1,000,000)	458,333
Issue of Series F preferred stock	$ 3,000			2,997,000					3,000,000
Issue of Series F preferred stock, shares	3,000,000
Series F Preferred stock conversions	$ (3,000)	$ 1,000		2,000
Series F Preferred stock conversions, shares	(3,000,000)	654,000
Cancellation of fraction shares		$ 0
Stock Split Adjustments, shares		1,019
Reclassification of accumulated translation adjustments upon deconsolidation of subsidiary					886,000		(886,000)
Balance at Dec. 31, 2025		$ 5,000	6,100,218	461,287,000	(39,000)	207,074	(454,411,000)	(1,847,502)	6,842,000	4,459,790
Balance, shares at Dec. 31, 2025	135,537	5,400,320
Stock-based compensation				1,000					1,000
Unrealized foreign exchange on intercompany loans
Foreign currency translation					9,000	(53,172)			9,000	(53,172)
Net income (loss)							(197,000)	(45,890)	(197,000)	(45,890)
Issue of common stock on warrant exchange agreement				125,000					125,000
Issue of common stock on Warrant Exchange Agreements, shares		119,136
Preferred stock dividends				(20,000)					(20,000)
Disposal of a subsidiary						62,734				62,734
Balance at Mar. 31, 2026		$ 5,000	$ 6,100,218	$ 461,393,000	$ (30,000)	$ 216,636	$ (454,608,000)	$ (1,893,392)	$ 6,760,000	$ 4,423,462
Balance, shares at Mar. 31, 2026	135,537	5,519,456

Consolidated Statements of Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Income Statement [Abstract]
Net loss	$ (197)	$ (81)
Translation adjustment	9	2,385
Translation adjustment on deconsolidation of subsidiary		886
Unrealized foreign exchange gain (loss) on intercompany loans		(2,380)
Total comprehensive income	$ (188)	$ 810

- Definition

Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.

+ References + Details

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480070/505-10-S50-6

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 4
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482705/350-40-65-4

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (e)(4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479719/606-10-65-2

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483499/205-20-50-7

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5A
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483499/205-20-50-5A

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 323
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481687/323-10-50-3

Reference 8: http://www.xbrl.org/2003/role/exampleRef
-Topic 946
-SubTopic 830
-Name Accounting Standards Codification
-Section 55
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479168/946-830-55-10

Reference 9: http://www.xbrl.org/2003/role/exampleRef
-Topic 220
-SubTopic 40
-Name Accounting Standards Codification
-Section 55
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476153/220-40-55-4

Reference 10: http://www.xbrl.org/2003/role/exampleRef
-Topic 220
-SubTopic 40
-Name Accounting Standards Codification
-Section 55
-Paragraph 21
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476153/220-40-55-21

Reference 11: http://www.xbrl.org/2003/role/exampleRef
-Topic 220
-SubTopic 40
-Name Accounting Standards Codification
-Section 55
-Paragraph 14
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476153/220-40-55-14

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(i))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(k)(2))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 28
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482907/825-10-50-28

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-4

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 480
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 480
-SubTopic 10
-Name Accounting Standards Codification
-Section S45
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 480
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 3A
-Subparagraph (24)(d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 105
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 9
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479343/105-10-65-9

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 17
-Subparagraph (d)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480336/718-10-65-17

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-6

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 60
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476176/805-60-65-1

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 323
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478666/740-323-65-2

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 27: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482765/220-10-50-6

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-3

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480175/815-40-65-1

Reference 32: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 33: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 34: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 35: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 36: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 8
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-8

Reference 37: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-9

Reference 38: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-11

Reference 39: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-11

Reference 40: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 41: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 42: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section 45
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479105/946-220-45-7

Reference 43: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1

Reference 44: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(9))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1

Reference 45: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.6-09(1)(d))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3

Reference 46: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 47: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 48: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 60B
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B

Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 230
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 28
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482740/230-10-45-28

Reference 50: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 1A
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A

Reference 51: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 1B
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B

Reference 52: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 65
-Paragraph 4
-Subparagraph (f)(4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481538/470-20-65-4

Reference 53: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 942
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1

+ Details

Commitments and Contingencies (Details Narrative)		3 Months Ended			12 Months Ended
Commitments and Contingencies (Details Narrative)	Jan. 01, 2026 MYR (RM)	Mar. 31, 2026 USD ($)	Mar. 31, 2026 EUR (€)	Mar. 31, 2025 USD ($)	Dec. 31, 2025 USD ($)	Dec. 31, 2025 MYR (RM)	Dec. 31, 2025 EUR (€)	Dec. 31, 2024 USD ($)	Dec. 31, 2024 MYR (RM)	Mar. 31, 2026 MYR (RM)	Dec. 31, 2025 MYR (RM)	Mar. 31, 2025 MYR (RM)	Dec. 31, 2024 MYR (RM)
Operating lease expense		$ 13,911		$ 1,176	$ 22,335			$ 82,830
Lease liability discount rate		12.00%								12.00%
Loss before income tax provision		$ 167,000		4,206,000	2,991,000			11,994,000
Future NRG Sdn. Bhd. [Member]
Loss before income tax provision		45,890			66,862	RM 271,526		123,433	RM 552,425
Working capital deficit					4,524,366			2,762,164			RM 18,373,451		RM 12,362,067
Accounts payable and accrued liabilities		477,406			5,113,187			3,440,900
Cash (used in)/generated by operating activities					86,228	RM 350,174			RM 784,774
Short term lease payments		2,224			8,864
Legal advice				$ 406,945	405,566			405,566			1,647,000	RM 1,647,000	1,647,000
Future NRG Sdn. Bhd. [Member] \| AHT Syngas Technology NV [Member]
Proceeds from claim amount \| €			€ 1,783,810				€ 1,783,810
Counterclaimed amount \| €			200,000				200,000
Allegedly unpaid amount \| €			€ 342,857				342,857
Alleged overpayment amount \| €							€ 949,000
Future NRG Sdn. Bhd. [Member] \| Subsequent Event [Member]
Proceeds from equity interest \| RM	RM 10,500,000
Outstanding amount due		$ 1,934,289								RM 7,855,337
Future NRG Sdn. Bhd. [Member] \| Fitters Diversified Berhad Group [Member]
Accounts payable and accrued liabilities					$ 4,655,340						RM 18,905,336		RM 19,885,572
Corporate Headquarters Tower 11 Kuala Lumpur Malaysia [Member]
Lease term					2 years						2 years
Dundee Facility [Member]
Operating lease expense					$ 12,813			$ 9,104
Kuala Lumpur Malaysia [Member]
Operating lease, remaining lease term					1 year 2 months 12 days						1 year 2 months 12 days
Berkeley Heights Facility [Member]
Lease liability discount rate					12.00%						12.00%

Leases (Details Narrative) - USD ($)	3 Months Ended		12 Months Ended
Leases (Details Narrative) - USD ($)	Mar. 31, 2026	Mar. 31, 2025	Dec. 31, 2025	Dec. 31, 2024
Lessee Disclosure [Abstract]
Operating lease, expense	$ 13,911	$ 1,176	$ 22,335	$ 82,830
Operating lease, payments	$ 13,911	$ 0
Weighted average term	10 months 24 days
Discount rate	12.00%

Accounts Payable and Accrued Liabilities (Tables)

3 Months Ended

12 Months Ended

Mar. 31, 2026

Dec. 31, 2025

Future NRG Sdn. Bhd. [Member]

Schedule of Accounts Payable and Accrued Liabilities

	Mar 31, 2026 (USD)
Trade payables		20,123
Non-trade payables and other creditors		35,509
Accrual for legal proceedings — AHT litigation (Note 13)		406,945
Deposit received from customer		14,829
Total accounts payable and accrued liabilities		477,406

	Note	2025		2024
		(USD)		(USD)
Trade payables			3,768		24,355
Amount due to ultimate holding company			4,655,340		2,154,420
Amount due to related companies			—		838,928
Amount due to companies			—		838,928
Accrual for material litigation			405,565		368,004
Deposit received			14,774		24,578
Transportation fee payables			33,740		30,615
Total			5,113,187		3,440,900

Schedule of Financial Assets and Liabilities Measured on a Recurring Basis (Details) - USD ($) $ in Thousands	Dec. 31, 2025	Dec. 31, 2024
Defined Benefit Plan Disclosure [Line Items]
Cash equivalents		$ 3,044
Fair Value, Recurring [Member]
Defined Benefit Plan Disclosure [Line Items]
Cash equivalents		3,044
Total Assets		3,044
Fair Value, Inputs, Level 1 [Member] \| Fair Value, Recurring [Member]
Defined Benefit Plan Disclosure [Line Items]
Cash equivalents		3,044
Total Assets		3,044
Fair Value, Inputs, Level 2 [Member] \| Fair Value, Recurring [Member]
Defined Benefit Plan Disclosure [Line Items]
Cash equivalents
Total Assets
Fair Value, Inputs, Level 3 [Member] \| Fair Value, Recurring [Member]
Defined Benefit Plan Disclosure [Line Items]
Cash equivalents
Total Assets

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (k)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (l)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (j)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (j)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (j)(4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (j)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (c)(iv)(02)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (c)(ii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-7

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (q)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (m)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

+ Details

Schedule of Stock Based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2026	Mar. 31, 2025	Dec. 31, 2025	Dec. 31, 2024
Stock-based compensation costs	$ 1	$ 1,666	$ 2,334	$ 592
General And Administrative Expenses [Member]
Stock-based compensation costs	1	1,592
Research and Development Expenses [Member]
Stock-based compensation costs		$ 74
General And Administrative Expenses [Member]
Stock-based compensation costs			2,297	498
Research and Development [Member]
Stock-based compensation costs			$ 37	$ 94

Schedule of Preliminary Allocation of Purchase Consideration (Details) - USD ($) $ / shares in Units, $ in Thousands	Sep. 11, 2025	Mar. 31, 2026	Dec. 31, 2025
Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]
Common Stock of BGMS (formerly CYCC) Shares O/S as of September 11, 2025	2,798,379
BGMS (formerly CYCC) Shares issued as consideration	699,158
Stock Price as of September 11, 2025	$ 6.3650
Cash consideration
Total Estimated Purchase Consideration	4,450,138
Cash and cash equivalents	784,090
Inventories	1,284,447
Accounts receivables	715,173
Prepaid & other current assets	464,129
Property, plant and equipment, net	129,423
Trade payables	(416,470)
Accrued and other current liabilities	(31,571)
Non-current liabilities - deferred tax	(48,739)
Goodwill	1,569,656	$ 1,570	$ 1,570
Total Net Assets Acquired	$ 4,450,138

Geographic and Segment Information (Details Narrative)	3 Months Ended	12 Months Ended
Geographic and Segment Information (Details Narrative)	Mar. 31, 2026 Segment	Dec. 31, 2025 Segment	Dec. 31, 2025 Integer
Segment Reporting [Abstract]
Number of reportable segments	1	1	1

Fair Value of Financial Assets and Liabilities (Tables)

12 Months Ended

Dec. 31, 2025

Fair Value Disclosures [Abstract]

Schedule of Financial Assets and Liabilities Measured on a Recurring Basis

The following tables present information about the Company’s financial assets and liabilities measured at fair value on a recurring basis and indicate the level of the fair value hierarchy utilized to determine such fair values (in thousands):

Fair Value Measurements

as of December 31, 2025 Using:

Level 1

Level 2

Level 3

Total

Assets:

Cash equivalents

—

Total Assets

—

	Level 1		Level 2		Level 3		Total
	Fair Value Measurements
	as of December 31, 2024 Using:
	Level 1		Level 2		Level 3		Total
Assets:
Cash equivalents	$	3,044	$	—	$	—	$	3,044
Total Assets	$	3,044	$	—	$	—	$	3,044

Significant Contracts

12 Months Ended

Dec. 31, 2025

Significant Contracts

Significant Contracts

3. Significant Contracts

The Company does not currently have any significant contracts in relation to the operations of its business.

Stockholders’ Equity

3 Months Ended

12 Months Ended

Mar. 31, 2026

Dec. 31, 2025

Stockholders’ Equity

12. Stockholders’ Equity

Convertible Preferred Stock Equity Offerings

Series E Preferred Stock

A total of 1,000,000 shares of the Company’s Series E Preferred Stock were issued pursuant to a March 2025 Securities Purchase Agreement with certain accredited investors (the “Investors”). The Company received proceeds of $1.0 million, net of issuance costs. All of the Series E preferred shares were converted into 458,333 shares of Common Stock and as of March 31, 2026, there were no remaining shares of the Series E Preferred Stock outstanding.

Series C and Series D Preferred Stock

A total of 1,000,000 shares of the Company’s Series C Preferred Stock and 2,100,000 shares of the Company’s Series D Preferred Stock were issued pursuant to a January 2025 Securities Purchase Agreement with David E. Lazar, pursuant to which he agreed to purchase from the Company 1,000,000 shares of Series C Convertible Preferred Stock (the “Series C Preferred Stock”) and 2,100,000 shares of Series D Convertible Preferred Stock (the “Series D Preferred Stock” and, together with the Series C Preferred Stock, the “Preferred Stock”) of the Company at a purchase price of $1.00 per share for aggregate gross proceeds of $3.1 million, subject to the terms and conditions of the January 2025 Securities Purchase Agreement. The proceeds of the transaction were used to repay and settle outstanding liabilities of the Company and for other general corporate and operating purposes.

Each share of Series C Preferred Stock was convertible into 0.011042 shares of the Company’s common stock, par value $0.001 per share (“Common Stock”), and each share of Series D Preferred Stock was convertible into 0.4583 shares of Common Stock. On February 24, 2025, all of the Series C preferred shares were converted in conjunction with the March 2025 Securities Purchase Agreement. As of March 31, 2026, there were no remaining shares of the Series C Preferred Stock outstanding.

All Series D preferred shares were converted in conjunction with the Purchase Agreement and as of March 31, 2026, there were no remaining shares of the Series D Preferred Stock outstanding.

Warrants

April 2024 Warrants

As of March 31, 2026, warrants to purchase a total of 1,242 shares of common stock issued pursuant to a securities purchase agreement in an April 2024 financing transaction (the “April 2024 Securities Purchase Agreement”) remained outstanding. A total of 62,750 warrants were issued pursuant to the April 2024 Securities Purchase Agreement. This consisted of i) pre-funded warrants to purchase 20,100 of common stock, exercisable immediately from the date of issuance, and with no expiry date, at an exercise price of $0.24 per warrant share, ii) series A warrants to purchase up to 20,704 shares of common stock, exercisable immediately from the date of issuance for a period of five and a half (5.5) years after the date of issuance, at an exercise price of $326.40 per warrant share, iii) series B warrants to purchase up to 20,704 shares of common stock, exercisable immediately from the date of issuance for a period of eighteen months after the date of issuance, at an exercise price of $326.40 per warrant share. The 1,242 Placement Agent Warrants issued pursuant to the Engagement Letter with the placement agent, are exercisable immediately from the date of issuance for a period of five and a half (5.5) years after the date of issuance, at an exercise price of $124.512 per warrant share.

There were no exercises of these warrants during the three months ended March 31, 2026 or March 31, 2025.

December 2023 Warrants

As of March 31, 2026, warrants to purchase a total of 1,750 shares of common stock issued pursuant to a securities purchase agreement in a December 2023 financing transaction remained outstanding. A total of 1,651 warrants, including 33 warrants issued in a concurrent private placement, are exercisable for a period of seven years after the date of issuance, at an exercise price of $765.60 per warrant share. A further 99 warrants issued in a concurrent placement agency agreement, are exercisable for a period of five years after the date of issuance, at an exercise price of $994.50 per warrant share.

There were no exercises of these warrants during the three months ended March 31, 2026 or March 31, 2025.

Other Outstanding Preferred Stock

Series A Preferred Stock

A total of 8,872 shares of the Company’s Series A Preferred Stock were issued in a July 2017 Underwritten Public Offering. Each share of Series A Preferred Stock is convertible at any time at the option of the holder thereof, into a number of shares of common stock determined by dividing $1,000 by the initial conversion price of $144,000.00 per share, subject to a 4.99% blocker provision, or, upon election by a holder prior to the issuance of shares of Series A Preferred Stock, 9.99%, and is subject to adjustment for stock splits, stock dividends, distributions, subdivisions and combinations.

As of March 31, 2026 and December 31, 2025, 264 shares of the Series A Preferred Stock remain issued and outstanding. The 264 shares of Series A Preferred Stock issued and outstanding at March 31, 2026, are convertible into 2 shares of common stock.

In the event of a liquidation, the holders of shares of the Series A Preferred Stock may participate on an as-converted-to-common-stock basis in any distribution of assets of the Company. The Company shall not pay any dividends on shares of common stock (other than dividends in the form of common stock) unless and until such time as dividends on each share of Series A Preferred Stock are paid on an as-converted basis. There is no restriction on the Company’s ability to repurchase shares of Series A Preferred Stock while there is an arrearage in the payment of dividends on such shares, and there are no sinking fund provisions applicable to Series A Preferred Stock.

Subject to certain conditions, at any time following the issuance of the Series A Preferred Stock, the Company has the right to cause each holder of the Series A Preferred Stock to convert all or part of such holder’s Series A Preferred Stock in the event that (i) the volume weighted average price of our common stock for 30 consecutive trading days, or Measurement Period exceeds 300% of the initial conversion price of the Series A Preferred Stock (subject to adjustment for forward and reverse stock splits, recapitalizations, stock dividends and similar transactions), (ii) the daily trading volume on each Trading Day during such Measurement Period exceeds $500,000 per trading day and (iii) the holder is not in possession of any information that constitutes or might constitute, material non-public information which was provided by the Company. The right to cause each holder of Series A Preferred Stock to convert all or part of such holder’s Series A Preferred Stock shall be exercised ratably among the holders of the then outstanding preferred stock.

The Series A Preferred Stock has no maturity date, will carry the same dividend rights as the common stock, and with certain exceptions contains no voting rights. In the event of any liquidation or dissolution of the Company, the Series A Preferred Stock ranks senior to the common stock in the distribution of assets, to the extent legally available for distribution.

6% Convertible Exchangeable Preferred Stock

As of March 31, 2026, there were 135,273 shares of the Company’s 6% Convertible Exchangeable Preferred Stock (the “6% Preferred Stock”) issued and outstanding at an issue price of $10.00 per share. Dividends on the 6% Preferred Stock are cumulative from the date of original issuance at the annual rate of 6% of the liquidation preference of the 6% Preferred Stock, payable quarterly on the first day of February, May, August and November, commencing February 1, 2005. Any dividends must be declared by the Company’s board of directors and must come from funds that are legally available for dividend payments. The 6% Preferred Stock has a liquidation preference of $10.00 per share, plus accrued and unpaid dividends. As of March 31, 2026, there were no accrued and unpaid dividends.

The Company may automatically convert the 6% Preferred Stock into common stock if the per share closing price of the Company’s common stock has exceeded a per share price of $213,192,000, which is 150% of the conversion price of the 6% Preferred Stock, for at least 20 trading days during any 30 day trading period, ending within five trading days prior to notice of automatic conversion.

The 6% Preferred Stock has no maturity date and no voting rights prior to conversion into common stock, except under limited circumstances.

The Company may, at its option, redeem the 6% Preferred Stock in whole or in part, out of funds legally available at the redemption price of $10.00 per share.

The 6% Preferred Stock is exchangeable, in whole but not in part, at the option of the Company on any dividend payment date beginning on November 1, 2005 (the “Exchange Date”) for the Company’s 6% Convertible Subordinated Debentures (the “Debentures”) at the rate of $10.00 principal amount of Debentures for each share of 6% Preferred Stock. The Debentures, if issued, will mature 25 years after the Exchange Date and have substantially similar terms to those of the 6% Preferred Stock. No such exchanges have taken place to date.

14. Stockholders’ Equity

The Company has completed the following equity issuances during the periods presented in the consolidated financial statements.

Convertible Preferred Stock Equity Offerings

Series F Preferred Stock

On June 20, 2025, Bio Green Med Solution, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain accredited investors (the “Investors”), pursuant to which the Investors agreed to purchase an aggregate of 3,000,000 shares of Series F Convertible Preferred Stock (the “Series F Preferred Stock”) of the Company at a purchase price of $1.00 per share for aggregate gross proceeds of $3,000,000, subject to the terms and conditions of the Purchase Agreement. In connection with the transaction, the Company issued a series A common stock purchase warrant, series B common stock purchase warrant and series C common stock purchase warrant to each Investor (collectively, the “Warrants”). The proceeds of the transaction will be used for general corporate and operating purposes.

In sum, the Investors agreed to invest a total of $3,000,000 at the closing of the transactions under the Purchase Agreement in exchange for an aggregate of 3,000,000 shares of Series F Preferred Stock and 1,962,000 Warrants, which occurred on or about June 20, 2025 (the “Closing”).

Each share of Series F Preferred Stock was convertible into 0.218 shares of the Company’s common stock, par value $0.001 per share (“Common Stock”). All 3,000,000 shares of Series F Preferred Stock were converted into 654,000 shares of Common Stock during 2025.

The series A common stock purchase warrants entitle each Investor to purchase 218,000 shares of Common Stock of the Company at an exercise price of $7.65 per share with an expiration date five years from the date of issuance. The series B common stock purchase warrants entitle each Investor to purchase 218,000 shares of Common Stock of the Company at an exercise price of $9.00 per share with an expiration date five years from the date of issuance. The series C common stock purchase warrants entitle each Investor to purchase 218,000 shares of Common Stock of the Company at an exercise price of $10.20 per share with an expiration date five years from the date of issuance.

Series E Preferred Stock

A total of 1,000,000 shares of the Company’s Series E Preferred Stock were issued pursuant to a March 2025 Securities Purchase Agreement with certain accredited investors (the “Investors”). The Company received proceeds of $1.0 million, net of issuance costs. During the year ended December 31, 2025, all of the Series E preferred shares were converted into 458,333 shares of Common Stock. As of December 31, 2025, there were no remaining shares of the Series E Preferred Stock outstanding.

Series C and Series D Preferred Stock

A total of 1,000,000 shares of the Company’s Series C Preferred Stock and 2,100,000 shares of the Company’s Series D Preferred Stock were issued pursuant to a January 2025 Securities Purchase Agreement with David E. Lazar, pursuant to which he agreed to purchase from the Company 1,000,000 shares of Series C Convertible Preferred Stock (the “Series C Preferred Stock”) and 2,100,000 shares of Series D Convertible Preferred Stock (the “Series D Preferred Stock” and, together with the Series C Preferred Stock, the “Preferred Stock”) of the Company at a purchase price of $1.00 per share for aggregate gross proceeds of $3.1 million, subject to the terms and conditions of the Purchase Agreement. The proceeds of the transaction were used to repay and settle outstanding liabilities of the Company and for other general corporate and operating purposes.

Each share of Series C Preferred Stock was convertible into 0.011042 shares of the Company’s common stock, par value $0.001 per share (“Common Stock”), and each share of Series D Preferred Stock was convertible into 0.4583 shares of Common Stock. On February 24, 2025, all of the Series C preferred shares were converted in conjunction with the Purchase Agreement. As of December 31, 2025, there were no remaining shares of the Series C Preferred Stock outstanding.

On February 24, 2025, 1,745,262 of the Series D preferred shares were converted in conjunction with the Purchase Agreement. On April 2, 2025, the remaining 354,738 Series D preferred shares were converted in conjunction with the Purchase Agreement. As of December 31, 2025, there were no remaining shares of the Series D Preferred Stock outstanding.

April 2024 Securities Purchase Agreement

On April 30, 2024, the Company entered into a securities purchase agreement (the “Purchase Agreement”) with an institutional investor (the “Purchaser”) for the issuance and sale in a private placement (the “Private Placement”) of (i) 604 shares of the Company’s common stock, (ii) pre-funded warrants to purchase up to 20,099 shares of common stock (the “Pre-Funded Warrants”), (iii) series A warrants to purchase up to 20,703 shares of common stock (the “Series A Warrants”), and (iv) series B warrants to purchase up to 20,703 shares of common stock (the “Series B Warrants” and together with the Series A Warrants, the “Common Warrants”). The purchase price of each share of common stock and associated Common Warrants was $386.40 and the purchase price of each Pre-Funded Warrant and associated Common Warrants was $386.38.

The Common Warrants are exercisable immediately upon issuance at an exercise price of $326.40 per share. The Series A Warrants will expire five and one-half years from the date of issuance and the Series B Warrants will expire 18eighteen months from the date of issuance. The Pre-Funded Warrants were exercisable immediately upon issuance at an exercise price of $0.024 per share and were fully exercised in 2024. A holder of Pre-Funded Warrants or Common Warrants (together with its affiliates) may not exercise any portion of such warrants to the extent that the holder would own more than 4.99% (or, at the election of the holder 9.99%) of the Company’s outstanding common stock immediately after exercise.

In connection with the Private Placement, the Company entered into a registration rights agreement (the “Registration Rights Agreement”), dated as of April 30, 2024, with the Purchaser, pursuant to which the Company agreed to prepare and file a registration statement with the Securities and Exchange Commission (the “SEC”) registering the resale of the securities issued in the Private Placement.

The Private Placement closed on May 2, 2024. The gross proceeds to the Company from the Private Placement were approximately $8.0 million, before deducting placement agent fees and estimated offering expenses payable by the Company.

H.C. Wainwright & Co., LLC (“Wainwright”) acted as the Company’s exclusive placement agent in connection with the Private Placement, pursuant to that certain engagement letter, dated as of April 29, 2024, between the Company and Wainwright (as amended, the “Engagement Letter”). Pursuant to the Engagement Letter, the Company paid Wainwright (i) a cash fee equal to 7.0% of the aggregate gross proceeds of the Private Placement and (ii) a management fee of 1.0% of the aggregate gross proceeds of the Private Placement. In addition, the Company agreed to pay Wainwright certain expenses and issued to Wainwright or its designees warrants (the “Placement Agent Warrants”) to purchase up to an aggregate of 1,242 shares of common stock at an exercise price equal to $483.00 per share. The Placement Agent Warrants are exercisable immediately upon issuance and have a term of exercise equal to five and a half years from the date of issuance.

In connection with this transaction, the Company was required to compensate Roth Capital Partners, LLC, pursuant to a tail provision contained in an engagement letter entered into on March 14, 2024, in an amount equal to 7.0% of the aggregate proceeds of the Private Placement plus the reimbursement of certain expenses. The Company was also required to compensate Ladenburg Thalmann & Co. Inc, pursuant to a tail provision contained in an engagement letter entered into on October 30, 2023, in an amount equal to 8.0% of the aggregate proceeds of the Private Placement.

Each of the instruments issued in the Private Placement have been classified and recorded as part of shareholders’ equity (deficit). The amounts allocated to each issued security were based on their relative fair values, resulting in initial carrying values of the respective instruments as follows:

	Allocated Amount
Common shares	$	72,108
Prefunded warrants		2,398,831
Common warrants		3,819,274
Net proceeds	$	6,290,213

The aggregate fair value of the Placement Agent Warrants was $609,179. These have been accounted for as a direct cost of the Private Placement, resulting in no net effect to overall shareholders’ equity (deficit).

In determining the fair values of the Pre-Funded Warrants, Common Warrants, and Placement Agent Warrants, the Company used a Black-Scholes Option Pricing model with the following assumptions:

	Pre-Funded Warrants			Common Warrants			Placement Agent Warrants
Expected volatility		100	%		103% - 121%			103	%
Contractual term		1 year			- 5.5 years			5 ½ years5.5
Risk-free interest rate		5.51	%		4.57% - 5.51%			4.57	%
Expected dividend yield		0	%		0	%		0	%

The fair value of the common stock was determined using the closing price of the Company’s common stock as of May 2, 2024, which is the date that the Private Placement closed.

Warrants

June 2025 Warrants

As part of a warrant exchange agreement on September 4, 2025, a total of 559,395 Series C common stock purchase warrants were exchanged for the issuance of 559,395 shares of common stock. The Company recorded a deemed dividend of $1,494,000 representing the difference between the fair value of the common stock received and the fair value of the warrants exchanged as of the exchange date.

As part of a warrant exchange agreement on November 5, 2025, 654,000 Series A common stock purchase warrants, 654,000 Series B common stock purchase warrants, and 94,605 Series C common stock purchase warrants, totaling 1,402,605 in aggregate, were exchanged for the issuance of 1,402,605 shares of common stock. The Company recorded a deemed dividend of $9,540,000 representing the difference between the fair value of the common stock received and the fair value of the warrants exchanged as of the exchange date.

A total of 1,962,000 warrants were exercised during the year ended December 31, 2025. As of December 31, 2025, no warrants to purchase Common Stock issued pursuant to the June 2025 financing transaction remained outstanding.

November 2024 Warrants (As Amended)

On November 13, 2024, we entered into a letter agreement (the “Warrant Exercise and Reload Agreement”) with the holder (the “Holder”) of its issued and outstanding Series B Warrants (the “Prior Warrants”) to purchase an aggregate of 20,703 shares of common stock of the Company offering the Holder the opportunity to exercise all of its Prior Warrants for cash at a reduced exercise price equal to $99.60 per share provided the Prior Warrants were exercised in full for cash on or before 12:30 P.M. Eastern Time on the date of the Warrant Exercise and Reload Agreement. In consideration for the exercise of the Prior Warrants, the Holder received new unregistered Series C Warrants (the “Series C Warrants”) exercisable for up to an aggregate of 41,407 shares of common stock (the “Series C Warrant Shares”) and new unregistered Series D Warrants (the “Series D Warrants” and, together with the Series C Warrants, the “New Warrants”) exercisable for up to an aggregate of 41,407 shares of common stock (the “Series D Warrant Shares” and, together with the Series C Warrant Shares, the “New Warrant Shares”). The Series C Warrants are exercisable beginning on the date upon which the Company receives stockholder approval of the issuance of the New Warrant Shares and the Placement Agent Warrant Shares (as defined below) (the “Stockholder Approval Date”) for a period of five and one-half (5.5) years following the Stockholder Approval Date and the Series D Warrants are exercisable beginning on the Stockholder Approval Date for a period of eighteen (18) months following the Stockholder Approval Date. The New Warrants each have an exercise price of $99.60 per share. The shares of common stock issued upon exercise of the Prior Warrants are registered pursuant to an effective registration statement on Form S-1 (No. 333-279157).

All of the 82,816 warrants issued pursuant to the Warrant Exercise and Reload Agreement were exchanged for cash during the year ended December 31, 2025. Pursuant to the Warrant Exchange Agreement, and as consideration for the exchange of warrants, a cash payment of $1.1 million was made by the Company in May 2025.No warrants related to these transactions remain outstanding as of December 31, 2025.

April 2024 Warrants

A total of 62,750 warrants were issued pursuant to the April 2024 Securities Purchase Agreement (the “April 2024 Securities Purchase Agreement”), consisting of Series A, Series B, Pre-funded, and Placement Agent warrants. As of December 31, 2025, only Placement Agent warrants to purchase a total of 1,242 shares of common stock remained outstanding. The 1,242 Placement Agent Warrants issued pursuant to the Engagement Letter with the placement agent, are exercisable immediately from the date of issuance for a period of five and one half (5.5) years after the date of issuance, at an exercise price of $124.512 per warrant share.

A total of 20,704 Series A warrants and 9,988 Series B warrants were exercised during the year ended December 31, 2025. A total of 20,100 pre-funded warrants and 10,716 Series B warrants were exercised during the year ended December 31, 2024.

December 2023 Warrants

As of December 31, 2025, warrants to purchase a total of 1,750 shares of common stock issued pursuant to a securities purchase agreement in a December 2023 financing transaction remained outstanding. A total of 1,651 warrants, including 33 warrants issued in a concurrent private placement, are exercisable immediately from the date of issuance for a period of seven years after the date of issuance, at an exercise price of $765.60 per warrant share. A further 99 warrants issued in a concurrent placement agency agreement, are exercisable immediately from the date of issuance for a period of five years after the date of issuance, at an exercise price of $994.50 per warrant share.

There were no exercises of these warrants during the years ended December 31, 2025 or December 31, 2024.

December 2020 Warrants

As of December 31, 2025, warrants to purchase 186 shares of common stock issued pursuant to a securities purchase agreement in a December 2020 financing transaction remained outstanding. Each warrant shall be exercisable beginning on the 12-month anniversary of the date of issuance for a period of five years after the date of issuance, at an exercise price of $14,868 per warrant share. The exercise price of the warrants will be subject to adjustment in the event of any stock dividends and splits, reverse stock split, recapitalization, reorganization or similar transaction, as described in the warrants. The warrants may be exercised on a “cashless” basis.

There were no exercises of these warrants during the years ended December 31, 2025 or December 31, 2024.

April 2020 Warrants

As of December 31, 2025, 0 warrants issued in connection with an April 2020 equity financing remained outstanding, each with an exercise price of $18,000.

No warrants were exercised during the year ended December 31, 2025. 111 warrants were exercised during the year ended December 31, 2024.

Preferred Stock

Series B Preferred Stock

A total of 237,745 shares of the Company’s Series B Preferred Stock were issued pursuant to a December 2020 Securities Purchase Agreement. During the year ended December 31, 2024, the remaining 119,000 shares of Series B Preferred Stock were converted, at the option of the holder, into 165 shares of common stock. As of December 31, 2025, there were no remaining shares of the Series B Preferred Stock outstanding.

Series A Preferred Stock

A total of 8,872 shares of the Company’s Series A Preferred Stock were issued in a July 2017 Underwritten Public Offering. Each share of Series A Preferred Stock is convertible at any time at the option of the holder thereof, into a number of shares of common stock determined by dividing $1,000 by the initial conversion price of $600.00 per share, subject to a 4.99% blocker provision, or, upon election by a holder prior to the issuance of shares of Series A Preferred Stock, 9.99%, and is subject to adjustment for stock splits, stock dividends, distributions, subdivisions and combinations.

As of December 31, 2025 and 2024, 264 shares of the Series A Preferred Stock remain issued and outstanding. The 264 shares of Series A Preferred Stock issued and outstanding at December 31, 2025, are convertible into 2 share of common stock.

In the event of a liquidation, the holders of shares of the Series A Preferred Stock may participate on an as-converted-to-common-stock basis in any distribution of assets of the Company. The Company shall not pay any dividends on shares of common stock (other than dividends in the form of common stock) unless and until such time as dividends on each share of Series A Preferred Stock are paid on an as-converted basis. There is no restriction on the Company’s ability to repurchase shares of Series A Preferred Stock while there is any arrearage in the payment of dividends on such shares, and there are no sinking fund provisions applicable to Series A Preferred Stock.

6% Convertible Exchangeable Preferred Stock

As of December 31, 2025, there were 135,273 shares of the Company’s 6% Convertible Exchangeable, or Preferred Stock issued and outstanding at an issue price of $10.00 per share. Dividends on the Preferred Stock are cumulative from the date of original issuance at the annual rate of 6% of the liquidation preference of the Preferred Stock, and if declared, payable quarterly on the first day of February, May, August and November, commencing February 1, 2005. Any dividends must be declared by the Company’s Board of Directors and must come from funds that are legally available for dividend payments. The Preferred Stock has a liquidation preference of $10.00 per share, plus accrued and unpaid dividends.

The Company’s Board of Directors considers numerous factors in determining whether to declare the quarterly dividend pursuant to the Certificate of Designations governing the terms of the Company’s Preferred Stock, including the requisite financial analysis and determination of a surplus. As of December 31, 2025, there were no accrued and unpaid dividends.

The Preferred Stock is convertible at the option of the holder at any time into the Company’s shares of common stock at a conversion rate of approximately 0.000000069 shares of common stock for each share of Preferred Stock based on a price of $142,128,000 per share. The Company has reserved 6 shares of common stock for issuance upon conversion of the remaining shares of Preferred Stock outstanding at December 31, 2025. The shares of previously converted Preferred Stock have been retired, cancelled and restored to the status of authorized but unissued shares of preferred stock, subject to reissuance by the Board of Directors as shares of Preferred Stock of one or more series.

The Company may automatically convert the Preferred Stock into common stock if the closing price of the Company’s common stock has exceeded $213,192,000, which is 150% of the conversion price of the Preferred Stock, for at least 20 trading days during any 30-day trading period, ending within five5 trading days prior to notice of automatic conversion.

The Certificate of Designations governing the Preferred Stock provides that if the Company fails to pay dividends on its Preferred Stock for six quarterly periods, holders of Preferred Stock are entitled to nominate and elect two directors to the Company’s Board of Directors. This right accrued to the holders of Preferred Stock as of August 2, 2010 and two directors were nominated and elected at the annual meeting held on May 24, 2011.

The Preferred Stock has no maturity date and no voting rights prior to conversion into common stock, except under limited circumstances.

The Company may, at its option, redeem the Preferred Stock in whole or in part, out of funds legally available at the redemption price of $10.00 per share.

The Preferred Stock is exchangeable, in whole but not in part, at the option of the Company on any dividend payment date beginning on November 1, 2005, or Exchange Date for the Company’s 6% Convertible Subordinated Debentures, or Debentures at the rate of $10.00 principal amount of Debentures for each share of Preferred Stock. The Debentures, if issued, will mature 25 years after the Exchange Date and have terms substantially similar to those of the Preferred Stock. No such exchanges have taken place as of December 31, 2025.

For the year ended December 31, 2024, the company passed a resolution to suspend payment of the quarterly cash dividend on the Company’s 6% Convertible Exchangeable Preferred Stock (the “Preferred Stock”) scheduled for February 1, 2025.

Future NRG Sdn. Bhd. [Member]

Stockholders’ Equity

10. STOCKHOLDERS’ EQUITY

Stockholders’ Equity

28,000,000 ordinary shares are authorized, issued, and outstanding throughout all periods presented, each at RM 1.00 par value. No shares were issued, repurchased, or cancelled in Q1 2026.

Stockholders’ Equity

9.	STOCKHOLDERS’ EQUITY

Common stock: 28,000,000 shares authorized, issued, and outstanding at RM 1 (USD 0.22 at December 31, 2025) per share. No shares were issued or repurchased during FY2025 or FY2024. Each share carries one vote.

- Definition

The entire disclosure for equity.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 20
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479951/505-20-S50-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 20
-Name Accounting Standards Codification
-Section S25
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479982/505-20-S25-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480070/505-10-S50-1

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-3

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section S45
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480100/505-10-S45-3

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section S45
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480100/505-10-S45-2

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-13

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 20
-Name Accounting Standards Codification
-Section S50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479951/505-20-S50-2

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 20
-Name Accounting Standards Codification
-Section S25
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479982/505-20-S25-2

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 4
-Subparagraph (SAB Topic 4.C)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480008/505-10-S99-4

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481520/505-30-50-2

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 20
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 1.D.2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479921/505-20-S99-1

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 20
-Name Accounting Standards Codification
-Section S50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479951/505-20-S50-3

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 855
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 1.B.3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480148/855-10-S99-1

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 20
-Name Accounting Standards Codification
-Section S25
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479982/505-20-S25-3

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/505/tableOfContent

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 11
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480657/210-10-S50-11

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480237/815-40-50-5

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 8A
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-13

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-13

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 14
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-14

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 235
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477968/946-235-50-2

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 235
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477968/946-235-50-2

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 505
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478448/946-505-50-6

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480237/815-40-50-6

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-13

Reference 32: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-13

Reference 33: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 14
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-14

Reference 34: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 14
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-14

Reference 35: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 16
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-16

+ Details

Geographic and Segment Information

12 Months Ended

Dec. 31, 2025

Segment Reporting [Abstract]

Geographic and Segment Information

19. Geographic and Segment Information

Geographic information for the years ended December 31, 2025 and 2024 is as follows (in thousands):

Schedule of Geographic Information

	2025			2024
	Year Ended December 31,
	2025			2024
Revenue
United Kingdom	$	—		$	43
Malaysia		747			—
Total Revenue	$	747		$	43

Net (loss) / gain
United States	$	(1,857	)	$	(37	)
Malaysia		119			—
United Kingdom		(1,260	)		(11,175	)
Total Net Loss	$	(2,998	)	$	(11,212	)

	2025			2024
	December 31,
	2025			2024
Total Assets
United States	$	2,031		$	3,285
Malaysia		6,154			—
United Kingdom		—			809
Total Assets	$	8,185		$	4,094
Long Lived Assets, net
United States	$	(0	)	$	1
Malaysia		137
United Kingdom		—			2
Total Long Lived Assets, net	$	137		$	3

For the latter part of 2025, following the acquisition of our wholly owned subsidiary, Fitters Sdn. Bhd. (“Fitters”), the Company operated as a single1 segment engaged in the distribution of fire safety materials, equipment and fire prevention systems. Prior to the acquisition of Fitters, the Company operated as a single segment engaged in the development of innovative cancer medicines based on cell cycle, transcriptional regulation and mitosis control biology. Consistent with our operational structure, our Chief Executive Officer (CEO), as the chief operating decision maker, makes resource allocation and business process decisions globally across our consolidated business.

Managing and allocating resources at the consolidated level enables our CEO to assess the overall level of resources available and how to best deploy these resources across functions such as production, research and development, business development, or administration and research and development projects in line with our overarching long-term corporate-wide strategic goals, rather than on a geographic or some other basis. Consistent with this decision-making process, our CEO considers consolidated net loss, which is our single segment’s principal measure of segment profit and loss, when evaluating performance and allocating company-wide resources.

Significant expenses are amounts that are regularly provided to the CEO and comprise the identical captions that are reported on the consolidated statement of operations.

A summary of our consolidated net loss for the years ended December 31, 2025 and 2024 is as follows, including the significant expenses provided to and regularly reviewed by our CEO:

	2025			2024
	December 31,
	2025			2024
Revenues	$	747		$	43

Operating expenses:
Cost of sales		609			—
Research and development		848			6,655
General and administrative		7,717			5,392
Total operating expenses		9,174			12,047

Operating loss		(8,427	)		(12,004	)

Total other income (expense), net		5,436			10
Loss before taxes		(2,991	)		(11,994	)

Income tax benefit / (charge)		(7	)		782

Net loss	$	(2,998	)	$	(11,212	)

- Definition

The entire disclosure for segment reporting.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 40
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-40

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 42
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-42

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 34
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-34

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (ee)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 31
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-31

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 26C
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 26B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 15
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-15

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 41
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-41

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 21
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-21

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 21
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-21

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 15: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 48
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-48

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 270
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482964/270-10-50-1

Reference 17: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 54
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-54

Reference 18: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 47
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-47

Reference 19: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 54
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-54

Reference 20: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 47
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-47

Reference 21: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 54
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-54

Reference 22: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 47
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-47

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/280/tableOfContent

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 26
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-26

+ Details

Related Party Transactions	3 Months Ended
Related Party Transactions	Mar. 31, 2026
Future NRG Sdn. Bhd. [Member]
Related Party Transaction [Line Items]
Related Party Transactions	Related Party Transactions 14. RELATED PARTY TRANSACTIONS Administrative charges and rental billed by Fitters Diversified Berhad entities to the Company for three months period ended March 31, 2026 amounted to USD 6,673. These charges ceased upon Fitters’ effective disposal of its shareholding on March 26, 2026. The intercompany payable to Fitters was fully extinguished during Q1 2026 (see Note 12); no balance remains outstanding at March 31, 2026.

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S45
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(7)(e)(1)(i))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(2)(g)(3))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(16))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(15)(4))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(15)(3))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1

Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 970
-SubTopic 810
-Name Accounting Standards Codification
-Section 45
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477383/970-810-45-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483326/850-10-50-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483326/850-10-50-1

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483326/850-10-50-3

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(k)(2))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(k)(1))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 310
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 13
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481990/310-10-45-13

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(2)(c)(2)(i))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(2)(c)(2)(ii))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1

+ Details

- Definition

The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S45
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(2)(g)(3))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(7)(e)(3))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483326/850-10-50-1

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480990/946-20-50-2

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480990/946-20-50-5

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480990/946-20-50-6

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 235
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477968/946-235-50-2

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 235
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477968/946-235-50-2

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(2)(c))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(2)(e))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/850/tableOfContent

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483326/850-10-50-6

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483326/850-10-50-1

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483326/850-10-50-1

+ Details

Disposal of Subsidiary

3 Months Ended

12 Months Ended

Mar. 31, 2026

Dec. 31, 2025

Future NRG Sdn. Bhd. [Member]

SubsidiaryLineItems [Line Items]

Disposal of Subsidiary

12. DISPOSAL OF EQUITY INTEREST IN SUBSIDIARY

On December 22, 2025, the Company entered into a Share Sale Agreement (“SSA”) with Fitters Diversified Berhad to dispose of its entire 100% equity interest in SOH for a cash consideration of RM10,500,000 (approximately USD2.586 million). The disposal was completed in January 2026, upon which the Company derecognised its investment in SOH and recognised a loss on disposal of RM1,919,251.

On January 8, 2026, SOH allotted 46,700,000 new ordinary shares at RM 1.00 per share to Fitters Diversified Berhad for total consideration of RM 46,700,000, injected directly into SOH. As a result, the Company’s equity interest in SOH was diluted from 100% to 18.36%. The Company ceased to hold a controlling financial interest effective that date and derecognized SOH’s net assets from its balance sheet. The resultant loss on disposal of equity interest of USD1,919,251 is included within operating expenses in the Q1 2026 Statement of Operations.

On January 23, 2026, the Company completed the disposal of its remaining 18.36% equity interest (comprising 10,500,000 shares) in SOH to Fitters for RM 10,500,000 (approximately USD 2,594,167), applied as an offset against the outstanding intercompany payable. Following this disposal, the Company held no equity interest in SOH.

On March 16, 2026, Fitters Diversified Berhad issued Credit Note to unconditionally waiving all the remaining intercompany payable balance of RM 7,855,337 (USD 1,941,507). This constitutes a forgiveness of debt recognized as a gain on waiver of debt in Q1 2026. This is a non-cash transaction.

Assets and Liabilities of the Disposal

	Mar 31, 2026 (USD)
Cash and cash equivalents		3,135,050
Trade and other receivables, net		795,614
Inventories		1,039,416
Income taxes receivable		(442	)
Property and equipment, net		16,437,583
Total assets held for sale		21,407,221
Trade and other payables		2,819,424
Banker’s acceptance — short term		1,216,780
Hire purchase obligations		111,338
Amount due to ultimate holding company		12,793,920
Total liabilities held for sale		16,941,462
Net assets of the disposal		4,465,759

Disposal of Subsidiary

4.	DISPOSAL OF SUBSIDIARY

The Company holds a 100% equity interest in its subsidiary, Solid Orient Holdings Sdn. Bhd. (“SOH”) (2024: 100%), a private limited company incorporated and domiciled in Malaysia. The principal activity of SOH is the operation of a palm oil mill.

On December 22, 2025, the Company entered into the SSA with the ultimate holding company to dispose of the wholly-owned subsidiary, Solid Orient Holdings Sdn. Bhd. for RM 10,500,000 (USD 2,585,620). As at the reporting date, the disposal had not been completed. On January 23, 2026, the Company completed the disposal of its entire equity interest in Solid Orient Holdings Sdn. Bhd... The resulting gain or loss on disposal will be recognized in the Company’s financial statements for the year ending December 31, 2026. As of December 31, 2025, the subsidiary meets all the criteria to be classified as Held for Sale.

Assets and Liabilities of the Disposal

	Note	2025			2024
		(USD)			(USD)
Assets:
Cash and cash equivalents			3,135,050			1,701,167
Trade and other receivables, net			795,614			579,260
Inventories			1,039,416			609,332
Income taxes receivable			(442	)		13,880
Property and equipment, net			16,437,583			15,832,453
Total assets held for sale			21,407,221			18,736,092

Liabilities:
Trade and other payables			2,819,424			1,941,697
Banker’s acceptance — short term			1,216,780			2,039,890
Hire purchase obligations			111,338			227,849
Amount due to ultimate holding company			12,793,920			14,245,034
Total liabilities held for sale			16,941,462			18,454,470

Net assets of the Disposal			4,465,759			281,622

Results of the Disposal

	Note	2025			2024
		(USD)			(USD)
Revenue			66,623,781			54,777,343
Cost of revenues			(62,151,255	)		(52,197,437	)
Gross profit			4,472,526			2,579,906
Operating expenses			(1,903,911	)		(1,656,639	)
Income before income taxes			2,568,615			923,267
Income tax expense			(11,065	)		(2,148	)
Net income from discontinued operations			2,557,550			921,119

Discontinued operations include administrative charges billed by Fitters Diversified Berhad to SOH of USD 51,220 (FY2024: USD 16,801). These are transactions between Fitters and SOH, outside the Group’s consolidation perimeter, and are not eliminated.

Investment in Subsidiary	3 Months Ended
Investment in Subsidiary	Mar. 31, 2026
Future NRG Sdn. Bhd. [Member]
InvestmentInSubsidiaryLineItems [Line Items]
Investment in Subsidiary	4. INVESTMENT IN SUBSIDIARY Investment in Subsidiary The Company’s wholly-owned subsidiary, Solid Orient Holdings Sdn. Bhd. (“SOH”), is engaged in the operation of a palm oil mill. On 22 December 2025, the Company entered into a Share Sale Agreement (“SSA”) with Fitters Diversified Berhad to dispose of its entire 100% equity interest in Solid Orient Holdings Sdn. Bhd. (“SOH”) for a cash consideration of RM10,500,000 (approximately USD2.586 million). Consequently, SOH was classified as a discontinued operation in FY2025, with its related assets and liabilities presented as held for sale. The disposal was subsequently completed in January 2026, at which point the Group derecognised its investment in SOH and recognised a loss on disposal of USD1,919,251.

Revenue from Continuing Operations

3 Months Ended

12 Months Ended

Mar. 31, 2026

Dec. 31, 2025

RevenueFromContinuingOperationsLineItem [Line Items]

Revenue from Continuing Operations

3. Revenue

The Company recognized $743,000 of revenue for the three months ended March 31, 2026 and $0 of revenue for the three months ended March 31, 2025, respectively. Revenue relates to product revenues from sales of fire safety equipment and services within the newly acquired Malaysian based subsidiary, Fitters Sdn. Bhd.

Future NRG Sdn. Bhd. [Member]

RevenueFromContinuingOperationsLineItem [Line Items]

Revenue from Continuing Operations

10. REVENUE FROM CONTINUING OPERATIONS

Revenue from Continuing Operations

	Note	2025		2024
		(USD)		(USD)
Clinic waste generator services			640,321		671,032
Clinic waste logistics services			209,915		196,179
Other revenue			4,101		4,530
Total revenue			854,337		871,741

Revenue recognized at point in time			854,337		871,741
Geography: Malaysia			854,337		871,741

- Definition

The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-7

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-9

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-10

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 15
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-15

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-12

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-12

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-12

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-12

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-12

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-13

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Name Accounting Standards Codification
-Topic 606
-Publisher FASB
-URI https://asc.fasb.org/606/tableOfContent

+ Details

Schedule of Movement in Provision for Doubtful Debt (Details)	3 Months Ended
	Mar. 31, 2026 USD ($)
Schedule Of Movement In Provision For Doubtful Debt
Beginning balance	$ 447,000
Reduction in provision	162,000
Foreign exchange translation adjustment	(1,000)
Foreign exchange translation adjustment
Closing balance	$ 286,000

Accounts Payable and Accrued Liabilities

3 Months Ended

12 Months Ended

Mar. 31, 2026

Dec. 31, 2025

Future NRG Sdn. Bhd. [Member]

Accounts Payable and Accrued Liabilities

9. ACCOUNTS PAYABLE AND ACCRUED LIABILITIES

	Mar 31, 2026 (USD)
Trade payables		20,123
Non-trade payables and other creditors		35,509
Accrual for legal proceedings — AHT litigation (Note 13)		406,945
Deposit received from customer		14,829
Total accounts payable and accrued liabilities		477,406

8.	ACCOUNTS PAYABLE AND ACCRUED LIABILITIES

	Note	2025		2024
		(USD)		(USD)
Trade payables			3,768		24,355
Amount due to ultimate holding company			4,655,340		2,154,420
Amount due to related companies			—		838,928
Amount due to companies			—		838,928
Accrual for material litigation			405,565		368,004
Deposit received			14,774		24,578
Transportation fee payables			33,740		30,615
Total			5,113,187		3,440,900

The Company enters into various transactions with its ultimate holding company, Fitters Diversified Berhad, and other related companies within the same group in the ordinary course of business. These transactions primarily consist of payments made on behalf by the ultimate holding company and related entities for the Company’s operational expenses, statutory obligations, and administrative costs in the normal course of business. The amount due to the ultimate holding company and related companies is unsecured, interest-free, and repayable on demand. These balances represent non-trade financing provided to the Company to support its working capital requirements. No guarantees have been given or received regarding these balances.

The accrual relates to a legal provision associated with the biomass gasification plant is described in Note 13. Refer to Note 14 for details of the post-year-end settlement of the payable to Fitters Diversified Berhad.

Schedule of Business Acquisitions Pro Forma Information (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024
Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]
Pro forma revenue	$ 2,080	$ 2,053
Pro forma net loss	$ (3,191)	$ (13,333)
Pro forma net loss per share attributable to common shareholders, Basic	$ (6.57)	$ (602.02)
Pro forma net loss per share attributable to common shareholders, Diluted	$ (6.57)	$ (602.02)

Consolidated Statements of Stockholders' Equity (Deficit) (Parenthetical)	12 Months Ended
	Dec. 31, 2024
Dividend rate on convertible exchangeable preferred stock	6.00%
6% Convertible Exchangeable Preferred Stock [Member]
Dividend rate on convertible exchangeable preferred stock	6.00%

Revenue

3 Months Ended

Mar. 31, 2026

Revenue from Contract with Customer [Abstract]

3. Revenue

Inventories

3 Months Ended

12 Months Ended

Mar. 31, 2026

Dec. 31, 2025

Inventory [Line Items]

Inventories

5. Inventory

Inventory consisted of the following (in $000s):

Schedule of Inventory

	March 31,		December 31,
	2026		2025
Raw materials		238		242
Work in progress		—		134
Finished goods		709		1,008
Total inventory	$	947	$	1,384

Inventory is recorded at the lower of cost or net realizable value, where cost is measured on a first-in, first-out basis.

6. Inventory

The following is a summary of inventory at December 31, 2025 and 2024 (in thousands):

Schedule of Inventory

	December 31,		December 31,
	2025		2024
Raw Materials		242		—
Spare parts
Consumables
Work in progress		134		—
Finished goods		1,008		—
Total inventory	$	1,384	$	—

Inventory is recorded at the lower of cost or net realizable value, where cost is measured on a first-in, first-out basis.

Future NRG Sdn. Bhd. [Member]

Inventory [Line Items]

Inventories

7. INVENTORIES

Schedule of Inventory

	Mar 31, 2026 (USD)
Spare parts		66,798
Consumables		1,977
Inventories — at lower of cost and NRV		68,776

Summary of Significant Accounting Policies (Tables)

3 Months Ended

12 Months Ended

Mar. 31, 2026

Dec. 31, 2025

Schedule of Disaggregation of Revenue by Product

The following table summarizes total revenue by product for the three months ended March 31, 2026 and 2025 (in thousands):

Product	March 31, 2026		March 31, 2025
	Product revenue in $000’s for the three months ended:
Product	March 31, 2026		March 31, 2025

Fire safety equipment		754		-
Safety apparel		11		-
Maintenance & Servicing		4		-
Project - supply & installation		9		-
Total Revenue	$	778	$	-

	-		-
	Product revenue in $000’s for the year ended:
Product	December 31, 2025		December 31, 2024

Safety apparel		119		-
Fire safety equipment		603		-
Maintenance & Servicing		6		-
Project - supply & installation		20		-
Clinical trial supply		-		43
Total Revenue	$	747	$	43

Future NRG Sdn. Bhd. [Member]

Schedule of Functional and Reporting Currency

Period

Closing Rate

(RM/USD)

March 31, 2026

4.046

December 31, 2025

4.061

Balance Sheet Date	RM / USD
December 31, 2023		4.5900
December 31, 2024		4.4755
December 31, 2025		4.0610

Net Loss Per Common Share

3 Months Ended

12 Months Ended

Mar. 31, 2026

Dec. 31, 2025

Net Loss Per Common Share

4. Net Loss per Common Share

Net Loss Per Common Share

The Company calculates net loss per common share in accordance with ASC 260 “Earnings Per Share” (“ASC 260”). Basic and diluted net loss per common share was determined by dividing net loss applicable to common stockholders by the weighted average number of shares of common stock outstanding during the period.

The following potentially dilutive securities have not been included in the computation of diluted net loss per share for the three months ended March 31, 2026 and March 31, 2025, as the result would be anti-dilutive:

	March 31,		March 31,
	2026		2025
Stock options		24,827		25,253
Restricted stock units		2		136
Series A preferred stock		2		2
Series D preferred stock		—		162,588
Series E preferred stock		—		458,333
Common stock warrants		3,178		101,906
Total shares excluded from calculation		28,009		748,218

18. Net Loss Per Share Net Loss Per Common Share

Basic and diluted net loss per share attributable to common stockholders was calculated as follows:

	2025			2024
	Years ended December 31,
	2025			2024
Numerator:
Net loss	$	(2,998	)	$	(11,212	)
Dividend on convertible exchangeable preferred shares		(61	)		—
Deemed dividend on warrant exchange		(11,033	)		—
Net loss attributable to common shareholders	$	(14,092	)	$	(11,212	)

Denominator:
Weighted-average number of common shares used in loss per share – basic and diluted		2,185,075			22,314
Loss per share - basic and diluted	$	(6.45	)	$	(502.46	)

Potential dilutive securities have been excluded from the computation of diluted net loss per share as the effect would be to reduce the net loss per share. Therefore, the weighted average number of common shares outstanding used to calculate both basic and diluted net loss per share attributable to common stockholders is the same. The Company excluded the following potential common shares, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share attributable to common stockholders for the periods indicated because including them would have had an anti-dilutive effect:

	December 31,		December 31,
	2025		2024
Stock options		24,921		494
Restricted Stock Units		10		164
Series A preferred stock		2		2
Common stock warrants		3,178		117,182
Total shares excluded from calculation		28,111		117,842

Future NRG Sdn. Bhd. [Member]

Net Loss Per Common Share

11. EARNINGS/(LOSS) PER SHARE

Net Loss Per Common Share

	Note	2025			2024
		(USD)			(USD)
Net loss from continuing operations			(67,140	)		(123,433	)
Net income from discontinued operations			2,557,550			921,119
Net income (loss)			2,490,410			797,686

Weighted average shares outstanding			28,000,000			28,000,000

Earnings (loss) per share — basic and diluted (USD):
Continuing operations			(0.0024	)		(0.0044	)
Discontinued operations			0.0913			0.0329
Total			0.0889			0.0285

No potentially dilutive securities existed in either period. Basic and diluted EPS are identical.

Schedule of Assumptions Used for Fair Value of the Stock Options Granted Using Black-Scholes Option-Pricing Model (Details) - Share-Based Payment Arrangement, Option [Member] - $ / shares	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Expected term (years)		6 years
Risk free interest rate		3.995%
Volatility		93.00%
Expected dividend yield over expected term	0.00%	0.00%
Resulting weighted average grant date fair value	$ 70.79	$ 424.80
Minimum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Expected term (years)	5 years
Risk free interest rate	4.06%
Volatility	100.00%
Maximum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Expected term (years)	10 years
Risk free interest rate	4.25%
Volatility	107.00%

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (f)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(v)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(iii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(iv)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(ii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (l)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 35
-Paragraph 1D
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 35
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480483/718-10-35-3

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(ii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(01)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(02)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(03)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(04)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(ii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(01)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(02)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(03)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Disposal of Subsidiary (Tables)

3 Months Ended

12 Months Ended

Mar. 31, 2026

Dec. 31, 2025

Future NRG Sdn. Bhd. [Member]

Schedule of Disposal Group of Financial Statements

Assets and Liabilities of the Disposal

	Mar 31, 2026 (USD)
Cash and cash equivalents		3,135,050
Trade and other receivables, net		795,614
Inventories		1,039,416
Income taxes receivable		(442	)
Property and equipment, net		16,437,583
Total assets held for sale		21,407,221
Trade and other payables		2,819,424
Banker’s acceptance — short term		1,216,780
Hire purchase obligations		111,338
Amount due to ultimate holding company		12,793,920
Total liabilities held for sale		16,941,462
Net assets of the disposal		4,465,759

Assets and Liabilities of the Disposal

	Note	2025			2024
		(USD)			(USD)
Assets:
Cash and cash equivalents			3,135,050			1,701,167
Trade and other receivables, net			795,614			579,260
Inventories			1,039,416			609,332
Income taxes receivable			(442	)		13,880
Property and equipment, net			16,437,583			15,832,453
Total assets held for sale			21,407,221			18,736,092

Liabilities:
Trade and other payables			2,819,424			1,941,697
Banker’s acceptance — short term			1,216,780			2,039,890
Hire purchase obligations			111,338			227,849
Amount due to ultimate holding company			12,793,920			14,245,034
Total liabilities held for sale			16,941,462			18,454,470

Net assets of the Disposal			4,465,759			281,622

Results of the Disposal

	Note	2025			2024
		(USD)			(USD)
Revenue			66,623,781			54,777,343
Cost of revenues			(62,151,255	)		(52,197,437	)
Gross profit			4,472,526			2,579,906
Operating expenses			(1,903,911	)		(1,656,639	)
Income before income taxes			2,568,615			923,267
Income tax expense			(11,065	)		(2,148	)
Net income from discontinued operations			2,557,550			921,119

- Definition

Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 360
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482099/360-10-50-3

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 360
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3A
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482099/360-10-50-3A

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 102
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483474/205-20-55-102

Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 45
-Paragraph 11
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483475/205-20-45-11

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 103
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483474/205-20-55-103

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5C
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483499/205-20-50-5C

Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480781/205-20-S99-3

Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5C
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483499/205-20-50-5C

Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B

Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 4B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483499/205-20-50-4B

Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483499/205-20-50-3

Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483499/205-20-50-1

Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483499/205-20-50-1

+ Details

Company Overview (Details Narrative)						3 Months Ended		12 Months Ended
Company Overview (Details Narrative)	Dec. 22, 2025 USD ($)	Dec. 22, 2025 MYR (RM)	Jul. 07, 2025	May 12, 2025	Jan. 24, 2025 USD ($)	Mar. 31, 2026 USD ($)	Mar. 31, 2025 USD ($)	Dec. 31, 2025 USD ($)	Dec. 31, 2024 USD ($)
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Net losses						$ 197,000	$ 81,000	$ 2,998,000	$ 11,212,000
Accumulated deficit						454,608,000		454,411,000	439,494,000
Cash and cash equivalents						3,339,000		3,505,000	3,137,000
Reverse stock split ratio			one-for-fifteen reverse stock split	one-for-sixteen reverse stock split
Gain on deconsolidation amount					$ 5,000,000.0			4,947,000
Future NRG Sdn. Bhd. [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Net losses						45,890		(2,490,410)	(797,686)
Accumulated deficit						1,893,392		1,847,502	4,337,912
Cash and cash equivalents						$ 9,649		$ 202,716	$ 268,780
Share Sale Agreement [Member] \| Future NRG Sdn. Bhd. [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Disposal of equity interest	$ 2,586,000	RM 10,500,000

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

+ Details

- Definition

Amount of accumulated undistributed earnings (deficit).

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section S45
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480100/505-10-S45-4

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S45
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(21))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30)(a)(3))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30)(b))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Topic 852
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481372/852-10-55-10

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(2)(i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480016/944-40-65-2

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (h)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480016/944-40-65-2

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480990/946-20-50-11

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(23)(a)(4))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-04(17))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1

+ Details

Commitments and Contingencies

3 Months Ended

12 Months Ended

Mar. 31, 2026

Dec. 31, 2025

Commitments and Contingencies

13. Commitments and Contingencies

Leases

Effective March 1, 2025, the Company entered into a two year lease agreement for our corporate headquarters at Level 10, Tower 11, Avenue 5, No. 8, Jalan Kerinchi, 59200 Kuala Lumpur, Malaysia, which we believe is adequate to accommodate our business needs. The Company terminated its lease agreement for its previous headquarters in Berkely Heights, New Jersey, effective January 31, 2025. Following the acquisition of Fitters Sub on September 12, 2025, the Company has three additional facilities in Malaysia, all on short term lease agreements.

For the years ended December 31, 2025 and December 31, 2024, the Company recognized operating lease expenses of $22,335 and $82,830 respectively, including $12,813 and $9,104 respectively relating to short term lease agreements for facilities in Scotland and Malaysia. The remaining lease term as of December 31, 2025 is approximately 1.2 years for the Kuala Lumpur, Malaysia facility. The discount rate used by the Company in determining the lease liability was 12%.

The following is a summary of the Company’s future contractual obligations and commitments relating to its facilities lease as at December 31, 2025 (in thousands):

	Operating Lease
	Obligation
2026	$	18
2027		2
Thereafter		—
Total future minimum lease obligation	$	20
Less imputed interest		—
Total	$	20

Future NRG Sdn. Bhd. [Member]

Commitments and Contingencies

13. COMMITMENTS AND CONTINGENCIES

Legal Proceedings — AHT Syngas Technology NV

Case 1 (BA-22NCC-104-08/2021): AHT claimed EUR 1,783,810 for allegedly unpaid invoices relating to a coal gasification system. AHT’s claim was struck out on September 8, 2025 (non-compliance with security-for-costs order). AHT has appealed (B-02(IM)(NCC)-1992-10/2025); hearing was fixed May 14, 2026. The Company’s counterclaim of EUR 200,000 was dismissed December 1, 2025; the Company has appealed (B-02(NCC)(W)-9-01/2026). No provision has been recognized as loss is not probable.

Case 2 (BA-22NCC-57-04/2022): AHT claimed EUR 342,857 relating to a biomass gasification plant contract. Trial dates: July 31, August 14, September 25, 2026. A provision of USD 406,945 (RM 1,647,000) has been recognized since the previous financial years, representing management’s best estimate of the probable loss.

Operating Leases

Short-term operating leases with terms under twelve months qualify for the ASC 842 short-term lease exemption. Lease expense: Q1 2026 USD 2,224 (FY2025: USD 8,864). No right-of-use assets or lease liabilities are recognized.

13. COMMITMENTS AND CONTINGENCIES

Commitments and Contingencies

(a)

Going Concern

Management evaluates whether conditions and events, considered in aggregate, raise substantial doubt about the Company’s ability to continue as a going concern within the twelve-month period following the date these financial statements are issued.

For the year ended December 31, 2025, the Company reported a loss from continuing operations before income taxes of RM 271,526 (USD 66,862) compared to a loss of RM 552,425 (USD 123,433) in 2024. As at December 31, 2025, the current liabilities of continuing operations exceeded current assets of continuing operations by RM 18,373,451 (USD 4,524,366) (December 31, 2024: RM 12,362,067 (USD 2,762,164)). This working capital deficiency is primarily attributable to amounts payable to the ultimate holding company and related companies within the Fitters Diversified Berhad group, totaling RM 18,905,336 (USD 4,655,340) as of December 31, 2025 (2024: RM 19,885,572 in aggregate). Additionally, for the year ended December 31, 2025, continuing operations generated a negative operating cash flow of RM 350,174 (USD 86,228), whereas the prior year generated a positive operating cash flow of RM 784,774.

As of December 31, 2025 and 2024, the ultimate holding company, Fitters Diversified Berhad, has not made any demand for the repayment of outstanding intercompany balances. Furthermore, the ultimate holding company has formally confirmed its commitment to provide continued financial and operational support to the Company to ensure that the Company is able to meet its financial obligations and settle its liabilities as and when they fall due.

Subsequent to the reporting date, as disclosed in Note 14, the Company executed a significant reorganization and capital restructuring plan. The proceeds from this disposal of RM10,500,000 were applied toward the offset of outstanding amounts due to the ultimate holding company. Subsequent to the completion of the disposal of SOH, Fitters Diversified Berhad has in March 2026 formally and unconditionally waived approximately RM 7,855,337 (USD 1,934,289) of the balance of all outstanding amount due from the Company.

(b)

Leases

The office premises under short-term non-cancellable operating leases qualify for the ASC 842 short-term lease exemption. Lease expense for FY2025 was USD 8,864 (FY2024: USD nil). No right-of-use asset or lease liability has been recognized.

(c)

Legal Proceedings

Case 1 — Shah Alam High Court Civil Suit BA-22NCC-104-08/2021

AHT Syngas Technology NV (“AHT”) claimed EUR 1,783,810 against the Company for allegedly unpaid invoices relating to the construction of a coal gasification system. AHT’s claim was struck out on September 8, 2025 due to non-compliance with a security-for-costs order. AHT has appealed (Appeal No. B-02(IM)(NCC)-1992-10/2025); a strike-out application is fixed for hearing on May 14, 2026. AHT’s appeal is fixed for hearing before the Court of Appeal on April 28, 2027.

The Company’s counterclaim of EUR 200,000 was dismissed on December 1, 2025 and the Company has appealed (Appeal No. B-02(NCC)(W)-9-01/2026). No provision has been recognized as it is not probable that a loss has been incurred.

Case 2 — Shah Alam High Court Civil Suit BA-22NCC-57-04/2022

AHT claimed EUR 342,857 against the Company in respect of an alleged unpaid balance under a biomass gasification plant contract. The Company denies the claim and counterclaims EUR 949,000 for alleged overpayment. Trial dates have been fixed for July 31, August 14, and September 25, 2026.

The Company has recognized a provision of USD 405,566 (RM 1,647,000) as of December 31, 2025 and 2024, as it is considered probable that a loss has been incurred and the amount can be reasonably estimated. The actual loss may differ.

Employee Benefit Plans (Details Narrative) - USD ($)	12 Months Ended
Employee Benefit Plans (Details Narrative) - USD ($)	Dec. 31, 2025	Dec. 31, 2024
Defined Benefit Plan Disclosure [Line Items]
Contribution made by the entity under the 401(k) Plan	$ 333	$ 40,000
Future NRG Sdn. Bhd. [Member]
Defined Benefit Plan Disclosure [Line Items]
Contribution made by the entity under the 401(k) Plan	11,706	10,619
Compensation and Benefits Trust	97,826	86,105
Pension Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Contribution made by the entity under the pension plan	500	$ 51,000
Statutorily prescribed annual limit of contributions made by an employee before attaining age of 50 years	$ 23,500
Specified age limit of employees for calculation of statutorily prescribed annual limit of contribution	50 years
Statutorily prescribed annual limit of contributions made by an employee after attaining age of 50 years	$ 31,000
Four Hundred And One K Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Matching contribution by employer as a percentage of the employee's deferral	100.00%
Matching contribution by employer as a percentage of U.S. employee's qualifying compensation	6.00%

Approval of the Financial Statements

3 Months Ended

12 Months Ended

Mar. 31, 2026

Dec. 31, 2025

Future NRG Sdn. Bhd. [Member]

Approval of the Financial Statements

17. AUTHORIZATION OF FINANCIAL STATEMENTS

Approval of the Financial Statements

These financial statements were authorized for issuance by the Board of Directors of Future NRG Sdn. Bhd. on May 28, 2026.

16.

APPROVAL OF THE FINANCIAL STATEMENTS

These consolidated financial statements were approved and authorized for issuance by the Board of Directors of the Company on May 28, 2026.

Revenue from Continuing Operations (Tables)

12 Months Ended

Dec. 31, 2025

Future NRG Sdn. Bhd. [Member]

Schedule of Revenue from Continuing Operations

	Note	2025		2024
		(USD)		(USD)
Clinic waste generator services			640,321		671,032
Clinic waste logistics services			209,915		196,179
Other revenue			4,101		4,530
Total revenue			854,337		871,741

Revenue recognized at point in time			854,337		871,741
Geography: Malaysia			854,337		871,741

Accounts Receivables (Tables)

3 Months Ended

12 Months Ended

Mar. 31, 2026

Dec. 31, 2025

Schedule of Accounts Receivables

Accounts receivables consisted of the following (in $000s):

Schedule of Accounts Receivables

	March 31,			December 31,
	2026			2025
Accounts receivables, gross		1,474			1,704
Allowance for doubtful debt		(286	)		(447	)
Total accounts receivable, net	$	1,188		$	1,257

The following is a summary of accounts receivable at December 31, 2025 and 2024 (in thousands):

Schedule of Accounts Receivables

	December 31,		December 31,
	2025		2024
Accounts receivables		1,257		—
Total accounts receivables	$	1,257	$	—

Schedule of Movement in Provision for Doubtful Debt

Movement in provision for doubtful debt
Provision for doubtful debt as December 31, 2025		(447	)
Reduction in provision during the three months ended March 31, 2026		162
Foreign exchange translation adjustment		(1	)
Addition		-
Provision for doubtful debt as March 31, 2026	$	(286	)

Future NRG Sdn. Bhd. [Member]

Schedule of Accounts Receivables

	Mar 31, 2026 (USD)
Trade receivables, gross		615,123
Less: Allowance for expected credit losses		(313,610	)
Trade receivables, net		301,513
Other receivables		9,887
Refundable deposits		20,619
Prepayments		2,875
Total accounts receivable, net		334,894

Schedule of Accounts Receivables

	Note	2025			2024
		(USD)			(USD)
Trade receivables, gross			602,579			538,423
Less: Accumulated impairment			(312,455	)		(251,199	)
Trade receivables, net			290,124			287,224

Other receivables			9,850			17,875
Refundable deposits			20,542			18,488
Total accounts receivable, net			320,516			323,587

Movement in accumulated impairment:
Opening balance			251,199			213,421
Charge for the year			35,616			32,318
Foreign exchange translation			25,640			5,460
Closing balance			312,455			251,199

Inventory

3 Months Ended

12 Months Ended

Mar. 31, 2026

Dec. 31, 2025

Inventory Disclosure [Abstract]

Inventory

5. Inventory

Inventory consisted of the following (in $000s):

Schedule of Inventory

	March 31,		December 31,
	2026		2025
Raw materials		238		242
Work in progress		—		134
Finished goods		709		1,008
Total inventory	$	947	$	1,384

Inventory is recorded at the lower of cost or net realizable value, where cost is measured on a first-in, first-out basis.

6. Inventory

The following is a summary of inventory at December 31, 2025 and 2024 (in thousands):

Schedule of Inventory

	December 31,		December 31,
	2025		2024
Raw Materials		242		—
Spare parts
Consumables
Work in progress		134		—
Finished goods		1,008		—
Total inventory	$	1,384	$	—

Inventory is recorded at the lower of cost or net realizable value, where cost is measured on a first-in, first-out basis.

Significant Event

3 Months Ended

Mar. 31, 2026

Future NRG Sdn. Bhd. [Member]

SignificantEventLineItems [Line Items]

Significant Event

15. SIGNIFICANT EVENT

Significant Event

On 16 March 2026, the holding company, Fitters, entered into Share Sale Agreements with multiple purchasers for the disposal of 28,000,000 ordinary shares in the Company, representing its entire equity interest, for a total cash consideration of RM15,200,000, as follows:

	●	5,600,000 shares to nine individual purchasers, representing 20% of the total shareholding, for an aggregate consideration of RM3.04 million;
	●	15,400,000 shares to Perfect Energy Sdn. Bhd., representing 55% of the total shareholding, for a consideration of RM8.36 million;
	●	7,000,000 shares to Antbiz Sdn. Bhd., representing 25% of the total shareholding, for a consideration of RM3.80 million.

Upon completion of the transaction, the Company will cease to be a wholly-owned subsidiary of Fitters. There have been no additional subsequent events that would require disclosure in, or adjustment to, the parent company financial statements as of and for the year ended December 31, 2025. On March 26, 2026, the conditions precedent in the Agreements have been fulfilled and hence become unconditional. Both the Company and the Purchasers have executed the registrable forms of transfer of securities and mutually agreed that the completion is effective on March 26, 2026.

Effective March 26, 2026, Perfect Energy Sdn. Bhd. became the majority shareholder (55%) of the Company following completion of share sale agreements executed on March 16, 2026, pursuant to which Fitters Diversified Berhad disposed of its entire shareholding of 28,000,000 shares in the Company for aggregate consideration of RM 15,200,000.

No other material subsequent events requiring disclosure or adjustment have been identified.

Net Loss Per Common Share (Tables)

3 Months Ended

12 Months Ended

Mar. 31, 2026

Dec. 31, 2025

Schedule of Earnings or Loss Per Share

Basic and diluted net loss per share attributable to common stockholders was calculated as follows:

	2025			2024
	Years ended December 31,
	2025			2024
Numerator:
Net loss	$	(2,998	)	$	(11,212	)
Dividend on convertible exchangeable preferred shares		(61	)		—
Deemed dividend on warrant exchange		(11,033	)		—
Net loss attributable to common shareholders	$	(14,092	)	$	(11,212	)

Denominator:
Weighted-average number of common shares used in loss per share – basic and diluted		2,185,075			22,314
Loss per share - basic and diluted	$	(6.45	)	$	(502.46	)

Schedule of Earnings Per Share, Basic and Diluted

	March 31,		March 31,
	2026		2025
Stock options		24,827		25,253
Restricted stock units		2		136
Series A preferred stock		2		2
Series D preferred stock		—		162,588
Series E preferred stock		—		458,333
Common stock warrants		3,178		101,906
Total shares excluded from calculation		28,009		748,218

	December 31,		December 31,
	2025		2024
Stock options		24,921		494
Restricted Stock Units		10		164
Series A preferred stock		2		2
Common stock warrants		3,178		117,182
Total shares excluded from calculation		28,111		117,842

Future NRG Sdn. Bhd. [Member]

Schedule of Earnings or Loss Per Share

	Note	2025			2024
		(USD)			(USD)
Net loss from continuing operations			(67,140	)		(123,433	)
Net income from discontinued operations			2,557,550			921,119
Net income (loss)			2,490,410			797,686

Weighted average shares outstanding			28,000,000			28,000,000

Earnings (loss) per share — basic and diluted (USD):
Continuing operations			(0.0024	)		(0.0044	)
Discontinued operations			0.0913			0.0329
Total			0.0889			0.0285

Accrued and Other Liabilities (Tables)

3 Months Ended

12 Months Ended

Mar. 31, 2026

Dec. 31, 2025

Payables and Accruals [Abstract]

Schedule of Accrued and Other Current Liabilities

Accrued and other current liabilities consisted of the following (in $000s):

	March 31,		December 31,
	2026		2025
Accrued legal and professional fees	$	446	$	500
Other current liabilities		94		215
	$	540	$	715

Accrued and other current liabilities consisted of the following items as of December 31, 2025 and 2024 (in thousands):

	December 31,		December 31,
	2025		2024
Accrued research and development	$	—	$	1,299
Accrued legal and professional fees		500		87
Other current liabilities		215		283
	$	715	$	1,669

Schedule of Geographic Information (Details) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2026	Mar. 31, 2025	Dec. 31, 2025	Dec. 31, 2024
Segment Reporting [Line Items]
Total Revenue	$ 778		$ 747	$ 43
Net loss	(197)	$ (81)	(2,998)	(11,212)
Total Assets	7,564		8,185	4,094
Total Long Lived Assets, net	$ 138		137	3
UNITED KINGDOM
Segment Reporting [Line Items]
Total Revenue				43
Net loss			(1,260)	(11,175)
Total Assets				809
Total Long Lived Assets, net				2
MALAYSIA
Segment Reporting [Line Items]
Total Revenue			747
Net loss			119
Total Assets			6,154
Total Long Lived Assets, net			137
UNITED STATES
Segment Reporting [Line Items]
Net loss			(1,857)	(37)
Total Assets			2,031	3,285
Total Long Lived Assets, net			$ (0)	$ 1

- Definition

Amount of asset recognized for present right to economic benefit.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480070/505-10-S50-6

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S45
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (ee)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 30
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(11))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483499/205-20-50-7

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5A
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483499/205-20-50-5A

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 323
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481687/323-10-50-3

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 235
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-05(b)(1))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 235
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(i))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 28
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482907/825-10-50-28

Reference 16: http://www.xbrl.org/2003/role/exampleRef
-Topic 480
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 64
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481620/480-10-55-64

Reference 17: http://www.xbrl.org/2003/role/exampleRef
-Topic 944
-SubTopic 605
-Name Accounting Standards Codification
-Section 55
-Paragraph 14
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477548/944-605-55-14

Reference 18: http://www.xbrl.org/2003/role/exampleRef
-Topic 944
-SubTopic 605
-Name Accounting Standards Codification
-Section 55
-Paragraph 11
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477548/944-605-55-11

Reference 19: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 48
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-48

Reference 20: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 49
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-49

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 270
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482964/270-10-50-1

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 810
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (bb)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481203/810-10-50-3

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 810
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 25
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481231/810-10-45-25

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 27: http://www.xbrl.org/2003/role/exampleRef
-Topic 852
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481372/852-10-55-10

Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 32: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 33: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 34: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 35: http://www.xbrl.org/2003/role/exampleRef
-Topic 946
-SubTopic 830
-Name Accounting Standards Codification
-Section 55
-Paragraph 12
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479168/946-830-55-12

Reference 36: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(12))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1

Reference 37: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-04(8))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1

Reference 38: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(18))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 39: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 40: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 41: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 852
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481404/852-10-50-7

+ Details

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

+ Details

- Definition

Amount, after accumulated depreciation, depletion, and amortization, of property, plant, and equipment. Includes, but is not limited to, land and land improvement; building; machinery and equipment; furniture and fixture; and work of art, historical treasure, or similar asset classified as collection.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 360
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482099/360-10-50-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 360
-Name Accounting Standards Codification
-Section 45
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478443/942-360-45-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 360
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478451/942-360-50-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S45
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(8))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 842
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 7A
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A

Reference 8: http://www.xbrl.org/2003/role/exampleRef
-Topic 852
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481372/852-10-55-10

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(8))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1

+ Details

- Definition

Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.

+ References

+ Details

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 34
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-34

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (ee)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 31
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-31

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 30
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 30
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 30
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 30
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 26C
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 26B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 26A
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-26A

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 25
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-25

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 25
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-25

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Subparagraph (j)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 15
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-15

+ Details

Employee Benefit Plans (Tables)

3 Months Ended

12 Months Ended

Mar. 31, 2026

Dec. 31, 2025

Schedule of Employee Benefit Plans

Schedule of Statutory Contributions Relating to Directors

Future NRG Sdn. Bhd. [Member]

Schedule of Employee Benefit Plans

	Mar 31, 2026 (USD)
EPF contributions		7,083
SOCSO contributions		766
EIS contributions		88
HRDC contributions		550
Total statutory contribution expense		8,487

Schedule of Employee Benefit Plans

	Note	2025		2024
		(USD)		(USD)
Employee contributions:
EPF			9,345		5,176
SOCSO			1,013		650
EIS			116		74
HRDF			728		373
HRDC contributions			-		-
Total employee benefit plan expense			11,201		6,272

Director statutory contributions:
EPF			474		3,781
SOCSO			14		244
EIS			2		28
HRDF			15		295
HRDC contributions			-		-
Total director statutory contributions			505		4,347

Acquisition (Tables)

12 Months Ended

Dec. 31, 2025

Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]

Schedule of Goodwill

Goodwill primarily represents the value of assembled workforce and other intangible assets that cannot be individually identified and recognized as a separate intangible asset under U.S. generally accepted accounting principles and is fully deductible for tax purposes. Goodwill consisted of the following (in $000s):

Schedule of Goodwill


Balance at December 31, 2024	$	—
Goodwill on acquisition of Fitters Sdn. Bhd.		1,570
Balance at December 31, 2025	$	1,570

Schedule of Preliminary Allocation of Purchase Consideration

		-
Allocation of purchase consideration

Common Stock of BGMS (formerly CYCC) Shares O/S as of September 11, 2025		2,798,379
19.99% of BGMS (formerly CYCC) Shares issued as consideration		699,158
Stock Price as of September 11, 2025	$	6.3650
Cash consideration	$	-
Total Estimated Purchase Consideration	$	4,450,138

Cash and cash equivalents		784,090
Inventories		1,284,447
Accounts receivables		715,173
Prepaid & other current assets		464,129
Property, plant and equipment, net		129,423
Trade payables		(416,470	)
Accrued and other current liabilities		(31,571	)
Non-current liabilities - deferred tax		(48,739	)
Goodwill		1,569,656

Total Net Assets Acquired	$	4,450,138

Schedule of Business Acquisitions Pro Forma Information

	2025			2024
	Year ended December 31,
	2025			2024

Pro forma revenue	$	2,080		$	2,053
Pro forma net loss	$	(3,191	)	$	(13,333	)
Pro forma net loss per share attributable to common shareholders	$	(6.57	)	$	(602.02	)

- Definition

Tabular disclosure of goodwill.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-2

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 24
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482548/350-20-55-24

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1A
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1A

+ Details

Fair Value of Financial Assets and Liabilities

12 Months Ended

Dec. 31, 2025

Fair Value Disclosures [Abstract]

Fair Value of Financial Assets and Liabilities

5. Fair Value of Financial Assets and Liabilities

Fair Value Measurements

as of December 31, 2025 Using:

Level 1

Level 2

Level 3

Total

Assets:

Cash equivalents

—

Total Assets

—

	Level 1		Level 2		Level 3		Total
	Fair Value Measurements
	as of December 31, 2024 Using:
	Level 1		Level 2		Level 3		Total
Assets:
Cash equivalents	$	3,044	$	—	$	—	$	3,044
Total Assets	$	3,044	$	—	$	—	$	3,044

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (bbb)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 107
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482078/820-10-55-107

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 100
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482078/820-10-55-100

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6A
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2E
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6A
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6A
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6A
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6A
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 940
-SubTopic 820
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478119/940-820-50-1

+ Details

Schedule of Share Option Activity (Details) - USD ($)	3 Months Ended		12 Months Ended
Schedule of Share Option Activity (Details) - USD ($)	Mar. 31, 2026	Mar. 31, 2025	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of Options Outstanding, Granted	0	24,818
Share-Based Payment Arrangement, Option [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of Options Outstanding, Balance	24,921	494	494	595
Weighted Average Exercise Price, Balance	$ 103.04	$ 10,658.14	$ 10,658.14	$ 12,048.00
Weighted Average Remaining Contractual Term (Years)			9 years 1 month 17 days	7 years 2 months 12 days	7 years 11 months 15 days
Aggregrate Intrinsic Value, Balance
Number of Options Outstanding, Granted			24,812	52
Weighted Average Exercise Price, Granted			$ 78.92	$ 547.20
Number of Options Outstanding, Exercised
Weighted Average Exercise Price, Exercised
Number of Options Outstanding, Cancelled/forfeited			(385)	(153)
Weighted Average Exercise Price, Cancelled/forfeited			$ 9,610.52	$ 12,327.88
Number of Options Outstanding, Balance			24,921	494	595
Weighted Average Exercise Price, Balance			$ 103.04	$ 10,658.14	$ 12,048.00
Aggregrate Intrinsic Value, Balance
Number of Options Outstanding, Unvested			4
Weighted Average Exercise Price, Unvested			$ 2,094.84
Weighted Average Remaining Contractual Term (Years)			7 years 5 months 26 days
Number of Options Outstanding, Vested and exercisable			24,917
Weighted Average Exercise Price, Vested and exercisable			$ 102.72
Weighted Average Remaining Contractual Term (Years) Vested and Exerciseable			9 years 1 month 17 days
Aggregrate Intrinsic Value, Vested and Exerciseable

Submission	Jun. 16, 2026
Submission [Line Items]
Central Index Key	0001130166
Registrant Name	Bio Green Med Solution, Inc.
Form Type	S-4
Submission Type	S-4
Fee Exhibit Type	EX-FILING FEES

Schedule of Basic and Diluted Net Loss Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2026	Mar. 31, 2025	Dec. 31, 2025	Dec. 31, 2024
EARNINGS PER SHARE — basic and diluted*
Net loss	$ (197)	$ (81)	$ (2,998)	$ (11,212)
Dividend on convertible exchangeable preferred shares	$ (20)		(61)
Deemed dividend on warrant exchange			(11,033)
Net loss attributable to common shareholders			$ (14,092)	$ (11,212)
Weighted-average number of common shares used in loss per share - basic	5,458,564	365,231	2,185,075	22,314
Weighted-average number of common shares used in loss per share - diluted	5,458,564	365,231	2,185,075	22,314
Loss per share - basic			$ (6.45)	$ (502.46)
Loss per share - diluted			$ (6.45)	$ (502.46)

- Definition

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482662/260-10-50-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 4
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482705/350-40-65-4

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (e)(4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479719/606-10-65-2

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-1

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-4

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 105
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 9
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479343/105-10-65-9

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 17
-Subparagraph (d)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480336/718-10-65-17

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-6

Reference 11: http://www.xbrl.org/2003/role/exampleRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 52
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482635/260-10-55-52

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 60
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476176/805-60-65-1

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 323
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478666/740-323-65-2

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-3

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 15
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482635/260-10-55-15

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (e)(4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480175/815-40-65-1

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480175/815-40-65-1

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-11

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-11

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-7

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482689/260-10-45-2

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 60B
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482689/260-10-45-10

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(25))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(27))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(23))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482689/260-10-45-7

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 65
-Paragraph 4
-Subparagraph (f)(4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481538/470-20-65-4

+ Details

- Definition

The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482662/260-10-50-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 4
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482705/350-40-65-4

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (e)(4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479719/606-10-65-2

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-1

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-4

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 105
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 9
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479343/105-10-65-9

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 17
-Subparagraph (d)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480336/718-10-65-17

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-6

Reference 11: http://www.xbrl.org/2003/role/exampleRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 52
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482635/260-10-55-52

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 60
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476176/805-60-65-1

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 323
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478666/740-323-65-2

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-3

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 15
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482635/260-10-55-15

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (e)(4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480175/815-40-65-1

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480175/815-40-65-1

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-11

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-11

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-7

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482689/260-10-45-2

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 60B
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(25))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(27))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(23))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482689/260-10-45-7

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 65
-Paragraph 4
-Subparagraph (f)(4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481538/470-20-65-4

+ Details

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

+ Details

- Definition

Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.

+ References + Details

Inventory (Tables)

3 Months Ended

12 Months Ended

Mar. 31, 2026

Dec. 31, 2025

Inventory Disclosure [Abstract]

Schedule of Inventory

Inventory consisted of the following (in $000s):

Schedule of Inventory

	March 31,		December 31,
	2026		2025
Raw materials		238		242
Work in progress		—		134
Finished goods		709		1,008
Total inventory	$	947	$	1,384

The following is a summary of inventory at December 31, 2025 and 2024 (in thousands):

Schedule of Inventory

	December 31,		December 31,
	2025		2024
Raw Materials		242		—
Spare parts
Consumables
Work in progress		134		—
Finished goods		1,008		—
Total inventory	$	1,384	$	—

Prepaid Expenses and Other Current Assets

3 Months Ended

12 Months Ended

Mar. 31, 2026

Dec. 31, 2025

Prepaid Expenses And Other Current Assets

Prepaid Expenses and Other Current Assets

7. Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consisted of the following (in $000s):

	March 31,		December 31,
	2026		2025
Prepayments		54		6
Other current assets		94		104
	$	148	$	110

8. Prepaid Expenses and Other Assets

The following is a summary of prepaid expenses and other current assets at December 31, 2025 and 2024 (in thousands):

	December 31,		December 31,
	2025		2024
Prepayments		6		212
Other current assets		104		325
	$	110	$	537

Schedule of Accrued and Other Current Liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2026	Dec. 31, 2025	Dec. 31, 2024
Payables and Accruals [Abstract]
Accrued research and development			$ 1,299
Accrued legal and professional fees	$ 446	500	87
Other current liabilities	94	215	283
Accrued and other current liabilities	$ 540	$ 715	$ 1,669

Prepaid Expenses and Other Current Assets (Tables)

3 Months Ended

12 Months Ended

Mar. 31, 2026

Dec. 31, 2025

Prepaid Expenses And Other Current Assets

Schedule of Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consisted of the following (in $000s):

	March 31,		December 31,
	2026		2025
Prepayments		54		6
Other current assets		94		104
	$	148	$	110

The following is a summary of prepaid expenses and other current assets at December 31, 2025 and 2024 (in thousands):

	December 31,		December 31,
	2025		2024
Prepayments		6		212
Other current assets		104		325
	$	110	$	537

Accrued and Other Liabilities

3 Months Ended

12 Months Ended

Mar. 31, 2026

Dec. 31, 2025

Payables and Accruals [Abstract]

Accrued and Other Liabilities

9. Accrued and Other Liabilities

Accrued and other current liabilities consisted of the following (in $000s):

	March 31,		December 31,
	2026		2025
Accrued legal and professional fees	$	446	$	500
Other current liabilities		94		215
	$	540	$	715

12. Accrued and Other Current Liabilities Accrued and Other Liabilities

Accrued and other current liabilities consisted of the following items as of December 31, 2025 and 2024 (in thousands):

	December 31,		December 31,
	2025		2024
Accrued research and development	$	—	$	1,299
Accrued legal and professional fees		500		87
Other current liabilities		215		283
	$	715	$	1,669

Revenue from Services	3 Months Ended
Revenue from Services	Mar. 31, 2026
Future NRG Sdn. Bhd. [Member]
RevenueFromServicesLineItems [Line Items]
Revenue from Services	11. REVENUE FROM SERVICES Revenue from Services Revenue comprises clinical waste generator services and transportation and logistics services. Revenue is recognised at a point in time when control of the services is transferred to the customer, which generally occurs upon completion of the contracted service. All revenue is denominated in Malaysian Ringgit (“RM”) and is generated from customers located in Malaysia. For the three months ended 31 March 2026, one customer accounted for approximately 68% of the Company’s total revenue (FY2025: approximately 70%), resulting in a significant concentration of credit and business risk.

Disposal of Subsidiary (Details Narrative)				3 Months Ended		12 Months Ended
Disposal of Subsidiary (Details Narrative)	Jan. 08, 2026 MYR (RM) RM / shares shares	Dec. 22, 2025 USD ($)	Dec. 22, 2025 MYR (RM)	Mar. 31, 2026 USD ($)	Mar. 31, 2025 USD ($)	Dec. 31, 2025 USD ($)	Dec. 31, 2024 USD ($)	Mar. 16, 2026 USD ($)	Mar. 16, 2026 MYR (RM)	Jan. 23, 2026 USD ($) shares	Jan. 23, 2026 MYR (RM) shares	Dec. 22, 2025 MYR (RM)
DisposalOfSubsidiaryLineItem [Line Items]
Depreciation expense				$ 1,000		$ 5,000	$ 6,000
Future NRG Sdn. Bhd. [Member]
DisposalOfSubsidiaryLineItem [Line Items]
Discontinued operations include administrative charges						51,220	16,801
Cash consideration						3,135,050	1,701,167
Loss on disposal of equity interest in subsidiary		$ 1,919,251		1,919,251
Depreciation expense				$ 48,114		$ 191,982	$ 173,709
Future NRG Sdn. Bhd. [Member] \| Common Stock [Member]
DisposalOfSubsidiaryLineItem [Line Items]
Shares issued \| shares	46,700,000
Ordinary shares per share \| RM / shares	RM 1.00
Future NRG Sdn. Bhd. [Member] \| Share Sale Agreement [Member]
DisposalOfSubsidiaryLineItem [Line Items]
Disposal of equity interest		2,586,000	RM 10,500,000
Cash consideration		$ 2,586,000						$ 1,941,507	RM 7,855,337	$ 2,594,167	RM 10,500,000	RM 10,500,000
Shares issued \| shares										10,500,000	10,500,000
Future NRG Sdn. Bhd. [Member] \| Share Sale Agreement [Member] \| FITTERS Diversified Berhad [Member]
DisposalOfSubsidiaryLineItem [Line Items]
Total consideration \| RM	RM 46,700,000
Solid Orient Holdings [Member] \| Future NRG Sdn. Bhd. [Member]
DisposalOfSubsidiaryLineItem [Line Items]
Ownership percentage		100.00%				100.00%	100.00%					100.00%
FITTERS Diversified Berhad [Member] \| Future NRG Sdn. Bhd. [Member]
DisposalOfSubsidiaryLineItem [Line Items]
Ownership percentage		100.00%								18.36%	18.36%	100.00%
FITTERS Diversified Berhad [Member] \| Future NRG Sdn. Bhd. [Member] \| Minimum [Member]
DisposalOfSubsidiaryLineItem [Line Items]
Ownership percentage	100.00%
FITTERS Diversified Berhad [Member] \| Future NRG Sdn. Bhd. [Member] \| Maximum [Member]
DisposalOfSubsidiaryLineItem [Line Items]
Ownership percentage		18.36%										18.36%

Schedule of Functional and Reporting Currency (Details)	Mar. 31, 2026	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Future NRG Sdn. Bhd. [Member]
FunctionalAndReportingCurrencyLineItem [Line Items]
Foreign Currency Exchange Rate, Translation	4.046	4.0610	4.4755	4.5900

Summary of Significant Accounting Policies (Policies)

3 Months Ended

12 Months Ended

Mar. 31, 2026

Dec. 31, 2025

Use of Estimates

Use of Estimates

The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities and related disclosures of contingent assets and liabilities at the date of the financial statements and the reported expenses during the reporting period. Critical estimates include inputs used to determine clinical trial accruals and stock-based compensation expense. The Company reviews its estimates on an ongoing basis. The estimates are based on historical experience and on various other assumptions that the Company believes to be reasonable under the circumstances. Actual results may differ from these estimates. The Company believes the judgments and estimates required by the following accounting policies to be significant in the preparation of the Company’s consolidated financial statements.

Foreign Currency and Currency Translation

Foreign Currency and Currency Translation

Transactions that are denominated in a foreign currency are remeasured into the functional currency at the current exchange rate on the date of the transaction. Any foreign currency-denominated monetary assets and liabilities are subsequently remeasured at current exchange rates, with gains or losses recognized as foreign exchange (losses) gains in the statement of operations. This accounting policy is also applied to foreign currency denominated intercompany payables or receivables for which settlement is planned or anticipated in the foreseeable future.

Through January 24, 2025, the assets and liabilities of the Company’s international subsidiary Cyclacel Limited were translated from its functional currency into United States dollars at exchange rates prevailing at the balance sheet date. Average rates of exchange during the period are used to translate the statement of operations, while historical rates of exchange are used to translate any equity transactions. Translation adjustments arising on consolidation due to differences between average rates and balance sheet rates, as well as unrealized foreign exchange gains or losses arising from translation of intercompany loans for which settlement is not planned or anticipated in the foreseeable future and that are of a long-term-investment nature, were recorded in other comprehensive loss.

Following the acquisition of Fitters Sdn. Bhd, the assets and liabilities this subsidiary have been translated from its functional currency into United States dollars at exchange rates prevailing at the balance sheet date. Average rates of exchange during the period are used to translate the statement of operations, while historical rates of exchange are used to translate any equity transactions. Translation adjustments arising on consolidation due to differences between average rates and balance sheet rates, as well as unrealized foreign exchange gains or losses arising from translation were recorded in other comprehensive loss

Foreign Currency and Currency Translation

The assets and liabilities of the Company’s international subsidiaries are translated from its functional currency into United States dollars at exchange rates prevailing at the balance sheet date. Average rates of exchange during the period are used to translate the statement of operations, while historical rates of exchange are used to translate any equity transactions. Translation adjustments arising on consolidation due to differences between average rates and balance sheet rates, as well as unrealized foreign exchange gains or losses arising from translation of intercompany loans for which settlement is not planned or anticipated in the foreseeable future and that are of a long-term-investment nature, are recorded in other comprehensive loss.

In 2025, the Company deconsolidated a foreign operation based in the United Kingdom. Upon loss of control of the foreign subsidiary, the accumulated translation adjustments recorded in other comprehensive income within equity were recycled as part of the gain on deconsolidation of former subsidiary.

Cash and Cash Equivalents

Cash and Cash Equivalents

Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash and cash equivalents. The Company considers all highly liquid investments with an original maturity of three months or less at the time of initial purchase to be cash equivalents. The objectives of the Company’s cash management policy are to safeguard and preserve funds, to maintain sufficient liquidity to meet the Company’s cash flow requirements and to attain a market rate of return. The Company deposits its cash in financial institutions that it believes have high credit quality and has not experienced any losses on such accounts and does not believe it is exposed to any significant credit risk on cash and cash equivalents.

The Company’s cash and cash equivalents balance at December 31, 2025 was $3.5 million and it maintains its cash accounts in several entities both within the United States as well as Malaysia and the United Kingdom. The cash balances for amounts held in the United States are insured by the Federal Deposit Insurance Corporation, or FDIC up to $250,000 per account. The Company has cash balances exceeding the balance insured by the FDIC that totaled approximately $0.1 million at December 31, 2025. The cash balances for amounts held in the United Kingdom are insured by the UK Government Financial Services Compensation Scheme, or FSCS up to £85,000 per account. The Company does not have cash balances exceeding the balance insured by the FSCS at December 31, 2025.

Property and equipment

Property and Equipment

The components of property and equipment are stated at cost and depreciated on a straight-line basis over the estimated useful lives of the related assets, which are generally 3three to five years. Amortization of leasehold improvements is performed using the straight-line method over the shorter of the remaining lease term or the estimated useful life of the related assets. Upon sale or retirement of assets, the costs and related accumulated depreciation and amortization are removed from the balance sheet and the resulting gain or loss on sale is reflected as a component of operating income or loss. Expenditures for maintenance and repairs are charged to operating expenses as incurred.

Impairment of Long-lived Assets

Impairment of Long-lived Assets

The Company reviews property and equipment for impairment whenever events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable. The Company assesses the recoverability of the potentially affected long-lived assets by determining whether the carrying value of such assets can be recovered through undiscounted future operating cash flows.

Impairment, if any, is measured as the amount by which the carrying amount of a long-lived asset or asset group exceeds its fair value.

Goodwill

Goodwill

Goodwill represents the cost of acquired businesses in excess of the fair value of net identifiable assets acquired. Goodwill is not amortized but is tested for impairment on an annual basis on July 1 of each fiscal year, or more frequently if events or changes in circumstances indicate that the carrying amount of a reporting unit exceeds its fair value. The quantitative goodwill impairment test compares the fair value of a reporting unit with its carrying amount. If the fair value of the reporting unit exceeds its carrying amount, goodwill is considered not impaired. If the carrying amount of a reporting unit exceeds its fair value, an impairment loss is recognized in an amount equal to that excess, not to exceed the total amount of goodwill allocated to that reporting unit.

The Company operates in a single operating segment and has just one reporting unit. The Company did not perform a goodwill impairment test in 2025 as the goodwill recognized in the financial statements resulted from the September 2025 acquisition of FITTERS, and there were no events or changes in circumstances indicating that the carrying amount of the goodwill was not recoverable in the few months post-acquisition.

Fair Value of Financial Instruments

Fair Value of Financial Instruments

Financial instruments consist of cash equivalents, accounts payable and accrued liabilities. The carrying amounts of cash equivalents, accounts payable and accrued liabilities approximate their respective fair values due to the nature of the accounts and their short maturities.

Fair Value of Financial Instruments

Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. Assets and liabilities measured at fair value are classified and disclosed in one of the following three levels of the fair value hierarchy, of which the first two are considered observable and the last is considered unobservable:

	●	Level 1 — Quoted prices in active markets for identical assets or liabilities.
	●	Level 2 — Observable inputs (other than Level 1 quoted prices), such as quoted prices in active markets for similar assets or liabilities, quoted prices in markets that are not active for identical or similar assets or liabilities, or other inputs that are observable or can be corroborated by observable market data.
	●	Level 3 — Unobservable inputs that are supported by little or no market activity that are significant to determining the fair value of the assets or liabilities, including pricing models, discounted cash flow methodologies and similar techniques.

The carrying values of cash and cash equivalents, accounts receivables, accounts payable and accrued expenses approximate their fair values due to the short-term nature of these assets and liabilities.

Segments

Segments

The Company is managed and operated as one business which is currently focused on the sale and distribution of fire safety materials, equipment and fire prevention systems. The entire business is managed by a single management team that reports to the Chief Executive Officer. Similarly, the Company’s legacy operations within the biotechnology industry was also managed entirely by a single management team that reported into the Chief Executive Officer. The Company has not operated separate lines of business with respect to any of its operations and the Company did not prepare discrete financial information with respect to separate products or product candidates or by location through March 31, 2026. Accordingly, the Company views its current business as one reportable operating segment with operations in one geographic area, namely Malaysia.

Segments

The Company is managed and operated as one business which is currently focused on the sale and distribution of fire safety materials, equipment and fire prevention systems. The entire business is managed by a single management team that reports to the Chief Executive Officer. Similarly, the Company’s legacy operations within the biotechnology industry were also managed entirely by a single management team that reported into the Chief Executive Officer. The Company has not operated separate lines of business with respect to any of its operations and the Company did not prepare discrete financial information with respect to separate products or product candidates separate businesses or by location through December 31, 2025. Accordingly, the Company views its current business as one reportable operating segment with operations in one geographic area, namely Malaysia. In 2024, the Company viewed its legacy business also as one reportable operating segment with operations in the United Kingdom and United States of America.

Revenue recognition

Revenue Recognition

Overview

The Company recognizes revenue in accordance with Accounting Standards Codification (ASC) 606, Revenue from Contracts with Customers. The Company derives revenue primarily from the sale of various protective and fire safety equipment.

Nature of Goods and Services

The Company’s revenue is generated from the sale of tangible products, including:

	●	Fire safety equipment and extinguishers;
	●	Foam system;
	●	Fire resistant doors; and
	●	Personal Protective Equipment (PPE) and Fire Safety Apparel.

All products are sold directly to customers (e.g., municipalities, fire contractors, distributors and individuals).

Disaggregation of Revenue

The Company disaggregates revenue by product category, which the Company believes best depicts how the nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factors.

The following table summarizes total revenue by product for the three months ended March 31, 2026 and 2025 (in thousands):

Product	March 31, 2026		March 31, 2025
	Product revenue in $000’s for the three months ended:
Product	March 31, 2026		March 31, 2025

Fire safety equipment		754		-
Safety apparel		11		-
Maintenance & Servicing		4		-
Project - supply & installation		9		-
Total Revenue	$	778	$	-

Performance Obligations

The Company’s contracts with customers generally include a single performance obligation, which is the promise to transfer the purchased products to the customer.

The Company satisfies its performance obligations at a point in time when control of the products transfers to the customer. Control typically transfers upon delivery, depending on the contractual delivery terms.

Revenue Recognition

Overview

Nature of Goods and Services

The Company’s revenue is generated from the sale of tangible products, including:

	●	Fire safety equipment and extinguishers;
	●	Foam system;
	●	Fire resistant doors; and
	●	Personal Protective Equipment (PPE) and Fire Safety Apparel.

All products are sold directly to customers (e.g., municipalities, fire contractors, distributors and individuals).

Disaggregation of Revenue

The following table summarizes total revenue by product for the years ended December 31, 2025 and 2024 (in thousands):

	-		-
	Product revenue in $000’s for the year ended:
Product	December 31, 2025		December 31, 2024

Safety apparel		119		-
Fire safety equipment		603		-
Maintenance & Servicing		6		-
Project - supply & installation		20		-
Clinical trial supply		-		43
Total Revenue	$	747	$	43

In addition, the Company recognized $43,000 of revenue for the year ended December 31, 2024. This revenue relates to recovery of clinical manufacturing costs associated with an investigator sponsored study managed by Cedars-Sinai Medical Center (“CSMC”). There were $0 revenues recognized for the comparative period in 2025. All revenues from this customer were recognized at the point in time that the related clinical supply were transferred to CSMC and CSMC obtains control over the goods. The arrangements with CSMC comprise a single performance obligation.

The Company invoiced CSMC following the transfer of the clinical supply and provided CSMC with typical payment terms. The Company collected all amounts due from CSMC. As of December 31, 2025 and December 31, 2024, the Company has not recognized any accounts receivable from CSMC, credit loss allowances, contract assets, contract liabilities, or warranty provisions. There were no remaining performance obligations outstanding as of December 31, 2025.

Performance Obligations

The Company’s contracts with customers generally include a single performance obligation, which is the promise to transfer the purchased products to the customer.

Transaction Price and Variable Consideration

Transaction Price and Variable Consideration

The transaction price is generally the stated contract price for the products sold. The Company’s contracts may include variable consideration in the form of discounts, price concessions, or other incentives.

Variable consideration is estimated using the method that best predicts the amount of consideration to which the Company expects to be entitled and is included in revenue only to the extent that it is probable that a significant reversal of cumulative revenue recognized will not occur.

Transaction Price and Variable Consideration

Contract Balances

Contract Balances

Contract assets represent the Company’s right to consideration in exchange for goods transferred to customers when that right is conditioned on something other than the passage of time. Contract liabilities represent amounts billed or collected from customers in advance of satisfying performance obligations.

Contract assets and contract liabilities are not material to the business. Accounts receivable, before allowance for doubtful debt was $1,474,000 and $1,257,000, as of March 31, 2026 and December 31, 2025, respectively.

Contract Balances

Contract assets and contract liabilities are not material to the business. Accounts receivable as of January 1, 2024 and 2025 was $0. Accounts receivable, before allowance for doubtful debt as of December 31, 2025 was $1,588,000.

Significant Payment Terms

Significant Payment Terms

The Company’s payment terms vary by customer and contract but generally require payment within 30–60 days from the invoice date. The Company does not have significant financing components in its contracts, as the period between the transfer of goods and customer payment is typically less than one year.

Significant Payment Terms

Warranties

Warranties

The Company provides assurance-type warranties that its products comply with agreed-upon specifications and are free from defects for a specified period. These warranties do not represent separate performance obligations Such warranty reserves are immaterial.

Warranties

Returns and Refunds

Returns and Refunds

The Company may allow customers to return products if they are deemed faulty or otherwise not fit for purpose. Expected returns are estimated and recorded as a reduction of revenue, with a corresponding refund liability and right-of-return asset.

The level of returns is of an immaterial value.

Returns and Refunds

The level of returns is of an immaterial value.

Practical Expedients and Policy Elections

Practical Expedients and Policy Elections

The Company applies practical expedient to expense incremental costs of obtaining a contract, such as commissions, when the amortization period would have been one year or less.

Practical Expedients and Policy Elections

The Company applies the practical expedient to expense incremental costs of obtaining a contract, such as commissions, when the amortization period would have been one year or less.

Remaining Performance Obligations

Remaining Performance Obligations

The Company’s performance obligations are generally satisfied within one year. As a result, the Company has elected the practical expedient not to disclose the value of remaining performance obligations.

Remaining Performance Obligations

Other Income

Other Income

Other income is primarily related to royalty income received under a historical Asset Purchase Agreement for activities which are not part of the Company’s ongoing operations and activities.

Leases

Leases

The Company accounts for lease contracts in accordance with ASC 842. As of March 31, 2026, the Company’s outstanding leases are classified as operating leases.

The Company recognizes an asset for the right to use an underlying leased asset for the lease term and records lease liabilities based on the present value of the Company’s obligation to make lease payments under the lease. As the Company’s leases do not indicate an implicit rate, the Company uses a best estimate of its incremental borrowing rate to discount the future lease payments. The Company estimates its incremental borrowing rate based on observable information about risk-free interest rates that are the same tenure as the lease term, adjusted for various factors, including the effects of assumed collateral, the nature of how the loan is repaid (e.g., amortizing versus bullet), and the Company’s credit risk.

The Company evaluates lessee-controlled options included in its lease agreements to extend or terminate the lease. The Company will reflect the effects of exercising those options in the lease term when it is reasonably certain that the Company will exercise that option. In assessing whether it is reasonably certain that the Company will exercise an option, the Company considers factors such as:

	●	The lease payments due in any optional period;

	●	Penalties for failure to exercise (or not exercise) the option;

	●	Market factors, such as the availability of similar assets and current rental rates for such assets;

	●	The nature of the underlying leased asset and its importance to the Company’s operations; and

	●	The remaining useful lives of any related leasehold improvements.

Lease expense for operating leases is recognized on a straight-line basis over the lease term. Variable lease payments, if any, are recognized in the period when the obligation to make those payments is incurred. Lease incentives received prior to lease commencement are recorded as a reduction in the right-of-use asset. Fixed lease incentives received after lease commencement reduce both the lease liability and the right-of-use asset.

The Company has elected an accounting policy to account for the lease and non-lease components as a single lease component.

Leases

The Company accounts for lease contracts in accordance with ASC 842. As of December 31, 2025 and 2024, all of the Company’s leases are classified as operating leases.

The Company recognizes an asset for the right to use an underlying leased asset for the lease term and records lease liabilities based on the present value of the Company’s obligation to make lease payments under the lease. As the Company’s leases do not indicate an implicit rate, the Company uses a best estimate of its incremental borrowing rate to discount the future lease payments. The Company estimates its incremental borrowing rate based on observable information about risk-free interest rates that are the same tenure as the lease term, adjusted for various factors, including the effects of assumed collateral, the nature of how a loan would be repaid (e.g., amortizing versus bullet), and the Company’s credit risk.

The Company evaluates options included in its lease agreements to extend or terminate the lease. The Company will reflect the effects of exercising those options in the lease term when it is reasonably certain that the Company will exercise that option. In assessing whether it is reasonably certain that the Company will exercise an option, the Company considers factors such as:

	●	The lease payments due in any optional period;
	●	Penalties for failure to exercise (or not exercise) the option;
	●	Market factors, such as the availability of similar assets and current rental rates for such assets;
	●	The nature of the underlying leased asset and its importance to the Company’s operations; and
	●	The remaining useful lives of any related leasehold improvements.

Lease expense for the Company’s operating leases is recognized on a straight-line basis over the lease term and is reported as a component of general and administrative expense. Variable lease payments, if any, are recognized in the period when the obligation to make those payments is incurred. Lease incentives received prior to lease commencement are recorded as a reduction in the right-of-use asset. Fixed lease incentives received after lease commencement reduce both the lease liability and the right-of-use asset.

The Company has elected an accounting policy to account for the lease and non-lease components as a single lease component.

Stock-based Compensation

Stock-based Compensation

The Company measures all stock options and other stock-based awards granted to employees, consultants, and directors based on the fair value on the date of the grant and recognizes compensation expense of those awards over the requisite service period, which for the Company is the period between the grant date and the date the award vests or becomes exercisable. Many awards granted by the Company vest ratably over three or four years. However, certain awards granted to members of the Company’s Board of Directors vest in their entirety on the one-year anniversary following the date of grant. Generally, the Company issues stock options and restricted stock awards to employees or consultants with only service-based vesting conditions and records the expense for these awards using the straight-line method. However, in certain years, the Company will grant share-based payment awards to employees or consultants that are dependent upon the fulfillment of certain clinical and financial conditions. In such instances where the performance condition must be met for the award to vest, the company only recognizes compensation expense when the award is probable of vesting (See Note 15 — Stock-Based Compensation).

The Company classifies stock-based compensation expenses in its statement of operations in the same manner in which the award recipient’s payroll costs are classified. The Company accounts for forfeitures as they occur.

The fair value of restricted stock and restricted stock units is determined based on the number of shares granted and the quoted price of the Company’s common stock on the date of grant. The determination of grant-date fair value for stock option awards is estimated using the Black-Scholes model, which includes variables such as the expected volatility of the Company’s share price, expected term of the award, interest rates, and dividend yields.

The Company relies on its historical volatility as an input to the option pricing model as management believes that this rate will be representative of future volatility over the expected term of the options.

The expected term assumption is estimated using past history of early exercise behavior and expectations about future behaviors.

The weighted average risk-free interest rate represents the interest rate for treasury constant maturities published by the Federal Reserve Board. If the term of available treasury constant maturity instruments is not equal to the expected term of an employee option, The Company interpolates a discount rate based on the two Federal Reserve securities closest to the expected term of the employee option.

The expected dividend yield is zero, as the Company has never paid cash dividends on common stock and does not expect to pay any cash dividends on common stock in the foreseeable future.

Income taxes

Income Taxes

The Company accounts for income taxes using the liability method. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to affect taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amounts expected to be realized.

The Company accounts for uncertainty in income taxes recognized in the financial statements by applying a two-step process to determine the amount of tax benefit to be recognized. First, the tax position must be evaluated to determine the likelihood that it will be sustained upon external examination by the taxing authorities. If the tax position is deemed more-likely-than-not-to be sustained, the tax position is then assessed to determine the amount of benefit to recognize in the financial statements. The amount of the benefit that may be recognized is the largest amount that has a greater than 50% likelihood of being realized upon ultimate settlement. The provision for income taxes includes the effects of any resulting tax reserves for unrecognized tax benefits that are considered appropriate as well as the related net interest and penalties.

The Company records research and development tax credits within income taxes. Credit is taken in the accounting period for research and development tax credits, when claimed from H.M. Revenue & Customs, or HMRC, the United Kingdom’s taxation and customs authority, in respect of qualifying research and development costs incurred in the same accounting period.

Loss Per Share

Net Loss Per Common Share

The Company calculates net loss per common share in accordance with ASC 260 “Earnings Per Share”. Basic and diluted net loss per common share was determined by dividing the net loss applicable to common stockholders by the weighted average number of common shares outstanding during the period.

In periods in which the Company reports a net loss attributable to common stockholders, diluted net loss per share attributable to common stockholders is the same as basic net loss per share attributable to common stockholders since potentially dilutive common shares are not assumed to have been issued if their effect is anti-dilutive. The Company reported a net loss attributable to common stockholders for the years ended December 31, 2025 and 2024.

Comprehensive Income (Loss)

Comprehensive Income (Loss)

All components of comprehensive income (loss), including net income (loss), are reported in the financial statements in the period in which they are recognized. Comprehensive income (loss) is defined as the change in equity during a period from transactions and other events and circumstances from non-owner sources. Net income (loss) and other comprehensive income (loss), including foreign currency translation adjustments, are reported, net of any related tax effect, to arrive at comprehensive income (loss). No taxes were recorded on items of other comprehensive income (loss). There were no reclassifications out of other comprehensive income (loss) during the three months ended March 31, 2026, and 2025 except that upon deconsolidation of the Company’s formerly wholly-owned United Kingdom based subsidiary on January 24, 2025, $0.9 million of accumulated comprehensive income (loss) was reclassified into earnings as part of the gain on deconsolidation, which is presented as a component of discontinued operations in the consolidated statements of operations

Comprehensive Income (Loss)

All components of comprehensive income (loss), including net income (loss), are reported in the financial statements in the period in which they are recognized. Comprehensive income (loss) is defined as the change in equity during a period from transactions and other events and circumstances from non-owner sources. Net income (loss) and other comprehensive income (loss), including foreign currency translation adjustments, are reported to arrive at comprehensive income (loss). There were no reclassifications out of other comprehensive income (loss) during the year ended December 31, 2024. In 2025, the Company deconsolidated a foreign operation based in the United Kingdom. Upon loss of control of the foreign subsidiary, the accumulated translation adjustments recorded in other comprehensive income within equity were recycled as part of the gain on deconsolidation of former subsidiary.

Recently Issued Accounting Pronouncements

Recently Issued Accounting Pronouncements

The FASB has issued ASU 2024-03, “Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses”. This standard will require all public entities to disclose additional information about specific expense categories in the notes to financial statements at interim and annual reporting periods. The amendments in ASU 2024-03 are effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. ASU 2024-03 will not change the way in which expenses are recognized or measured. However, the Company is currently evaluating the effects of ASU 20243-03 on its financial statement presentation and disclosures.

Recently Issued Accounting Pronouncements

The FASB has issued ASU 2024-03, “Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses”, as amended by ASU 2025-01, “Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Clarifying the Effective Date”. This standard will require all public entities to disclose additional information about specific expense categories in the notes to financial statements at interim and annual reporting periods. The amendments in ASU 2024-03 are effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. ASU 2024-03 will not change the way in which expenses are recognized or measured. However, the Company is currently evaluating the effects of ASU 2023-07 on its financial statement presentation and disclosures.

Policies Prior to the Disposition of Pharmaceutical Development Business

Research and Development Costs

Research and Development Costs

Research and development expenses consist primarily of costs associated with the development of the Company’s product candidates, including upfront fees, milestones, compensation and other expenses for research and development personnel, supplies and development materials, costs for consultants and related contract research, facility costs and depreciation. Expenditures relating to research and development are expensed as incurred.

Clinical Trial Accounting

Clinical Trial Accounting

Data management and monitoring of the Company’s clinical trials are performed with the assistance of contract research organizations, or CROs or clinical research associates, or CRAs in accordance with the Company’s standard operating procedures. Typically, CROs and CRAs bill monthly for services performed, and others bill based upon milestones achieved. The Company accrues unbilled clinical trial expenses based on estimates of the level of services performed each period. Clinical trial costs related to patient enrollment are accrued as patients are entered into and progress through the trial.

Patent Costs

Patent Costs

Patent prosecution costs are charged to general and administrative expenses as incurred as recoverability of such expenditure is uncertain.

Basis of Presentation

Basis of Presentation

The consolidated balance sheet as of March 31, 2026, the consolidated statements of operations, comprehensive loss, and stockholders’ equity for the three months ended March 31, 2026, and 2025 and the consolidated statements of cash flows for three months ended March 31, 2026, and 2025, and all related disclosures contained in the accompanying notes, are unaudited. The consolidated balance sheet as of December 31, 2025 is derived from the audited consolidated financial statements included in the Annual Report on Form 10-K for the fiscal year ended December 31, 2025 filed with the Securities and Exchange Commission (the “SEC”) on March 30, 2026. The consolidated financial statements are presented on the basis of accounting principles that are generally accepted in the United States (“GAAP”) for interim financial information and in accordance with the rules and regulations of the SEC. Accordingly, they do not include all the information and footnotes required by accounting principles generally accepted in the United States for a complete set of financial statements.

In the opinion of management, all adjustments, which include only normal recurring adjustments necessary to present fairly the consolidated balance sheet as of March 31, 2026, and the results of operations, comprehensive loss, and changes in stockholders’ equity for the three months ended March 31, 2026, and cash flows for the three months ended March 31, 2026, have been made. The interim results for three months ended March 31, 2026 are not necessarily indicative of the results to be expected for the year ending December 31, 2025 or for any other reporting period. The consolidated financial statements should be read in conjunction with the audited consolidated financial statements and the accompanying notes for the year ended December 31, 2025 that are included in the Company’s Annual Report on Form 10-K filed with the SEC on March 30, 2026.

The consolidated financial statements of operations, comprehensive loss, and stockholders’ equity for the three months ended March 31, 2026 include Fitters Sdn. Bhd.

Reverse Stock Splits

Reverse Stock Splits

On May 12, 2025, the Company completed a one-for-sixteen reverse stock split, which reduced the number of shares of the Company’s common stock that were issued and outstanding immediately prior to the effectiveness of the reverse stock split. On July 7, 2025, the Company completed a one-for-fifteen reverse stock split, which reduced the number of shares of the Company’s common stock that were issued and outstanding immediately prior to the effectiveness of the reverse stock split. The number of shares of the Company’s authorized common stock was not affected by the reverse stock splits and the par value of the Company’s common stock remained unchanged at $0.001 per share. In addition, the number of shares or other equity instruments issuable under the Company’s equity incentive plans were not adjusted in connection with the May or July 2025 reverse stock splits. No fractional shares were issued in connection with the reverse stock splits. Stockholders who otherwise held fractional shares of the Company’s common stock as a result of the reverse stock split received a cash payment in lieu of such fractional shares. All amounts related to number of shares and per share amounts have been retroactively restated in these consolidated financial statements.

Going Concern

Going Concern

Pursuant to the requirements of Accounting Standard Codification (ASC) 205-40, Presentation of Financial Statements-Going Concern, management is required at each reporting period to evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about an entity’s ability to continue as a going concern within one year after the date that the financial statements are issued. This evaluation initially does not take into consideration the potential mitigating effect of management’s plans that have not been fully implemented as of the date the financial statements are issued. When substantial doubt exists under this methodology, management evaluates whether the mitigating effects of its plans sufficiently alleviate the substantial doubt about the Company’s ability to continue as a going concern. The mitigating effect of management’s plans, however, is only considered if both (1) it is probable that the plans will be effectively implemented within one year after the date that the financial statements are issued, and (2) it is probable that the plans, when implemented, will mitigate the relevant conditions or events that raise substantial doubt about the entity’s ability to continue as a going concern for one year after the date that these financial statements are issued.

In performing its analysis, management excluded certain elements of its operating plan that cannot be considered probable. Under ASC 205-40, the future receipts of potential funding from future equity or debt issuances or by entering into partnership agreements cannot be considered probable at this time because these plans are not entirely within the Company’s control nor have they been approved by the Board of Directors as of the date of these consolidated financial statements.

Based on the Company’s current operating plan, it is anticipated that cash and cash equivalents of $3.3 million as of March 31, 2026, will allow it to meet its liquidity requirements into the fourth quarter of 2026. The Company’s history of losses, negative cash flows from operations, liquidity resources currently on hand, and its dependence on the ability to obtain additional financing to fund its operations after the current resources are exhausted, about which there can be no certainty, have resulted in the assessment that there is substantial doubt about the Company’s ability to continue as a going concern for a period of at least twelve months from the issuance date of these financial statements. While the Company has plans in place to mitigate this risk, which primarily consist of raising additional capital through equity financing or by entering into a strategic transaction, there is no guarantee that it will be successful in these mitigation efforts. In the event that we are not able to secure funding, we may be forced to curtail operations, delay or stop ongoing development activities, cease operations altogether, and/or file for bankruptcy.

The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates realization of assets and the satisfaction of liabilities in the normal course of business.

Newly Adopted Accounting Pronouncements

Newly Adopted Accounting Pronouncements

On January 1, 2025, the Company adopted Accounting Standards Update (“ASU”) 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures”. This standard requires all entities to include specified captions when reconciling the statutory income tax rate to the effective tax rate, on both a percentage and absolute dollar basis, in the annual financial statements. ASU 2023-09 also requires entities to disclose the amount of income taxes paid (net of refunds received) disaggregated by federal (national), state, and foreign for each annual reporting period, with separate disclosure of individual jurisdictions for which tax payments to, or receipts from, exceed a defined threshold. The Company does not anticipate the adoption of ASU 2023-09 will require significant adjustments to the presentation of that information in the Company’s annual financial statements.

Discontinued Operations

Discontinued Operations

Operating losses for the three months ended March 31, 2025 from discontinued operations related wholly to research and development expenditures during the period.

Total operating cash flows for the three months ended March 31, 2025 from discontinued operations amounted to $4.1 million.

Future NRG Sdn. Bhd. [Member]

Use of Estimates

(c)

Use of Estimates

The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions. Material estimates include the allowance for expected credit losses on trade receivables, accruals for contingent liabilities, classification of discontinued operations, and the carrying values of assets held for sale.

Cash and Cash Equivalents

(d)

Cash and Cash Equivalents

The Group considers all highly liquid investments with original maturities of three months or less as cash equivalents. Cash and cash equivalents are maintained with regulated financial institutions in Malaysia.

Property and equipment

Property and equipment : Recognized under the cost model; depreciated straight-line over useful lives of 5–50 years. Land is not depreciated.

(g)

Property and Equipment, Net

Property and equipment are stated at cost less accumulated depreciation, computed using the straight-line method over estimated useful lives of 3 to 50 years. Land is not depreciated. Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate the carrying amount may not be recoverable.

Revenue recognition

Revenue recognition : Revenue is recognized upon completion of service delivery or transfer of control of goods. Payment terms are 30–60 days.

(i)

Revenue Recognition

Continuing operations revenue is derived from medical waste collection and logistics services to clinic operators, and from the sale of related consumables. Revenue is recognized when services are performed or control of goods transfers to the customer. Payment terms are 30–60 days.

Leases

Leases : Short-term lease exemption applied for leases with terms of twelve months or less. No right-of-use assets or lease liabilities are recognized.

Income taxes

Income taxes : Liability method; deferred tax assets are reduced by a valuation allowance where it is more likely than not that they will not be realized.

(h)

Income Taxes

Deferred taxes are accounted for under the liability method. Deferred tax assets are reduced by a valuation allowance when it is more likely than not that some portion will not be realized.

Loss Per Share

(k)

Loss Per Share

Basic earnings (loss) per share is computed by dividing net income (loss) by the weighted average shares outstanding. No dilutive securities existed in either period presented.

Basis of Presentation

(a)

Basis of Presentation

These consolidated financial statements are prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) as established by the Financial Accounting Standards Board (“FASB”).

The Company’s date of transition to U.S. GAAP is January 1, 2024. U.S. GAAP accounting policies have been applied retrospectively to all periods presented.

Discontinued Operations

(j)

Discontinued Operations

A component is reported as discontinued operations when it represents a strategic shift that has, or will have, a major effect on operations and financial results, and meets the held-for-sale criteria under ASC 360-10-45. Results of discontinued operations are presented separately, net of tax.

Functional and Reporting Currency

Functional and Reporting Currency

The functional currency of the Company is the Malaysian Ringgit (“RM”). Financial statements are presented in USD using the translation rates below:

Period

Closing Rate

(RM/USD)

March 31, 2026

4.046

December 31, 2025

4.061

Other Significant Accounting Policies

(b)

Functional and Reporting Currency

The functional currency of the Group is the Malaysian Ringgit (“RM”). These consolidated financial statements are presented in U.S. Dollars (“USD”), translated at the following period-end exchange rates:

Balance Sheet Date	RM / USD
December 31, 2023		4.5900
December 31, 2024		4.4755
December 31, 2025		4.0610

Income statement items are translated at the average rate for the period. USD amounts are provided for convenience only and do not represent that RM amounts have been or could be converted into USD at these rates.

Trade accounts receivable and ECL

Trade accounts receivable and ECL : Receivables are carried at amortized cost, net of an allowance for expected credit losses estimated on aging analysis and forward-looking factors.

(e)

Trade Accounts Receivable, Net

Trade accounts receivable are carried at amortized cost, net of an allowance for expected credit losses. The allowance is estimated using an aging schedule based on historical loss experience, current conditions, and reasonable and supportable forecasts.

Inventories

Inventories : Stated at the lower of cost (FIFO method) and net realizable value.

(f)

Inventories

Inventories are stated at the lower of cost (first-in, first-out) and net realizable value.

Concentrations of Risk

(l)

Concentrations of Risk

For the year ended December 31, 2025, one customer accounted for approximately 70% of total continuing operations revenue (2024: 71%). The loss of this customer could have a material adverse effect on the Group’s business, financial position, results of operations, and cash flows.

Schedule of Employee Benefit Plans (Details) - Future NRG Sdn. Bhd. [Member] - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2026	Dec. 31, 2025	Dec. 31, 2024
Defined Benefit Plan Disclosure [Line Items]
HRDC contributions	$ 28,433	$ 97,826	$ 86,105
Total employee benefit plan expense		11,201	6,272
Total statutory contribution expense	8,487	505	4,347
EPF [Member]
Defined Benefit Plan Disclosure [Line Items]
HRDC contributions		9,345	5,176
Total statutory contribution expense	7,083	474	3,781
SOCSO [Member]
Defined Benefit Plan Disclosure [Line Items]
HRDC contributions		1,013	650
Total statutory contribution expense	766	14	244
EIS [Member]
Defined Benefit Plan Disclosure [Line Items]
HRDC contributions		116	74
Total statutory contribution expense	88	2	28
HRDF [Member]
Defined Benefit Plan Disclosure [Line Items]
HRDC contributions		728	373
Total statutory contribution expense		15	295
Human Resource Development Corporation [Member]
Defined Benefit Plan Disclosure [Line Items]
HRDC contributions
Total statutory contribution expense	$ 550

Schedule of Restricted Stock Units Activity (Details) - Restricted Stock Units (RSUs) [Member] - $ / shares		1 Months Ended	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2023	Dec. 31, 2025	Dec. 31, 2024
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Restricted Stock Units outstanding, Beginning balance			164	144
Weighted Average Grant Date Value Per Share, Beginning balance			$ 2,881.62	$ 3,902.40
Restricted Stock Units, Granted			500,178	52
Weighted Average Grant Date Value Per Share, Granted	$ 3,240.00		$ 1.40	$ 547.20
Restricted Stock Units, Cancelled/forfeited			(162)	(32)
Weighted Average Grant Date Value Per Share, Cancelled/forfeited			$ 3,284.47	$ 3,675.17
Restricted Stock Units, Vested and converted to Common Stock		(71)	(500,178)
Weighted Average Grant Date Value Per Share, Vested and converted to Common Stock			$ 1.40
Restricted Stock Units outstanding, Ending balance			2	164
Weighted Average Grant Date Value Per Share, Ending balance			$ 3,240.00	$ 2,881.62

Acquisition

12 Months Ended

Dec. 31, 2025

Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]

Acquisition

9. Acquisition

On September 12, 2025, the Company completed the acquisition of Fitters Sdn. Bhd. (“Fitters Sub”), a Malaysian private limited company and wholly-owned subsidiary of FITTERS Diversified Berhad, a Malaysian publicly listed company (“FITTERS”). Following the closing of the Transaction, Fitters Sub became a wholly-owned subsidiary of the Company.

Schedule of Goodwill


Balance at December 31, 2024	$	—
Goodwill on acquisition of Fitters Sdn. Bhd.		1,570
Balance at December 31, 2025	$	1,570

		-
Allocation of purchase consideration

Common Stock of BGMS (formerly CYCC) Shares O/S as of September 11, 2025		2,798,379
19.99% of BGMS (formerly CYCC) Shares issued as consideration		699,158
Stock Price as of September 11, 2025	$	6.3650
Cash consideration	$	-
Total Estimated Purchase Consideration	$	4,450,138

Cash and cash equivalents		784,090
Inventories		1,284,447
Accounts receivables		715,173
Prepaid & other current assets		464,129
Property, plant and equipment, net		129,423
Trade payables		(416,470	)
Accrued and other current liabilities		(31,571	)
Non-current liabilities - deferred tax		(48,739	)
Goodwill		1,569,656

Total Net Assets Acquired	$	4,450,138

Inventories, receivables, and other short-term assets and liabilities have been valued at their historical carrying amounts, as the Company believes there are no material differences between those amounts and fair value. The Company similarly determined that fair value of the acquired property, plant, and equipment is materially the same as its historical carrying value as of the acquisition date.

The following unaudited pro forma information for the years ended December 31, 2025 and December 31, 2024 gives effect to the Transaction as if it took place as of January 1, 2024, and combines the historical results of Fitters and the Company for each period. The pro forma results do not include any anticipated cost synergies or other effects of the combined Company. Accordingly, pro forma amounts are not necessarily indicative of the results that actually would have occurred had the acquisitions been completed on the dates indicated, nor are they indicative of the Company’s future operating results.

UNAUDITED SUPPLEMENTAL PRO FORMA INFORMATION FOR REVENUE AND EARNINGS

	2025			2024
	Year ended December 31,
	2025			2024

Pro forma revenue	$	2,080		$	2,053
Pro forma net loss	$	(3,191	)	$	(13,333	)
Pro forma net loss per share attributable to common shareholders	$	(6.57	)	$	(602.02	)

- Definition

The entire disclosure for business combination.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 8
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479328/805-10-50-8

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 38
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479303/805-10-55-38

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 46
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479303/805-10-55-46

Reference 4: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 43
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479303/805-10-55-43

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 45
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479303/805-10-55-45

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 29
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479303/805-10-55-29

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 29
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479303/805-10-55-29

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479907/805-20-50-5

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)(1)(ii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479907/805-20-50-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479907/805-20-50-3

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479581/805-30-50-3

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479328/805-10-50-2

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479907/805-20-50-2

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479581/805-30-50-2

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479581/805-30-50-1

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (f)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479581/805-30-50-1

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479328/805-10-50-3

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479581/805-30-50-1

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479328/805-10-50-2

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479328/805-10-50-4

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Subparagraph (a)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479581/805-30-50-4

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479907/805-20-50-1

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479907/805-20-50-1

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (h)(4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479328/805-10-50-2

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479328/805-10-50-2

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 40
-Name Accounting Standards Codification
-Section 45
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479326/805-40-45-1

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 30
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/805-30/tableOfContent

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/805-20/tableOfContent

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479328/805-10-50-7

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479328/805-10-50-5

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/805-10/tableOfContent

+ Details

Subsequent Events

3 Months Ended

12 Months Ended

Mar. 31, 2026

Dec. 31, 2025

Subsequent Event [Line Items]

Subsequent Events

13. Subsequent Events

Dividends on 6% Preferred Stock

On April 13, 2026, the board of directors of the Company declared a quarterly cash dividend of $0.15 per share on the Company’s 6% Convertible Exchangeable Preferred Stock scheduled for May 1, 2026. The cash dividend was paid on May 1, 2026, to Preferred Stock stockholders of record as of the close of business on April 23, 2026. The Board of Directors will continue to evaluate the payment of a quarterly cash dividend on a quarterly basis.

20. Subsequent Events

Preferred Stock

On January 12, 2026, the Board of Directors of Bio Green Med Solution, Inc. (the “Company”) declared a quarterly cash dividend of $0.15 per share on the Company’s 6% Convertible Exchangeable Preferred Stock (the “Preferred Stock”). The dividend was paid on February 1, 2026, to Preferred Stock stockholders of record as of the close of business on January 22, 2026.

Delisting of 6% Convertible Exchangeable Preferred Stock

Further to Nasdaq notices received September 11, 2025 and March 12, 2026 in connection with the Company’s failure to satisfy a continued listing rule in relation to its 6% Convertible Exchangeable Preferred Stock (listed on The Nasdaq Capital Market under the symbol “BGMSP”), trading of the Preferred Stock was suspended at the opening of business on March 23, 2026, and a Form 25-NSE was filed with the Securities and Exchange Commission, which removed the Company’s securities from listing and registration on The Nasdaq Stock Market.

It is expected that the Preferred Stock will be delisted from The Nasdaq Capital Market on or after April 2, 2026. The Company believes that the Preferred Stock may be quoted and traded on the OTC Markets after April 2, 2026. The delisting does not affect the Company’s Common Stock (listed on The Nasdaq Capital Market under the symbol “BGMS”).

Future NRG Sdn. Bhd. [Member]

Subsequent Event [Line Items]

Subsequent Events

Subsequent Events

14.

SUBSEQUENT EVENTS

(a)

Change of shareholder

	●	5,600,000 shares to nine individual purchasers, representing 20% of the total shareholding, for an aggregate consideration of RM3.04 million;
	●	15,400,000 shares to Perfect Energy Sdn. Bhd., representing 55% of the total shareholding, for a consideration of RM8.36 million;
	●	7,000,000 shares to Antbiz Sdn. Bhd., representing 25% of the total shareholding, for a consideration of RM3.80 million.

(b)

Disposal of subsidiary, Solid Orient Holdings Sdn. Bhd.

On December 22, 2025, the Company entered into a Share Sale Agreement (“SSA”) with the ultimate holding company, Fitters to dispose of its 100% equity interest in SOH, which represents the Company’s entire palm oil milling segment. On January 8, 2026, the Company’s wholly-owned subsidiary, SOH, allotted 46,700,000 new ordinary shares at an issue price of RM1.00 per share to the ultimate holding company, Fitters for a total cash consideration of RM46,700,000. As a result of this share allotment, the Company’s equity interest in SOH was diluted from 100% to 18.36%, and the Company ceased to exercise a controlling financial interest, leading to the deconsolidation of SOH as a subsidiary effective from that date. In conjunction with this restructuring, the intercompany payable previously due to the ultimate holding company was settled through a combination of this capital injection and a subsequent waiver of the remaining balance, which is expected to result in a gain on debt settlement in the 2026 fiscal year.

The Company completed the disposal of its remaining 18.36% equity interest (comprising 10,500,000 shares) in SOH to the ultimate holding company on January 23, 2026 pursuant to the Share Sale Agreement (“SSA”) executed on December 22, 2025. The transaction was finalized for a total cash consideration of RM10,500,000 (equivalent to USD 2,585,620). Proceeds from the sale were utilized to settle outstanding obligations and provide additional working capital for the Company’s continuing operations. The disposal proceeds were applied toward the reduction of outstanding payables due to Fitters Diversified Berhad. Any resulting gain or loss arising from the disposal will be recognized in the Group’s consolidated financial statements for the year ending December 31, 2026.

No other subsequent events requiring disclosure or adjustment have occurred.

Schedule of Benefit (Provision) for Income Taxes from Continuing Operations (Details) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2026	Mar. 31, 2025	Dec. 31, 2025	Dec. 31, 2024
Income Tax Disclosure [Abstract]
Current – domestic				$ (21)
Current – foreign			(7)	803
Current – total			(7)	782
Deferred – domestic
Income tax benefit	$ 30		$ 7	$ (782)

- Definition

Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (ee)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 45
-Paragraph 3A
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483475/205-20-45-3A

Reference 4: http://www.xbrl.org/2003/role/exampleRef
-Topic 220
-SubTopic 40
-Name Accounting Standards Codification
-Section 55
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476153/220-40-55-4

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Topic 220
-SubTopic 40
-Name Accounting Standards Codification
-Section 55
-Paragraph 21
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476153/220-40-55-21

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Topic 220
-SubTopic 40
-Name Accounting Standards Codification
-Section 55
-Paragraph 14
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476153/220-40-55-14

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 270
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482964/270-10-50-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-12

Reference 10: http://www.xbrl.org/2003/role/exampleRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 231
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482663/740-10-55-231

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 6.I.7)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 8
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-8

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-9

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-10

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(9))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Name Accounting Standards Codification
-Section 45
-Paragraph 2
-Subparagraph (a)
-SubTopic 20
-Topic 740
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482659/740-20-45-2

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h))
-SubTopic 10
-Topic 235
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

+ Details

Company Overview

3 Months Ended

12 Months Ended

Mar. 31, 2026

Dec. 31, 2025

Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]

Company Overview

1. Company Overview

Nature of Operations

Bio Green Med Solution, Inc. (the “Company” (formerly Cyclacel Pharmaceuticals, Inc.) is a diversified company that was formerly engaged in the biopharmaceutical industry but as of September 2025 has shifted its operations to focus on provision of fire safety protection and distribution activities. Specifically, on September 12, 2025, the Company completed its acquisition of Fitters Sdn. Bhd., a Malaysia-based company specializing in fire protection products and services. Headquartered in Malaysia, the Company is now focused on advancing opportunities across these distinct sectors whilst maintaining its commitment to driving long-term value creation for shareholders. Since that time, substantially all efforts of the Company have been focused on the supply and trading of protective and fire safety equipment providing a wide range of fire safety products, including fire extinguishers, foam system, fire-resistant doors, personal protective equipment, and fire safety apparel. Our mission is to deliver high-quality, certified safety solutions that enhance protection across commercial, industrial, healthcare, and residential sectors with a focus on trading and distribution to position us as a key player in Malaysia’s fire safety market, with a reputation for reliability and compliance with stringent regulatory standards.

On January 24, 2025, the Company’s previous wholly owned United Kingdom subsidiary, Cyclacel Limited, entered into a creditors voluntary liquidation. Upon the commencement of the liquidation of Cyclacel Limited, the Company lost operational and strategic control over Cyclacel Limited and the financial results of Cyclacel Limited have been deconsolidated from the Company as of January 24, 2025. The deconsolidation of the subsidiary resulted in a gain on deconsolidation of approximately $5.0 million shown as a component of gain from discontinued operations within the income statement for the period.

1. Organization of the Company and Basis of Presentation Company Overview

Bio Green Med Solution, Inc. (“BGMS” or “the Company”) is engaged primarily in the fire safety and protection industry through its wholly owned subsidiary Fitters Sdn. Bhd. (“FITTERS”), a Malaysia-based group specializing in fire protection products and services.

Through December 31, 2025, the Company has funded all of its operations and capital expenditures with proceeds from the issuance of public equity securities, private placements of securities, government grants, research and development tax credits, interest on investments, royalty income, product revenue and licensing revenue. The Company has incurred recurring losses since its inception, including net losses of $3.0 million and $11.2 million for the years ended December 31, 2025 and 2024 respectively. As of December 31, 2025, the Company had an accumulated deficit of $454.4 million. The Company expects to continue to generate operating losses for the near term as it builds and expands its portfolio of businesses and improves operating margins at FITTERS.

The Company is subject to risks and uncertainties common to small market capitalization companies. If the Company is unable to obtain the necessary financing to build and expand its asset portfolio, there will be a material adverse impact on the Company’s financial condition and results of operations.

Going Concern

Based on the Company’s current operating plan, it is anticipated that cash and cash equivalents of $3.5 million as of December 31, 2025 will allow it to meet liquidity requirements into the third quarter of 2026. The Company continues to work to raise additional capital however as of the date of these financial statements there is no guarantee that the Company will be able to raise additional funds to extend operations beyond the third quarter of 2026. The Company’s history of losses, negative cash flows from operations, liquid resources currently on hand, and dependence on the ability to obtain additional financing to fund its operations, about which there can be no certainty, have resulted in the assessment that there is substantial doubt about the Company’s ability to continue as a going concern for a period of at least twelve months from the issuance date of these financial statements. While the Company has plans in place to mitigate this risk, which primarily consist of raising additional capital through a combination of public or private equity or debt financings or by entering into partnership agreements, there is no guarantee that it will be successful in these mitigation efforts. The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates realization of assets and the satisfaction of liabilities in the normal course of business.

Basis of Presentation

The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America, or GAAP and include the financial statements of Bio Green Med Solution, Inc. and all of the Company’s wholly owned subsidiaries. All intercompany accounts and transactions have been eliminated.

Reverse Stock Split

On May 12, 2025, the Company effected a one-for-sixteen reverse stock split of its common stock and subsequently on July 7, 2025, effected a further one-for-fifteen reverse stock split of its common stock. All share and per share data for all periods presented in the consolidated financial statements have been retrospectively adjusted to give effect to these reverse stock splits.

Future NRG Sdn. Bhd. [Member]

Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]

Company Overview

1. NATURE OF OPERATIONS AND BASIS OF PRESENTATION

Company Overview

The Company

Future NRG Sdn. Bhd. (the “Company” or “FNRG”), Registration No. 200801012859 (814147-M), is incorporated in Malaysia under the Companies Act 2016. The Company is principally engaged in the provision of medical waste collection, packaging, transportation, and treatment services to clinic operators in Malaysia, together with the management of associated logistics infrastructure and renewable energy development activities. Its principal place of business is Lot PT 6127, 3A/1, Jalan Tech Valley, Bandar Sri Sendayan, Seremban, Negeri Sembilan, Malaysia.

Basis of Presentation

These financial statements present the financial position of the Company as at 31 March 2026 and the results of its operations and cash flows for the three-month period then ended. The financial statements are unaudited, are presented in United States Dollars (“USD”), and have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”).

The Q1 2026 financial statements are presented on a company-level (standalone entity) basis. As described in Note 12, the Company’s sole subsidiary, Solid Orient Holdings Sdn. Bhd. (“SOH”), was deconsolidated on January 8, 2026 and the Company’s remaining equity interest in SOH was fully disposed of on January 23, 2026. Accordingly, no consolidated financial statements are presented for Q1 2026.

Effective March 26, 2026, the Company ceased to be a wholly-owned subsidiary of Fitters Diversified Berhad (“Fitters”) following completion of share sale agreements. The Company’s share capital is now held by Perfect Energy Sdn. Bhd. (55%), Antbiz Sdn. Bhd. (25%), and nine individual purchasers (20% in aggregate).

1.	NATURE OF OPERATIONS AND BASIS OF CONSOLIDATION Company Overview

Future NRG Sdn. Bhd. (the “Company” or “FNRG”) is incorporated in Malaysia and is principally engaged in renewable energy development and the provision of medical waste collection and logistics services to clinic operators.

The Company’s wholly-owned subsidiary, Solid Orient Holdings Sdn. Bhd. (“SOH”), is engaged in the operation of a palm oil mill. Together, the Company and SOH are referred to as the “Group”. The Company is wholly owned by Fitters Diversified Berhad (“Fitters”), a company listed on the Main Market of Bursa Malaysia Securities Berhad, which is the ultimate holding company of the Group.

The principal place of business is Lot PT 6127, 3A/1, Jalan Tech Valley, Bandar Sri Sendayan, Seremban, Negeri Sembilan, Malaysia.

Basis of Consolidation

The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary. Subsidiary is entity over which the Company has a controlling financial interest. All material intercompany transactions and balances have been eliminated in consolidation in accordance with ASC 810, Consolidation.

Discontinued Operations and Held-for-Sale Classification

On December 22, 2025, the Company entered into a Share Sale Agreement (“SSA”) with its ultimate holding company, Fitters Diversified Berhad to dispose of its entire 100% equity interest in SOH for cash consideration of RM 10,500,000 (USD 2,585,620). Upon execution of the SSA, the disposal group met the criteria to be classified as held for sale in accordance with applicable US GAAP.

The assets and liabilities of SOH are presented as single line items on the consolidated balance sheets. Comparative figures as of December 31, 2024 have been retrospectively reclassified in accordance with SEC Financial Reporting Manual Topic 13 § 13210.2. The disposal was completed on January 23, 2026 (see Note 14).

Inventories (Tables)

3 Months Ended

12 Months Ended

Mar. 31, 2026

Dec. 31, 2025

Schedule of Inventory

Inventory consisted of the following (in $000s):

Schedule of Inventory

	March 31,		December 31,
	2026		2025
Raw materials		238		242
Work in progress		—		134
Finished goods		709		1,008
Total inventory	$	947	$	1,384

The following is a summary of inventory at December 31, 2025 and 2024 (in thousands):

Schedule of Inventory

	December 31,		December 31,
	2025		2024
Raw Materials		242		—
Spare parts
Consumables
Work in progress		134		—
Finished goods		1,008		—
Total inventory	$	1,384	$	—

Future NRG Sdn. Bhd. [Member]

Schedule of Inventory

	Mar 31, 2026 (USD)
Spare parts		66,798
Consumables		1,977
Inventories — at lower of cost and NRV		68,776

Schedule of the Company’s Future Contractual Obligations and Commitments Relating to Its Facilities Leases (Details) - USD ($) $ in Thousands	Mar. 31, 2026	Dec. 31, 2025
Commitments and Contingencies Disclosure [Abstract]
2026	$ 9	$ 18
2027	2	2
Thereafter
Total future minimum lease obligation	$ 11	20
Less imputed interest
Total		$ 20

Schedule of Fair value of Warrants Valuation Assumption (Details)	Mar. 31, 2026	Dec. 31, 2025
Class of Warrant or Right [Line Items]
Contractual term	5 years 6 months	18 months
PreFunded Warrants [Member] \| Measurement Input, Price Volatility [Member]
Class of Warrant or Right [Line Items]
Warrants and rights outstanding		100
PreFunded Warrants [Member] \| Measurement Input, Expected Term [Member]
Class of Warrant or Right [Line Items]
Contractual term		1 year
PreFunded Warrants [Member] \| Measurement Input, Risk Free Interest Rate [Member]
Class of Warrant or Right [Line Items]
Warrants and rights outstanding		5.51
PreFunded Warrants [Member] \| Measurement Input, Expected Dividend Rate [Member]
Class of Warrant or Right [Line Items]
Warrants and rights outstanding		0
Common Stock Warrants [Member] \| Measurement Input, Price Volatility [Member] \| Minimum [Member]
Class of Warrant or Right [Line Items]
Warrants and rights outstanding		103
Common Stock Warrants [Member] \| Measurement Input, Price Volatility [Member] \| Maximum [Member]
Class of Warrant or Right [Line Items]
Warrants and rights outstanding		121
Common Stock Warrants [Member] \| Measurement Input, Expected Term [Member]
Class of Warrant or Right [Line Items]
Contractual term		5 years 6 months
Common Stock Warrants [Member] \| Measurement Input, Risk Free Interest Rate [Member] \| Minimum [Member]
Class of Warrant or Right [Line Items]
Warrants and rights outstanding		4.57
Common Stock Warrants [Member] \| Measurement Input, Risk Free Interest Rate [Member] \| Maximum [Member]
Class of Warrant or Right [Line Items]
Warrants and rights outstanding		5.51
Common Stock Warrants [Member] \| Measurement Input, Expected Dividend Rate [Member]
Class of Warrant or Right [Line Items]
Warrants and rights outstanding		0
Placement Agent Warrants [Member]
Class of Warrant or Right [Line Items]
Contractual term	5 years 6 months
Placement Agent Warrants [Member] \| Measurement Input, Price Volatility [Member]
Class of Warrant or Right [Line Items]
Warrants and rights outstanding		103
Placement Agent Warrants [Member] \| Measurement Input, Expected Term [Member]
Class of Warrant or Right [Line Items]
Contractual term		5 years 6 months
Placement Agent Warrants [Member] \| Measurement Input, Risk Free Interest Rate [Member]
Class of Warrant or Right [Line Items]
Warrants and rights outstanding		4.57
Placement Agent Warrants [Member] \| Measurement Input, Expected Dividend Rate [Member]
Class of Warrant or Right [Line Items]
Warrants and rights outstanding		0

Investment in Subsidiary (Details Narrative) - Future NRG Sdn. Bhd. [Member]			1 Months Ended
	Dec. 22, 2025 USD ($)	Dec. 22, 2025 MYR (RM)	Jan. 31, 2026 USD ($)	Dec. 31, 2025	Dec. 31, 2024
Share Sale Agreement [Member]
InvestmentinSubsidiaryLineItem [Line Items]
Disposal of equity interest	$ 2,586,000	RM 10,500,000
Solid Orient Holdings [Member]
InvestmentinSubsidiaryLineItem [Line Items]
Ownership percentage	100.00%	100.00%		100.00%	100.00%
Ownership percentage			$ 1,919,251

Property and Equipment (Tables)

3 Months Ended

12 Months Ended

Mar. 31, 2026

Dec. 31, 2025

Schedule of Property and Equipment

Property and equipment consisted of the following at December 31, 2025 and 2024 (in thousands):

Schedule of Property and Equipment

	Lives in years	2025			2024
		December 31,
	Lives in years	2025			2024
Leasehold improvements	1 to 2	$	138		$	6
Plant & Equipment	3 to 5		1			—
Office equipment and furniture	3 to 5		282			420
Property and equipment, gross			421			427
Less: accumulated depreciation and amortization			(284	)		(424	)
Property and equipment, net		$	137		$	3

Future NRG Sdn. Bhd. [Member]

Schedule of Property and Equipment

	Mar 31, 2026 (USD)
Freehold land		404,377
Building — net		2,632,773
Plant and machinery — net		1,436,396
Computer and office equipment — net		13,048
Air conditioners, furniture and fittings — net		440
Property and equipment, net — continuing operations		4,487,034

Schedule of Property and Equipment

	Note	2025			2024
		(USD)			(USD)
Cost:
Land			402,883			365,570
Building			3,155,999			2,863,705
Machinery			2,455,818			2,228,372
Computer & office equipment			64,280			51,730
Other assets			4,188			3,340
Total cost			6,083,168			5,512,717
Less: Accumulated depreciation:
Building			(517,170	)		(411,998	)
Machinery			(994,282	)		(791,695	)
Other assets			(53,319	)		(41,496	)
Total depreciation			(1,564,771	)		(1,245,189	)

Property and equipment, net			4,518,397			4,267,528

Schedule of Disaggregation of Revenue by Product (Details) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2026	Mar. 31, 2025	Dec. 31, 2025	Dec. 31, 2024
Total Revenue	$ 778		$ 747	$ 43
Safety Aparel [Member]
Total Revenue	11		119
Fire Safety Equipment [Member]
Total Revenue	754		603
Maintenance and Servicing [Member]
Total Revenue	4		6
Project Supply and Installation [Member]
Total Revenue	$ 9		20
Clinical Trial Supply [Member]
Total Revenue				$ 43

- Definition

+ References

+ Details

Commitments and Contingencies (Tables)

12 Months Ended

Dec. 31, 2025

Commitments and Contingencies Disclosure [Abstract]

Schedule of the Company’s Future Contractual Obligations and Commitments Relating to Its Facilities Leases

The following is a summary of the Company’s future contractual obligations and commitments relating to its facilities lease as at December 31, 2025 (in thousands):

	Operating Lease
	Obligation
2026	$	18
2027		2
Thereafter		—
Total future minimum lease obligation	$	20
Less imputed interest		—
Total	$	20

Schedule of Cash of Discontinued Operations (Details) - USD ($)	Mar. 31, 2026	Dec. 31, 2025	Mar. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Cash at bank — continuing operations	$ 3,339,000	$ 3,505,000		$ 3,137,000
Total consolidated cash	3,339,000	3,505,000	$ 3,450,000	3,137,000	$ 3,378,000
Future NRG Sdn. Bhd. [Member]
Cash at bank — continuing operations	9,649	202,716		268,780
Cash — discontinued operations (within held-for-sale)		3,135,050		1,701,167
Total consolidated cash	$ 9,649	$ 3,337,766		$ 1,969,947	$ 1,429,002

Stockholders’ Equity (Tables)

12 Months Ended

Dec. 31, 2025

Stockholders' Equity Note [Abstract]

Schedule of Fair Value of Instruments Issued in Offering

	Allocated Amount
Common shares	$	72,108
Prefunded warrants		2,398,831
Common warrants		3,819,274
Net proceeds	$	6,290,213

Schedule of Fair value of Warrants Valuation Assumption

In determining the fair values of the Pre-Funded Warrants, Common Warrants, and Placement Agent Warrants, the Company used a Black-Scholes Option Pricing model with the following assumptions:

	Pre-Funded Warrants			Common Warrants			Placement Agent Warrants
Expected volatility		100	%		103% - 121%			103	%
Contractual term		1 year			- 5.5 years			5 ½ years5.5
Risk-free interest rate		5.51	%		4.57% - 5.51%			4.57	%
Expected dividend yield		0	%		0	%		0	%

Offerings - Offering: 1	Jun. 16, 2026 USD ($) shares
Offering:
Fee Previously Paid	false
Other Rule	true
Security Type	Equity
Security Class Title	common stock, par value $0.001 per share
Amount Registered \| shares	3,000,000,000
Maximum Aggregate Offering Price	$ 6,100,218.00
Fee Rate	0.01381%
Amount of Registration Fee	$ 842.44
Offering Note	Represents the maximum number of shares of Common Stock, par value $0.001 per share ("Parent Common Stock"), of Bio Green Med Solution, Inc. (the "Registrant"), issuable to the selling shareholders of Future NRG Sdn. Bhd. ("Future NRG") pursuant to the Transaction contemplated by the Business Combination Agreement, dated as of June 4, 2026, by and among the Registrant, Future NRG and all of the shareholders of Future NRG. Estimated solely for the purpose of calculating the registration fee under Rule 457(f)(2) under the Securities Act of 1933, as amended (the "Securities Act"). As Future NRG is a private company, there is no market for its securities, therefore, the proposed maximum aggregate offering price per share was calculated based on the book value as of June 4, 2026 of the Future NRG Ordinary Shares that will be exchanged in the Transaction, which amount equals $6,100,218. The registration fee is determined in accordance with Section 6(b) of the Securities Act and calculated by multiplying the estimated aggregate offering price of securities to be registered by 0.00013810.

Taxes (Tables)

12 Months Ended

Dec. 31, 2025

Income Tax Disclosure [Abstract]

Schedule of Components of (Loss) Income Before Taxes from Continuing Operations

(Loss) income from continuing operations before taxes is comprised of the following components for the years ended December 31, 2025 and 2024 (in thousands):

	2025			2024
	Year Ended December 31,
	2025			2024
Domestic	$	(1,839	)	$	36
Foreign		(1,152	)		(12,030	)
Loss from continuing operations before taxes	$	(2,991	)	$	(11,994	)

Schedule of Benefit (Provision) for Income Taxes from Continuing Operations

The benefit (provision) for income taxes from continuing operations consists of the following (in thousands):

	2025			2024
	Year Ended December 31,
	2025			2024
Current – domestic	$	—		$	(21	)
Current – foreign		(7	)		803
Current – total		(7	)		782
Deferred – domestic		—			—
Income tax benefit	$	(7	)	$	782

Schedule of Effective Income Tax Rate Reconciliation

A reconciliation of the (benefit) provision for income taxes from continuing operations with the amount computed by applying the statutory federal tax rate to loss from continuing operations before income taxes is as follows (in thousands):

	2025
	Year Ended December 31,
	2025
U.S. Federal Statutory Tax Rate	$	(609	)
State and local income taxes, net of federal income tax effect		(483	)
Foreign Tax Effects
UK
Statutory Tax Rate Difference		8,940
Change in Valuation Allowance		(55,877	)
Non-deductible expenses		47,251
Malaysia
Statutory Tax Rate Difference		(35	)
US
Change in Valuation Allowance		1,921
Non-deductible expenses		(1,039	)
Other adjustments		(62	)
Income tax benefit	$	7

	2024
	Year Ended December 31,
	2024
Loss from continuing operations before taxes	$	(11,994	)
Income tax expense computed at statutory federal tax rate		(2,527	)
Disallowed expenses and non-taxable income		35
Loss surrendered to generate R&D credit		—
Additional research and development tax relief		-
Stock Compensation		30
Change in valuation allowance		2,798
Foreign items, including change in tax rates, and other		(1,158	)
Change in Tax Rate		-
Section 382 Limitation		—
Other items		40
Income tax benefit	$	(782	)

Schedule of Deferred Tax Assets

Significant components of the Company’s deferred tax assets are shown below (in thousands):

Schedule of Deferred Tax Assets

	2025			2024
	Year Ended December 31,
	2025			2024
Net operating loss and tax credit carryforwards	$	3,203		$	59,417
Depreciation, amortization and impairment of property and equipment		—			39
Stock options		907			250
Research and development credits		—			—
Right of use asset		(3	)		(1	)
Lease liability		3			1
Other		—			114
Total deferred tax assets		4,110			59,820
Valuation allowance for deferred tax assets		(4,110	)		(59,820	)
Net deferred tax assets	$	—		$	—

Summary of Cash and Cash Equivalents (Details) - USD ($) $ in Thousands	Mar. 31, 2026	Dec. 31, 2025	Dec. 31, 2024
Cash and Cash Equivalents [Abstract]
Cash		$ 3,505	$ 93
Cash equivalents			3,044
Total cash and cash equivalents	$ 3,339	$ 3,505	$ 3,137

- Definition

Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(1))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 230
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482740/230-10-45-4

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 230
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 8
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482913/230-10-50-8

Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S45
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1

Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1

Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(1))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Topic 944
-SubTopic 605
-Name Accounting Standards Codification
-Section 55
-Paragraph 14
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477548/944-605-55-14

Reference 8: http://www.xbrl.org/2003/role/exampleRef
-Topic 944
-SubTopic 605
-Name Accounting Standards Codification
-Section 55
-Paragraph 11
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477548/944-605-55-11

Reference 9: http://www.xbrl.org/2003/role/exampleRef
-Topic 852
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481372/852-10-55-10

Reference 10: http://www.xbrl.org/2003/role/exampleRef
-Topic 946
-SubTopic 830
-Name Accounting Standards Codification
-Section 55
-Paragraph 12
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479168/946-830-55-12

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(2))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-04(4))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 45
-Paragraph 21
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477796/946-210-45-21

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Name Accounting Standards Codification
-Section 45
-Paragraph 20
-SubTopic 210
-Topic 946
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477796/946-210-45-20

+ Details

Cover	3 Months Ended
Cover	Mar. 31, 2026
Entity Addresses [Line Items]
Document Type	S-4
Amendment Flag	false
Entity Registrant Name	BIO GREEN MED SOLUTION, INC.
Entity Central Index Key	0001130166
Entity Tax Identification Number	93-2403210
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	Level 10, Tower 11
Entity Address, Address Line Two	Avenue 5, The Horizon
Entity Address, Address Line Three	Bangsar South City, No. 8, Jalan Kerinchi
Entity Address, City or Town	Kuala Lumpur
Entity Address, Postal Zip Code	59200
City Area Code	(908)
Local Phone Number	955 0526
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Business Contact [Member]
Entity Addresses [Line Items]
Entity Address, Address Line One	Level 10, Tower 11
Entity Address, Address Line Two	Avenue 5
Entity Address, Address Line Three	Bangsar South City, No. 8, Jalan Kerinchi
Entity Address, City or Town	Kuala Lumpur
Entity Address, Country	MY
Entity Address, Postal Zip Code	59200
City Area Code	(908)
Local Phone Number	955 0526
Contact Personnel Name	Datuk Dr. Doris Wong

Cash and Cash Equivalents

3 Months Ended

12 Months Ended

Mar. 31, 2026

Dec. 31, 2025

CashAndCashEquivalentsLineItem [Line Items]

Cash and Cash Equivalents

4. Cash and Cash Equivalents

The following is a summary of cash and cash equivalents at December 31, 2025 and 2024 (in thousands):

Summary of Cash and Cash Equivalents

	2025		2024
	December 31,
	2025		2024
Cash	$	3,505	$	93
Cash equivalents		—		3,044
Total cash and cash equivalents	$	3,505	$	3,137

Cash equivalents are made up entirely of money market funds.

Future NRG Sdn. Bhd. [Member]

CashAndCashEquivalentsLineItem [Line Items]

Cash and Cash Equivalents

5. CASH AND CASH EQUIVALENTS

	Mar 31, 2026 (USD)
Cash at bank — continuing operations		9,649
Cash — discontinued operations (within held-for-sale)		—
Total consolidated cash		9,649

Cash and Cash Equivalents

5.	CASH AND CASH EQUIVALENTS

	Note	2025		2024
		(USD)		(USD)
Cash — continuing operations			202,716		268,780
Cash — discontinued operations			3,135,050		1,701,167
Consolidated cash per cash flow statement			3,337,766		1,969,947

Subsequent Events (Details Narrative)										3 Months Ended		12 Months Ended
Subsequent Events (Details Narrative)	Apr. 13, 2026 $ / shares	Mar. 16, 2026 MYR (RM) shares	Mar. 12, 2026	Jan. 23, 2026 shares	Jan. 12, 2026 $ / shares	Jan. 08, 2026 MYR (RM) RM / shares shares	Dec. 22, 2025 USD ($)	Dec. 22, 2025 MYR (RM)	Sep. 11, 2025	Mar. 31, 2026 $ / shares	Mar. 31, 2025 USD ($)	Dec. 31, 2025 USD ($) $ / shares	Dec. 31, 2024 USD ($)
Subsequent Event [Line Items]
Preferred stock, dividend rate										6.00%		6.00%	6.00%
Cash \| $												$ 3,505,000	$ 93,000
Cash consideration \| $												$ (125,000)
Future NRG Sdn. Bhd. [Member] \| Solid Orient Holdings [Member]
Subsequent Event [Line Items]
Equity method investment interest							100.00%	100.00%				100.00%	100.00%
Share Sale Agreements [Member] \| Future NRG Sdn. Bhd. [Member]
Subsequent Event [Line Items]
Disposal ordinary shares \| shares		28,000,000
Cash \| RM		RM 15,200,000
Share Sale Agreements [Member] \| Future NRG Sdn. Bhd. [Member] \| Perfect Energy Sdn Bhd [Member]
Subsequent Event [Line Items]
Shares issued \| shares		15,400,000
Aggregate consideration amount \| RM		RM 8,360,000
Share Sale Agreements [Member] \| Future NRG Sdn. Bhd. [Member] \| Antbiz Sdn Bhd [Member]
Subsequent Event [Line Items]
Shares issued \| shares		7,000,000
Aggregate consideration amount \| RM		RM 3,800,000
Share Sale Agreements [Member] \| Future NRG Sdn. Bhd. [Member] \| Solid Orient Holdings Sdn. Bhd. [Member]
Subsequent Event [Line Items]
Cash consideration \| RM						RM 46,700,000
Share Sale Agreements [Member] \| Future NRG Sdn. Bhd. [Member] \| Individual Purchasers [Member]
Subsequent Event [Line Items]
Shares issued \| shares		5,600,000
Aggregate consideration amount \| RM		RM 3,040,000.00
Share Sale Arrangements [Member] \| Future NRG Sdn. Bhd. [Member]
Subsequent Event [Line Items]
Issue price \| RM / shares						RM 1.00
Issue of common stock on Securities Purchase Agreement, shares \| shares				10,500,000		46,700,000
Disposal of equity interest							$ 2,585,620	RM 10,500,000
Share Sale Arrangements [Member] \| Future NRG Sdn. Bhd. [Member] \| Minimum [Member] \| Solid Orient Holdings [Member]
Subsequent Event [Line Items]
Equity method investment interest						18.36%
Share Sale Arrangements [Member] \| Future NRG Sdn. Bhd. [Member] \| Individual Purchasers [Member]
Subsequent Event [Line Items]
Equity interest		20.00%
Share Sale Arrangements [Member] \| Future NRG Sdn. Bhd. [Member] \| Perfect Energy Sdn Bhd [Member]
Subsequent Event [Line Items]
Equity interest		55.00%
Share Sale Arrangements [Member] \| Future NRG Sdn. Bhd. [Member] \| Antbiz Sdn Bhd [Member]
Subsequent Event [Line Items]
Equity interest		25.00%
Share Sale Arrangements [Member] \| Future NRG Sdn. Bhd. [Member] \| Solid Orient Holdings [Member]
Subsequent Event [Line Items]
Equity interest							100.00%	100.00%
Share Sale Arrangements [Member] \| Future NRG Sdn. Bhd. [Member] \| Solid Orient Holdings [Member] \| Minimum [Member]
Subsequent Event [Line Items]
Equity interest						100.00%
Share Sale Arrangements [Member] \| Future NRG Sdn. Bhd. [Member] \| Solid Orient Holdings [Member] \| Maximum [Member]
Subsequent Event [Line Items]
Equity interest						18.36%
Convertible Preferred Stock [Member]
Subsequent Event [Line Items]
Issue price \| $ / shares										$ 10.00		$ 10.00
Preferred stock, dividend rate									6.00%	6.00%		6.00%	6.00%
Subsequent Event [Member]
Subsequent Event [Line Items]
Preferred stock, dividend rate	6.00%
Preferred stock dividend date declared	Apr. 13, 2026
Preferred stock, dividend per share \| $ / shares	$ 0.0015
Preferred stock dividend paid date	May 01, 2026
Preferred stock dividend record date	Apr. 23, 2026
Subsequent Event [Member] \| Convertible Preferred Stock [Member]
Subsequent Event [Line Items]
Issue price \| $ / shares					$ 0.15
Preferred stock, dividend rate			6.00%		6.00%

Schedule of Prepaid Expenses and Other Current Assets (Details) - USD ($) $ in Thousands	Mar. 31, 2026	Dec. 31, 2025	Dec. 31, 2024
Prepaid Expenses And Other Current Assets
Prepayments	$ 54	$ 6	$ 212
Other current assets	94	104	325
Prepaid expenses and other current assets	$ 148	$ 110	$ 537

Non-Current Assets (Details Narrative) RM in Millions, $ in Millions	Mar. 31, 2026 USD ($)	Mar. 31, 2026 MYR (RM)	Dec. 31, 2025 USD ($)	Dec. 31, 2025 MYR (RM)	Dec. 31, 2024 USD ($)
Defined Benefit Plan Disclosure [Line Items]
Non-current assets	$ 0.2	RM 1.7	$ 0.2		$ 0.4
Debt instrument interest rate, percentage	8.00%	8.00%	8.00%	8.00%
Unrelated Customer [Member]
Defined Benefit Plan Disclosure [Line Items]
Non-current assets	$ 0.4		$ 0.4	RM 1.7

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

+ Details

Summary of Significant Accounting Policies

3 Months Ended

12 Months Ended

Mar. 31, 2026

Dec. 31, 2025

Summary of Significant Accounting Policies

2. Summary of Significant Accounting Policies

Basis of Presentation

The consolidated financial statements of operations, comprehensive loss, and stockholders’ equity for the three months ended March 31, 2026 include Fitters Sdn. Bhd.

Reverse Stock Splits

Going Concern

Newly Adopted Accounting Pronouncements

Recently Issued Accounting Pronouncements

Fair Value of Financial Instruments

Segments

Comprehensive Income (Loss)

Foreign Currency and Currency Translation

Leases

The Company accounts for lease contracts in accordance with ASC 842. As of March 31, 2026, the Company’s outstanding leases are classified as operating leases.

	●	The lease payments due in any optional period;

	●	Penalties for failure to exercise (or not exercise) the option;

	●	Market factors, such as the availability of similar assets and current rental rates for such assets;

	●	The nature of the underlying leased asset and its importance to the Company’s operations; and

	●	The remaining useful lives of any related leasehold improvements.

The Company has elected an accounting policy to account for the lease and non-lease components as a single lease component.

Discontinued Operations

Operating losses for the three months ended March 31, 2025 from discontinued operations related wholly to research and development expenditures during the period.

Total operating cash flows for the three months ended March 31, 2025 from discontinued operations amounted to $4.1 million.

Revenue Recognition

Overview

Nature of Goods and Services

The Company’s revenue is generated from the sale of tangible products, including:

	●	Fire safety equipment and extinguishers;
	●	Foam system;
	●	Fire resistant doors; and
	●	Personal Protective Equipment (PPE) and Fire Safety Apparel.

All products are sold directly to customers (e.g., municipalities, fire contractors, distributors and individuals).

Disaggregation of Revenue

The following table summarizes total revenue by product for the three months ended March 31, 2026 and 2025 (in thousands):

Product	March 31, 2026		March 31, 2025
	Product revenue in $000’s for the three months ended:
Product	March 31, 2026		March 31, 2025

Fire safety equipment		754		-
Safety apparel		11		-
Maintenance & Servicing		4		-
Project - supply & installation		9		-
Total Revenue	$	778	$	-

Performance Obligations

The Company’s contracts with customers generally include a single performance obligation, which is the promise to transfer the purchased products to the customer.

Transaction Price and Variable Consideration

Contract Balances

Significant Payment Terms

Warranties

Returns and Refunds

The level of returns is of an immaterial value.

Practical Expedients and Policy Elections

The Company applies practical expedient to expense incremental costs of obtaining a contract, such as commissions, when the amortization period would have been one year or less.

Remaining Performance Obligations

2. Summary of Significant Accounting Policies

Use of Estimates

Foreign Currency and Currency Translation

Cash and Cash Equivalents

Property and Equipment

Impairment of Long-lived Assets

Impairment, if any, is measured as the amount by which the carrying amount of a long-lived asset or asset group exceeds its fair value.

Goodwill

Fair Value of Financial Instruments

	●	Level 1 — Quoted prices in active markets for identical assets or liabilities.
	●	Level 2 — Observable inputs (other than Level 1 quoted prices), such as quoted prices in active markets for similar assets or liabilities, quoted prices in markets that are not active for identical or similar assets or liabilities, or other inputs that are observable or can be corroborated by observable market data.
	●	Level 3 — Unobservable inputs that are supported by little or no market activity that are significant to determining the fair value of the assets or liabilities, including pricing models, discounted cash flow methodologies and similar techniques.

Segments

The Company is managed and operated as one business which is currently focused on the sale and distribution of fire safety materials, equipment and fire prevention systems. The entire business is managed by a single management team that reports to the Chief Executive Officer. Similarly, the Company’s legacy operations within the biotechnology industry were also managed entirely by a single management team that reported into the Chief Executive Officer. The Company has not operated separate lines of business with respect to any of its operations and the Company did not prepare discrete financial information with respect to separate products or product candidates separate businesses or by location through December 31, 2025. Accordingly, the Company views its current business as one reportable operating segment with operations in one geographic area, namely Malaysia. In 2024, the Company viewed its legacy business also as one reportable operating segment with operations in the United Kingdom and United States of America.

Revenue Recognition

Overview

Nature of Goods and Services

The Company’s revenue is generated from the sale of tangible products, including:

	●	Fire safety equipment and extinguishers;
	●	Foam system;
	●	Fire resistant doors; and
	●	Personal Protective Equipment (PPE) and Fire Safety Apparel.

All products are sold directly to customers (e.g., municipalities, fire contractors, distributors and individuals).

Disaggregation of Revenue

The following table summarizes total revenue by product for the years ended December 31, 2025 and 2024 (in thousands):

	-		-
	Product revenue in $000’s for the year ended:
Product	December 31, 2025		December 31, 2024

Safety apparel		119		-
Fire safety equipment		603		-
Maintenance & Servicing		6		-
Project - supply & installation		20		-
Clinical trial supply		-		43
Total Revenue	$	747	$	43

Performance Obligations

The Company’s contracts with customers generally include a single performance obligation, which is the promise to transfer the purchased products to the customer.

Transaction Price and Variable Consideration

Contract Balances

Significant Payment Terms

Warranties

Returns and Refunds

The level of returns is of an immaterial value.

Practical Expedients and Policy Elections

The Company applies the practical expedient to expense incremental costs of obtaining a contract, such as commissions, when the amortization period would have been one year or less.

Remaining Performance Obligations

Other Income

Other income is primarily related to royalty income received under a historical Asset Purchase Agreement for activities which are not part of the Company’s ongoing operations and activities.

Leases

The Company accounts for lease contracts in accordance with ASC 842. As of December 31, 2025 and 2024, all of the Company’s leases are classified as operating leases.

The Company recognizes an asset for the right to use an underlying leased asset for the lease term and records lease liabilities based on the present value of the Company’s obligation to make lease payments under the lease. As the Company’s leases do not indicate an implicit rate, the Company uses a best estimate of its incremental borrowing rate to discount the future lease payments. The Company estimates its incremental borrowing rate based on observable information about risk-free interest rates that are the same tenure as the lease term, adjusted for various factors, including the effects of assumed collateral, the nature of how a loan would be repaid (e.g., amortizing versus bullet), and the Company’s credit risk.

	●	The lease payments due in any optional period;
	●	Penalties for failure to exercise (or not exercise) the option;
	●	Market factors, such as the availability of similar assets and current rental rates for such assets;
	●	The nature of the underlying leased asset and its importance to the Company’s operations; and
	●	The remaining useful lives of any related leasehold improvements.

The Company has elected an accounting policy to account for the lease and non-lease components as a single lease component.

Stock-based Compensation

The expected term assumption is estimated using past history of early exercise behavior and expectations about future behaviors.

The expected dividend yield is zero, as the Company has never paid cash dividends on common stock and does not expect to pay any cash dividends on common stock in the foreseeable future.

Income Taxes

Net Loss Per Common Share

Comprehensive Income (Loss)

All components of comprehensive income (loss), including net income (loss), are reported in the financial statements in the period in which they are recognized. Comprehensive income (loss) is defined as the change in equity during a period from transactions and other events and circumstances from non-owner sources. Net income (loss) and other comprehensive income (loss), including foreign currency translation adjustments, are reported to arrive at comprehensive income (loss). There were no reclassifications out of other comprehensive income (loss) during the year ended December 31, 2024. In 2025, the Company deconsolidated a foreign operation based in the United Kingdom. Upon loss of control of the foreign subsidiary, the accumulated translation adjustments recorded in other comprehensive income within equity were recycled as part of the gain on deconsolidation of former subsidiary.

Recently Issued Accounting Pronouncements

The FASB has issued ASU 2024-03, “Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses”, as amended by ASU 2025-01, “Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Clarifying the Effective Date”. This standard will require all public entities to disclose additional information about specific expense categories in the notes to financial statements at interim and annual reporting periods. The amendments in ASU 2024-03 are effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. ASU 2024-03 will not change the way in which expenses are recognized or measured. However, the Company is currently evaluating the effects of ASU 2023-07 on its financial statement presentation and disclosures.

Policies Prior to the Disposition of Pharmaceutical Development Business

Research and Development Costs

Clinical Trial Accounting

Patent Costs

Patent prosecution costs are charged to general and administrative expenses as incurred as recoverability of such expenditure is uncertain.

Future NRG Sdn. Bhd. [Member]

Summary of Significant Accounting Policies

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Functional and Reporting Currency

The functional currency of the Company is the Malaysian Ringgit (“RM”). Financial statements are presented in USD using the translation rates below:

Period

Closing Rate

(RM/USD)

March 31, 2026

4.046

December 31, 2025

4.061

Other Significant Accounting Policies

Revenue recognition : Revenue is recognized upon completion of service delivery or transfer of control of goods. Payment terms are 30–60 days.

Trade accounts receivable and ECL : Receivables are carried at amortized cost, net of an allowance for expected credit losses estimated on aging analysis and forward-looking factors.

Inventories : Stated at the lower of cost (FIFO method) and net realizable value.

Property and equipment : Recognized under the cost model; depreciated straight-line over useful lives of 5–50 years. Land is not depreciated.

Income taxes : Liability method; deferred tax assets are reduced by a valuation allowance where it is more likely than not that they will not be realized.

Leases : Short-term lease exemption applied for leases with terms of twelve months or less. No right-of-use assets or lease liabilities are recognized.

2.	SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

(a)

Basis of Presentation

The Company’s date of transition to U.S. GAAP is January 1, 2024. U.S. GAAP accounting policies have been applied retrospectively to all periods presented.

(b)

Functional and Reporting Currency

Balance Sheet Date	RM / USD
December 31, 2023		4.5900
December 31, 2024		4.4755
December 31, 2025		4.0610

(c)

Use of Estimates

(d)

Cash and Cash Equivalents

(e)

Trade Accounts Receivable, Net

(f)

Inventories

Inventories are stated at the lower of cost (first-in, first-out) and net realizable value.

(g)

Property and Equipment, Net

(h)

Income Taxes

Deferred taxes are accounted for under the liability method. Deferred tax assets are reduced by a valuation allowance when it is more likely than not that some portion will not be realized.

(i)

Revenue Recognition

(j)

Discontinued Operations

(k)

Loss Per Share

Basic earnings (loss) per share is computed by dividing net income (loss) by the weighted average shares outstanding. No dilutive securities existed in either period presented.

(l)

Concentrations of Risk

Significant Event (Details Narrative) - Future NRG Sdn. Bhd. [Member] - MYR (RM)	Mar. 16, 2026	Mar. 26, 2026
Perfect Energy Sdn Bhd [Member]
Ownership percentage		55.00%
Share Sale Agreements [Member] \| Nine Individual Purchasers [Member]
Number of ordinary shares disposed	5,600,000
Cash consideration	RM 3,040,000.00
Share holding percentage	20.00%
Share Sale Agreements [Member] \| Perfect Energy Sdn Bhd [Member]
Number of ordinary shares disposed	15,400,000
Cash consideration	RM 8,360,000
Share holding percentage	55.00%
Share Sale Agreements [Member] \| Antbiz Sdn Bhd [Member]
Number of ordinary shares disposed	7,000,000
Cash consideration	RM 3,800,000
Share holding percentage	25.00%
Share Sale Agreements [Member] \| FITTERS Diversified Berhad [Member]
Number of ordinary shares disposed	28,000,000
Cash consideration	RM 15,200,000

Schedule of Components of (Loss) Income Before Taxes from Continuing Operations (Details) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2026	Mar. 31, 2025	Dec. 31, 2025	Dec. 31, 2024
Income Tax Disclosure [Abstract]
Domestic			$ (1,839)	$ 36
Foreign			(1,152)	(12,030)
Income / (loss) before income taxes	$ (167)	$ (4,206)	$ (2,991)	$ (11,994)

- Definition

Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 30
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 4: http://www.xbrl.org/2003/role/exampleRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 45
-Paragraph 3A
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483475/205-20-45-3A

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Topic 220
-SubTopic 40
-Name Accounting Standards Codification
-Section 55
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476153/220-40-55-4

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Topic 220
-SubTopic 40
-Name Accounting Standards Codification
-Section 55
-Paragraph 21
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476153/220-40-55-21

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Topic 220
-SubTopic 40
-Name Accounting Standards Codification
-Section 55
-Paragraph 14
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476153/220-40-55-14

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 235
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 235
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-05(b)(2))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1

Reference 10: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 48
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-48

Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 270
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482964/270-10-50-1

Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (ee)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(11))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1

Reference 14: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 31
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-31

Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(10))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2

Reference 16: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 942
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(15))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1

+ Details

Property and Equipment

3 Months Ended

12 Months Ended

Mar. 31, 2026

Dec. 31, 2025

Property, Plant, and Equipment [Line Items]

Property and Equipment

11. Property and Equipment

Property and equipment consisted of the following at December 31, 2025 and 2024 (in thousands):

Schedule of Property and Equipment

	Lives in years	2025			2024
		December 31,
	Lives in years	2025			2024
Leasehold improvements	1 to 2	$	138		$	6
Plant & Equipment	3 to 5		1			—
Office equipment and furniture	3 to 5		282			420
Property and equipment, gross			421			427
Less: accumulated depreciation and amortization			(284	)		(424	)
Property and equipment, net		$	137		$	3

Future NRG Sdn. Bhd. [Member]

Property, Plant, and Equipment [Line Items]

Property and Equipment

8. PROPERTY AND EQUIPMENT, NET

Property and Equipment

Schedule of Property and Equipment

	Mar 31, 2026 (USD)
Freehold land		404,377
Building — net		2,632,773
Plant and machinery — net		1,436,396
Computer and office equipment — net		13,048
Air conditioners, furniture and fittings — net		440
Property and equipment, net — continuing operations		4,487,034

Depreciation expense from continuing operations: Q1 2026 USD 48,114 (included within cost of revenues and operating expenses).

Property and Equipment

7.	PROPERTY AND EQUIPMENT, NET – CONTINUING OPERATIONS

Schedule of Property and Equipment

	Note	2025			2024
		(USD)			(USD)
Cost:
Land			402,883			365,570
Building			3,155,999			2,863,705
Machinery			2,455,818			2,228,372
Computer & office equipment			64,280			51,730
Other assets			4,188			3,340
Total cost			6,083,168			5,512,717
Less: Accumulated depreciation:
Building			(517,170	)		(411,998	)
Machinery			(994,282	)		(791,695	)
Other assets			(53,319	)		(41,496	)
Total depreciation			(1,564,771	)		(1,245,189	)

Property and equipment, net			4,518,397			4,267,528

Depreciation expense from continuing operations: USD 191,982 (FY2025); USD 173,709 (FY2024).

- Definition

The entire disclosure for property, plant, and equipment. Includes, but is not limited to, land and land improvement; building; machinery and equipment; furniture and fixture; and work of art, historical treasure, or similar asset classified as collection.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 360
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482099/360-10-50-3

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 360
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482099/360-10-50-3

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 360
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/360/tableOfContent

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 360
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482099/360-10-50-2

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 360
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 13
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482130/360-10-45-13

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 360
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 5.CC)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480091/360-10-S99-2

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-SubTopic 360
-Topic 958
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477798/958-360-50-6

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-SubTopic 360
-Topic 958
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477798/958-360-50-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-SubTopic 360
-Topic 958
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477798/958-360-50-7

+ Details

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 905
-SubTopic 360
-Name Accounting Standards Codification
-Section 25
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478704/905-360-25-4

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 360
-SubTopic 10
-Name Accounting Standards Codification
-Section 05
-Paragraph 3
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482338/360-10-05-3

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 360
-SubTopic 10
-Name Accounting Standards Codification
-Section 30
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482222/360-10-30-2

Reference 4: http://www.xbrl.org/2003/role/exampleRef
-Topic 360
-SubTopic 10
-Name Accounting Standards Codification
-Section 05
-Paragraph 3
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482338/360-10-05-3

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 360
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482099/360-10-50-1

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Topic 360
-SubTopic 10
-Name Accounting Standards Codification
-Section 05
-Paragraph 3
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482338/360-10-05-3

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Topic 360
-SubTopic 10
-Name Accounting Standards Codification
-Section 05
-Paragraph 3
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482338/360-10-05-3

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 360
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482099/360-10-50-1

Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482558/350-40-50-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 842
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 7A
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A

+ Details

Leases (Tables)

3 Months Ended

Mar. 31, 2026

Lessee Disclosure [Abstract]

Schedule of Remaining Lease Payments

Remaining lease payments for the facilities are as follows (in $000s):

Schedule of Remaining Lease Payments


2026	$	9
2027		2
Thereafter		—
Total future minimum lease obligation	$	11

Schedule of Revenue from Continuing Operations (Details) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2026	Mar. 31, 2025	Dec. 31, 2025	Dec. 31, 2024
Total revenues	$ 778,000		$ 747,000	$ 43,000
MALAYSIA
Total revenues			747,000
Future NRG Sdn. Bhd. [Member]
Total revenues	$ 183,976		854,337	871,741
Future NRG Sdn. Bhd. [Member] \| MALAYSIA
Total revenues			854,337	871,741
Future NRG Sdn. Bhd. [Member] \| Clinic Waste Generator Services [Member]
Total revenues			640,321	671,032
Future NRG Sdn. Bhd. [Member] \| Clinic Waste Logistics Services [Member]
Total revenues			209,915	196,179
Future NRG Sdn. Bhd. [Member] \| Other Revenue For Services [Member]
Total revenues			$ 4,101	$ 4,530

- Definition

+ References

+ Details

Fair Value Measurement

12 Months Ended

Dec. 31, 2025

FairValueMeasurementLineItems [Line Items]

Fair Value Measurement

5. Fair Value of Financial Assets and Liabilities

Fair Value Measurements

as of December 31, 2025 Using:

Level 1

Level 2

Level 3

Total

Assets:

Cash equivalents

—

Total Assets

—

	Level 1		Level 2		Level 3		Total
	Fair Value Measurements
	as of December 31, 2024 Using:
	Level 1		Level 2		Level 3		Total
Assets:
Cash equivalents	$	3,044	$	—	$	—	$	3,044
Total Assets	$	3,044	$	—	$	—	$	3,044

Future NRG Sdn. Bhd. [Member]

FairValueMeasurementLineItems [Line Items]

Fair Value Measurement

12. FAIR VALUE MEASUREMENT

Fair Value Measurement

The Group applies the following fair value hierarchy: Level 1 — quoted prices in active markets; Level 2 — observable inputs other than Level 1; Level 3 — unobservable inputs reflecting management’s assumptions.

The Group had no financial assets or liabilities measured at fair value on a recurring basis as of December 31, 2025 or 2024. The carrying amounts of cash and cash equivalents, accounts receivable, and accounts payable approximate fair value due to their short-term nature.

- Definition

+ References

+ Details

Recent Accounting Pronouncements

3 Months Ended

12 Months Ended

Mar. 31, 2026

Dec. 31, 2025

Future NRG Sdn. Bhd. [Member]

Recent Accounting Pronouncements

3. RECENT ACCOUNTING PRONOUNCEMENTS

Recent Accounting Pronouncements

ASU 2023-09 (Income Taxes — disaggregated disclosures): effective for annual periods beginning after December 15, 2025; the Company is evaluating impact. ASU 2023-07 (Segment Reporting): the Company operates as a single segment; impact is expected to be limited. ASU 2024-03 (DISE — disaggregated expense disclosures): effective December 15, 2026; the Company is evaluating impact. No other recently issued but not yet effective standards are expected to have a material effect on these financial statements.

Recent Accounting Pronouncements

3.	RECENT ACCOUNTING PRONOUNCEMENTS

The Company evaluates all recently issued accounting pronouncements issued by the Financial Accounting Standards Board (“FASB”) and adopts those that are applicable and expected to have a material impact on its consolidated financial statements.

The following Accounting Standards Updates (“ASUs”) were issued by the FASB but were not yet effective or adopted by the Company as of December 31, 2025:

In December 2023, the FASB issued ASU 2023-09 to enhance the transparency and decision usefulness of income tax disclosures. The amendments require additional disclosures relating to the effective tax rate reconciliation and income taxes paid by jurisdiction. The amendments are effective for annual periods beginning after December 15, 2025, with early adoption permitted. The Company is currently evaluating the impact that the adoption of this standard will have on its consolidated financial statements and related disclosures.

In November 2023, the FASB issued ASU 2023-07: Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which expands disclosure requirements for reportable segments, primarily through enhanced disclosures about significant segment expenses and other segment items. The amendments are effective for annual periods beginning after December 15, 2024, and interim periods beginning after December 15, 2025. The Company is currently assessing the impact of adopting this guidance on its disclosures.

In November 2024, the FASB issued ASU 2024-03: Disaggregation of Income Statement Expenses (DISE) which requires additional disaggregated disclosures relating to certain income statement expense captions, including purchases of inventory, employee compensation, depreciation, and amortization expenses. The amendments are effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating the impact of adopting this guidance on its consolidated financial statement disclosures.

Management does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s consolidated financial statements.

- Definition

The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 20
-Name Accounting Standards Codification
-Section 65
-Paragraph 7
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480528/815-20-65-7

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 5
-Subparagraph (SAB Topic 11.M.Q2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480530/250-10-S99-5

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 3
-Subparagraph (e)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479719/606-10-65-3

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 3
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479719/606-10-65-3

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 8
-Subparagraph (f)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480339/815-10-65-8

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 8
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480339/815-10-65-8

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 4
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482705/350-40-65-4

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 4
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482705/350-40-65-4

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 4
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482705/350-40-65-4

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-1

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (e)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479719/606-10-65-2

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (d)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479719/606-10-65-2

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 5
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479279/805-10-65-5

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-1

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 105
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 9
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479343/105-10-65-9

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 17
-Subparagraph (d)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480336/718-10-65-17

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 17
-Subparagraph (d)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480336/718-10-65-17

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)(4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-1

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 105
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 7
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479343/105-10-65-7

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 60
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476176/805-60-65-1

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 848
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483550/848-10-65-2

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 323
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478666/740-323-65-2

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 323
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478666/740-323-65-2

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 323
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478666/740-323-65-2

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 848
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (d)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483550/848-10-65-2

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Topic 848
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (e)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483550/848-10-65-1

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(2)(i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480016/944-40-65-2

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(2)(ii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480016/944-40-65-2

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(2)(iii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480016/944-40-65-2

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(2)(iv)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480016/944-40-65-2

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (h)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480016/944-40-65-2

Reference 32: http://www.xbrl.org/2003/role/disclosureRef
-Topic 326
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 4
-Subparagraph (e)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479654/326-10-65-4

Reference 33: http://www.xbrl.org/2003/role/disclosureRef
-Topic 326
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 4
-Subparagraph (e)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479654/326-10-65-4

Reference 34: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480530/250-10-S99-6

Reference 35: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 65
-Paragraph 4
-Subparagraph (f)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481538/470-20-65-4

Reference 36: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 65
-Paragraph 4
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481538/470-20-65-4

Reference 37: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-1

Reference 38: http://www.xbrl.org/2003/role/disclosureRef
-Name Accounting Standards Codification
-Topic 250
-Publisher FASB
-URI https://asc.fasb.org/250/tableOfContent

Reference 39: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (e)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480175/815-40-65-1

+ Details

Schedule of Goodwill (Details) $ in Thousands	12 Months Ended
Schedule of Goodwill (Details) $ in Thousands	Dec. 31, 2025 USD ($)
Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]
Balance at December 31, 2024
Goodwill on acquisition of Fitters Sdn. Bhd.	1,570
Balance at December 31, 2025	$ 1,570

- Definition

Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S45
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 41
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479303/805-10-55-41

Reference 4: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 8
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479328/805-10-50-8

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480657/210-10-S50-6

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(15))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 24
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482548/350-20-55-24

Reference 8: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 740
-Name Accounting Standards Codification
-Section 55
-Paragraph 13
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478064/805-740-55-13

Reference 9: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 39
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479303/805-10-55-39

Reference 10: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 49
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-49

Reference 11: http://www.xbrl.org/2003/role/exampleRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 100
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482078/820-10-55-100

Reference 12: http://www.xbrl.org/2003/role/exampleRef
-Topic 852
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481372/852-10-55-10

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 45
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482598/350-20-45-1

Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(10)(1))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1

Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 805
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479581/805-30-50-4

+ Details

Geographic and Segment Information (Tables)

12 Months Ended

Dec. 31, 2025

Segment Reporting [Abstract]

Schedule of Geographic Information

Geographic information for the years ended December 31, 2025 and 2024 is as follows (in thousands):

Schedule of Geographic Information

	2025			2024
	Year Ended December 31,
	2025			2024
Revenue
United Kingdom	$	—		$	43
Malaysia		747			—
Total Revenue	$	747		$	43

Net (loss) / gain
United States	$	(1,857	)	$	(37	)
Malaysia		119			—
United Kingdom		(1,260	)		(11,175	)
Total Net Loss	$	(2,998	)	$	(11,212	)

	2025			2024
	December 31,
	2025			2024
Total Assets
United States	$	2,031		$	3,285
Malaysia		6,154			—
United Kingdom		—			809
Total Assets	$	8,185		$	4,094
Long Lived Assets, net
United States	$	(0	)	$	1
Malaysia		137
United Kingdom		—			2
Total Long Lived Assets, net	$	137		$	3

Schedule of Summary of Consolidated Net Loss

A summary of our consolidated net loss for the years ended December 31, 2025 and 2024 is as follows, including the significant expenses provided to and regularly reviewed by our CEO:

	2025			2024
	December 31,
	2025			2024
Revenues	$	747		$	43

Operating expenses:
Cost of sales		609			—
Research and development		848			6,655
General and administrative		7,717			5,392
Total operating expenses		9,174			12,047

Operating loss		(8,427	)		(12,004	)

Total other income (expense), net		5,436			10
Loss before taxes		(2,991	)		(11,994	)

Income tax benefit / (charge)		(7	)		782

Net loss	$	(2,998	)	$	(11,212	)

- Definition

Tabular disclosure of segment reporting. Includes, but is not limited to, reconciliation of reportable segment amount to corresponding consolidated total.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 31
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-31

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 34
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-34

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 30
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 26C
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C

Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 26B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B

Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 26A
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-26A

Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 25
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-25

Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 15
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-15

+ Details

Revenue from Services (Details Narrative)	3 Months Ended	12 Months Ended
Revenue from Services (Details Narrative)	Mar. 31, 2026	Dec. 31, 2025	Dec. 31, 2024
Revenue Benchmark [Member] \| Customer Concentration Risk [Member] \| Customer One [Member] \| Future NRG Sdn. Bhd. [Member]
Product Information [Line Items]
Concentration risk percentage	68.00%	70.00%	71.00%

- Definition

For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.

+ References + Details

Schedule of Property and Equipment (Details) - USD ($)	Mar. 31, 2026	Dec. 31, 2025	Dec. 31, 2024
Property, Plant, and Equipment [Line Items]
Property and equipment, gross		$ 421,000	$ 427,000
Less: accumulated depreciation and amortization		284,000	424,000
Property and equipment, net	$ 138,000	137,000	3,000
Accumulated depreciation and amortization		(284,000)	(424,000)
Future NRG Sdn. Bhd. [Member]
Property, Plant, and Equipment [Line Items]
Property and equipment, gross		6,083,168	5,512,717
Less: accumulated depreciation and amortization		1,564,771	1,245,189
Property and equipment, net	$ 4,487,034	4,518,397	4,267,528
Accumulated depreciation and amortization		$ (1,564,771)	(1,245,189)
Minimum [Member]
Property, Plant, and Equipment [Line Items]
Lives in years		3 years
Minimum [Member] \| Future NRG Sdn. Bhd. [Member]
Property, Plant, and Equipment [Line Items]
Lives in years	5 years	3 years
Maximum [Member]
Property, Plant, and Equipment [Line Items]
Lives in years		5 years
Maximum [Member] \| Future NRG Sdn. Bhd. [Member]
Property, Plant, and Equipment [Line Items]
Lives in years	50 years	50 years
Leasehold Improvements [Member]
Property, Plant, and Equipment [Line Items]
Property and equipment, gross		$ 138,000	6,000
Leasehold Improvements [Member] \| Minimum [Member]
Property, Plant, and Equipment [Line Items]
Lives in years		1 year
Leasehold Improvements [Member] \| Maximum [Member]
Property, Plant, and Equipment [Line Items]
Lives in years		2 years
Property, Plant and Equipment [Member]
Property, Plant, and Equipment [Line Items]
Property and equipment, gross		$ 1,000
Property, Plant and Equipment [Member] \| Minimum [Member]
Property, Plant, and Equipment [Line Items]
Lives in years		3 years
Property, Plant and Equipment [Member] \| Maximum [Member]
Property, Plant, and Equipment [Line Items]
Lives in years		5 years
Office Equipment And Furniture [Member]
Property, Plant, and Equipment [Line Items]
Property and equipment, gross		$ 282,000	420,000
Office Equipment And Furniture [Member] \| Minimum [Member]
Property, Plant, and Equipment [Line Items]
Lives in years		3 years
Office Equipment And Furniture [Member] \| Maximum [Member]
Property, Plant, and Equipment [Line Items]
Lives in years		5 years
Land [Member] \| Future NRG Sdn. Bhd. [Member]
Property, Plant, and Equipment [Line Items]
Property and equipment, gross	$ 404,377	$ 402,883	365,570
Building [Member] \| Future NRG Sdn. Bhd. [Member]
Property, Plant, and Equipment [Line Items]
Property and equipment, gross	2,632,773	3,155,999	2,863,705
Less: accumulated depreciation and amortization		517,170	411,998
Accumulated depreciation and amortization		(517,170)	(411,998)
Machinery and Equipment [Member] \| Future NRG Sdn. Bhd. [Member]
Property, Plant, and Equipment [Line Items]
Property and equipment, gross	1,436,396	2,455,818	2,228,372
Less: accumulated depreciation and amortization		994,282	791,695
Accumulated depreciation and amortization		(994,282)	(791,695)
Computer Equipment [Member] \| Future NRG Sdn. Bhd. [Member]
Property, Plant, and Equipment [Line Items]
Property and equipment, gross	13,048	64,280	51,730
Other Machinery and Equipment [Member] \| Future NRG Sdn. Bhd. [Member]
Property, Plant, and Equipment [Line Items]
Property and equipment, gross		4,188	3,340
Less: accumulated depreciation and amortization		53,319	41,496
Accumulated depreciation and amortization		$ (53,319)	$ (41,496)
Furniture and Fixtures [Member] \| Future NRG Sdn. Bhd. [Member]
Property, Plant, and Equipment [Line Items]
Property and equipment, gross	$ 440

Consolidated Statements of Cash Flows - USD ($)	3 Months Ended		12 Months Ended
Consolidated Statements of Cash Flows - USD ($)	Mar. 31, 2026	Mar. 31, 2025	Dec. 31, 2025	Dec. 31, 2024
CASH FLOWS FROM OPERATING ACTIVITIES
Net income for the period / year	$ (197,000)	$ (81,000)	$ (2,998,000)	$ (11,212,000)
Adjustments for non-cash items:
Depreciation and amortization	1,000		5,000	6,000
Gain on deconsolidation of subsidiary			4,947,000
Stock-based compensation	1,000	1,666,000	2,334,000	592,000
Changes in lease liability	(2,000)	9,000	2,000	(37,000)
Changes in operating assets and liabilities:
Trade accounts receivable	69,000		(1,257,000)
Inventories	437,000		(1,384,000)
Prepaid expenses and other assets	(52,000)	658,000	4,087,000	4,472,000
Accounts payable and accrued liabilities	(535,000)	(5,499,000)	(10,506,000)	(1,811,000)
Net cash from operating activities	(278,000)	(3,247,000)	(4,770,000)	(7,990,000)
CASH FLOWS FROM INVESTING ACTIVITIES
Acquisition of property and equipment — continuing	(1,000)
Net cash used in investing activities	(1,000)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds, net of issuance costs, from issuing common stock and pre-funded warrants, net	125,000	3,894,000	6,425,000	6,209,000
Costs from issuing common stock and pre-funded warrants		(248,000)
Payment made under the Warrant Exchange Amendment			(1,100,000)
Proceeds from the exercise of stock options and warrants, net of issuance costs				1,613,000
Payment of preferred stock dividend	(20,000)		(61,000)
Net cash used in financing activities	105,000	3,646,000	5,264,000	7,822,000
Effect of exchange rate changes on cash	8,000	(86,000)	(126,000)	(73,000)
Net (decrease) / increase in cash and cash equivalents	(166,000)	313,000	368,000	(241,000)
Cash at beginning of year	3,505,000	3,137,000	3,137,000	3,378,000
Cash at end of year	3,339,000	3,450,000	3,505,000	3,137,000
Non cash financing activities:
Issuance of shares in acquisition of Fitters Sdn. Bhd.			4,450,000
Warrant Exchange			11,033,000
Cash received during the period for:
Interest	9,000	9,000	68,000	96,000
Research & development tax credits				3,715,000
Cash paid during the period for:
Interest		4,000	7,000
Taxes			18,000	2,000
Composition of cash at end of period / year:
Continuing operations	3,339,000		3,505,000	3,137,000
Future NRG Sdn. Bhd. [Member]
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss from continuing operation			(67,140)	(123,433)
Net income from discontinued operation			2,557,550	921,119
Net income for the period / year	(45,890)		2,490,410	797,686
Adjustments for non-cash items:
Depreciation and amortization	48,114		191,982	173,709
Depreciation and amortization — continuing			191,982	173,709
Depreciation and amortization — discontinued			1,187,900	1,062,817
Impairment on financial assets — continuing			35,616	32,318
Allowance for expected credit losses	8,937
Bad debts written off			104,588
Loss on disposal of equity interest in subsidiary	1,919,251
Waiver of debts	(1,941,507)
Interest expense on hire purchase
Changes in operating assets and liabilities:
Trade accounts receivable	123,350
Inventories	(3,459)
Accounts payable and accrued liabilities	(14,848)
Trade accounts receivable — continuing			(104,105)	2,811,351
Inventories — continuing			26,308	17,030
Accounts payable and accrued liabilities — continuing			(276,764)	(2,734,688)
Income taxes (paid) / refunded — continuing			3,287	(938)
Net changes in working capital —discontinued			(1,171,032)	(894,736)
Net cash from operating activities	93,948		2,488,190	1,264,549
CASH FLOWS FROM INVESTING ACTIVITIES
Acquisition of property and equipment — continuing			(7,270)	(282)
Acquisition of property and equipment — discontinued			(155,543)	(8,336)
Net cash used in investing activities			(162,813)	(8,618)
CASH FLOWS FROM FINANCING ACTIVITIES
Repayment of banker’s acceptance — discontinued			(1,031,318)	(361,710)
Repayment of hire purchase obligations — discontinued			(152,226)	(389,834)
Net cash used in financing activities			(1,183,544)	(751,544)
Effect of exchange rate changes on cash	(287,015)		225,986	36,558
Net (decrease) / increase in cash and cash equivalents	(193,067)		1,367,819	540,945
Cash at beginning of year	3,337,766	$ 1,969,947	1,969,947	1,429,002
Cash at end of year	9,649		3,337,766	1,969,947
Cash — beginning of period / year (continuing operations)	202,716
Cash — end of period / year	9,649		202,716
Composition of cash at end of period / year:
Continuing operations	9,649		202,716	268,780
Discontinued operations			$ 3,135,050	$ 1,701,167
Total cash and cash equivalents	$ 9,649

Consolidated Statements of Operations

3 Months Ended

12 Months Ended

Mar. 31, 2026

USD ($)

$ / shares

Mar. 31, 2025

USD ($)

$ / shares

Dec. 31, 2025

USD ($)

$ / shares

Dec. 31, 2024

USD ($)

$ / shares

Revenues:

Total revenues

$ 778,000

$ 747,000

$ 43,000

Operating expenses

Cost of sales

635,000

609,000

Research and development

848,000

6,655,000

General and administrative expenses

389,000

4,214,000

7,717,000

5,392,000

Total operating expenses

1,024,000

4,214,000

9,174,000

12,047,000

Operating loss from continuing operations

(246,000)

(4,214,000)

(8,427,000)

(12,004,000)

Other income

Foreign exchange gains (losses)

39,000

(8,000)

73,000

(54,000)

Interest income

9,000

6,000

62,000

12,000

Gain on deconsolidation of former subsidiary

4,947,000

Other income, net

31,000

10,000

354,000

52,000

Total other income, net

79,000

8,000

5,436,000

10,000

Income / (loss) before income taxes

(167,000)

(4,206,000)

(2,991,000)

(11,994,000)

Income tax provision

(30,000)

(7,000)

782,000

Net income / (loss) from continuing operations

(197,000)

(4,206,000)

DISCONTINUED OPERATIONS

Operating losses from discontinued operations

(822,000)

Gain on deconsolidation of subsidiary

4,947,000

Net income from discontinued operations, net of tax

4,125,000

NET INCOME (LOSS)

(197,000)

(81,000)

(2,998,000)

(11,212,000)

OTHER COMPREHENSIVE INCOME (LOSS)

Foreign currency translation adjustments

9,000

2,385,000

2,346,000

2,916,000

Total comprehensive income

(188,000)

810,000

(3,032,000)

(11,195,000)

Dividend on convertible exchangeable preferred shares

(20,000)

(61,000)

Deemed dividend on warrant exchange

(11,033,000)

Net loss applicable to common shareholders

$ (217,000)

$ (81,000)

$ (14,092,000)

$ (11,212,000)

EARNINGS PER SHARE — basic and diluted*

EARNINGS (LOSS) PER SHARE - Basic | $ / shares

$ (6.45)

$ (502.46)

EARNINGS (LOSS) PER SHARE - Diluted | $ / shares

$ (6.45)

$ (502.46)

Continuing operations Basic (USD per share) | $ / shares

$ (0.04)

$ (11.52)

Continuing operations Diluted (USD per share) | $ / shares

(0.04)

(11.52)

Discontinued operations Basic (USD per share) | $ / shares

11.29

Discontinued operations Diluted (USD per share) | $ / shares

$ 11.29

Weighted average shares outstanding - Basic | shares

5,458,564

365,231

2,185,075

22,314

Weighted average shares outstanding - Diluted | shares

5,458,564

365,231

2,185,075

22,314

Future NRG Sdn. Bhd. [Member]

Revenues:

Total revenues

$ 183,976

$ 854,337

$ 871,741

Cost of revenues

Total cost of revenues

(137,688)

(580,357)

(598,307)

Gross profit

46,288

273,980

273,434

Operating expenses

General and administrative expenses

13,406

35,708

114,979

Selling and distribution costs

(324)

(5,907)

(8,669)

Loss on disposal of equity interest in subsidiary

(1,919,251)

Compensation and benefits

(28,433)

(97,826)

(86,105)

Depreciation and amortization

(48,114)

(191,982)

(173,709)

Professional fees

(24,157)

(14,480)

(16,595)

Impairment on financial assets / ECL

(35,616)

(32,318)

Total operating expenses

2,033,685

381,519

432,375

Operating loss from continuing operations

(1,987,397)

(107,539)

(158,941)

Other income

Interest income

40,677

35,508

Total other income, net

1,941,507

Income / (loss) before income taxes

(45,890)

(66,862)

(123,433)

Income tax provision

(278)

Net income / (loss) from continuing operations

(45,890)

(67,140)

(123,433)

DISCONTINUED OPERATIONS

Net income from discontinued operations, net of tax

2,557,550

921,119

NET INCOME (LOSS)

(45,890)

2,490,410

797,686

OTHER COMPREHENSIVE INCOME (LOSS)

Foreign currency translation adjustments

(28,493)

174,075

22,645

Total comprehensive income

$ (74,383)

$ 2,664,485

$ 820,331

EARNINGS PER SHARE — basic and diluted*

EARNINGS (LOSS) PER SHARE - Basic | $ / shares

$ (0.0016)

^[1]

$ 0.0889

$ 0.0285

EARNINGS (LOSS) PER SHARE - Diluted | $ / shares

(0.0016)

^[1]

0.0889

0.0285

Continuing operations Basic (USD per share) | $ / shares

(0.0016)

^[1]

(0.0024)

(0.0044)

Continuing operations Diluted (USD per share) | $ / shares

(0.0016)

^[1]

(0.0024)

(0.0044)

Discontinued operations Basic (USD per share) | $ / shares

^[1]

0.0913

0.0329

Discontinued operations Diluted (USD per share) | $ / shares

^[1]

$ 0.0913

$ 0.0329

Weighted average shares outstanding - Basic | shares

28,000,000

Weighted average shares outstanding - Diluted | shares

28,000,000

Product Revenue Fire Safety [Member]

Revenues:

Total revenues

$ 747,000

Clinical Trial Supply [Member]

Revenues:

Total revenues

43,000

Compensation and Benefits [Member] | Future NRG Sdn. Bhd. [Member]

Cost of revenues

Total cost of revenues

$ (20,691)

(72,663)

(83,223)

Upkeep of Plant [Member] | Future NRG Sdn. Bhd. [Member]

Cost of revenues

Total cost of revenues

(86,163)

(345,172)

(371,934)

Other Cost Of Revenues [Member] | Future NRG Sdn. Bhd. [Member]

Cost of revenues

Total cost of revenues

(30,834)

$ (162,522)

$ (143,150)

Revenue from Services [Member] | Future NRG Sdn. Bhd. [Member]

Revenues:

Total revenues

$ 183,976

[1]	No potentially dilutive securities existed in any period presented. Basic and diluted EPS are identical.

Related Party Transactions (Details Narrative)	3 Months Ended
Related Party Transactions (Details Narrative)	Mar. 31, 2026 USD ($)
FITTERS Diversified Berhad [Member] \| Future NRG Sdn. Bhd. [Member]
Defined Benefit Plan Disclosure [Line Items]
Administrative charges and rental	$ 6,673

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

+ Details

Stock Based Compensation (Details Narrative) - USD ($)		1 Months Ended	3 Months Ended		12 Months Ended
Stock Based Compensation (Details Narrative) - USD ($)	Jan. 31, 2023	Jan. 31, 2023	Mar. 31, 2026	Mar. 31, 2025	Dec. 31, 2025	Dec. 31, 2024	Feb. 06, 2025	Oct. 31, 2020
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Restricted stock options granted			0	24,818
Restricted stock units granted				0
Remaining unrecognized compensation cost of non-vested stock options					$ 1,500,000
Weighted-average remaining requisite service period of recognition of unrecognized compensation cost					6 months
Share-Based Payment Arrangement, Option [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Stock option awards granted term						6 years
Restricted stock options granted					24,812	52
Restricted stock units granted					1,066
Options granted, grant date fair value per share						$ 424.80
Options exercised
Restricted Stock Units (RSUs) [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of shares granted					500,178	52
Restricted stock units, grant date fair value per share vested					$ 1.40	$ 547.20
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Requisite Service Period						6 months
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period		71			500,178
Stock awards vesting period		3 years
Restricted stock units, grant date fair value per share non-vested	$ 3,240.00				$ 1.40	$ 547.20
Shares forfeited					2
Shares forfeited, value					$ 92,000
Unrecognized compensation expense, awards					$ 1,000
Maximum [Member] \| Share-Based Payment Arrangement, Option [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Stock option awards granted term					10 years
Options granted, grant date fair value per share					$ 72.38
Minimum [Member] \| Share-Based Payment Arrangement, Option [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Stock option awards granted term					5 years
Options granted, grant date fair value per share					$ 60.86
2018 Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Common stock reserved for future issuance					4,282,026		500,000
Additional shares aproved					4,281,987
Stock option awards description					vest over a one to four-year period from the date of grant
2018 Plan [Member] \| Maximum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Stock option awards granted term					10 years
2020 Inducement Equity Incentive Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of authorized shares								55
Number of shares issued					55

Consolidated Balance Sheets (Parenthetical)	3 Months Ended	12 Months Ended
Consolidated Balance Sheets (Parenthetical)	Mar. 31, 2026 USD ($) $ / shares shares	Dec. 31, 2025 USD ($) $ / shares shares	Dec. 31, 2024 USD ($) $ / shares shares
Preferred stock, par value \| $ / shares	$ 0.001	$ 0.001	$ 0.001
Preferred stock, shares authorized	5,000,000	5,000,000	5,000,000
Dividend rate on convertible exchangeable preferred stock percentage	6.00%	6.00%	6.00%
Common stock, par value \| $ / shares	$ 0.001	$ 0.001	$ 0.001
Common stock, shares authorized	600,000,000	600,000,000	100,000,000
Common stock, shares issued	5,519,456	5,400,320	36,913
Common stock, shares outstanding	5,519,456	5,400,320	36,913
Net of allowances \| $	$ 286,000	$ 447,000
Future NRG Sdn. Bhd. [Member]
Common stock, par value \| (per share)		$ 0.22	$ 0.22
Common stock, shares authorized	28,000,000	28,000,000	28,000,000
Common stock, shares issued	28,000,000
Common stock, shares outstanding	28,000,000
Net of allowances \| $		$ 312,455	$ 251,199
6% Convertible Exchangeable Preferred Stock [Member]
Dividend rate on convertible exchangeable preferred stock percentage			6.00%
Preferred stock, shares issued	135,273	135,273	135,273
Preferred stock, shares outstanding	135,273	135,273	135,273
Preferred stock, liquidation preference value \| $	$ 1,717,967	$ 1,717,967	$ 4,006,512
Series A Preferred Stock [Member]
Preferred stock, par value \| $ / shares	$ 0.001	$ 0.001	$ 0.001
Preferred stock, shares issued	264	264	264
Preferred stock, shares outstanding	264	264	264
Series B Preferred Stock [Member]
Preferred stock, par value \| $ / shares		$ 0.001	$ 0.001
Preferred stock, shares issued		0	119,000
Preferred stock, shares outstanding		0	119,000

Schedule of Accounts Receivables (Details) - USD ($)	3 Months Ended	12 Months Ended
Schedule of Accounts Receivables (Details) - USD ($)	Mar. 31, 2026	Dec. 31, 2025	Dec. 31, 2024
Accounts, Notes, Loans and Financing Receivable [Line Items]
Accounts receivable, net	$ 1,188,000	$ 1,257,000
Accounts receivables, gross	1,474,000	1,704,000
Allowance for doubtful debt	(286,000)	(447,000)
Total accounts receivable, net	1,188,000	1,257,000
Beginning balance	447,000
Charge for the year
Foreign exchange translation	(1,000)
Closing balance	286,000	447,000
Future NRG Sdn. Bhd. [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Accounts receivable, net	334,894	320,516	323,587
Allowance for doubtful debt		(312,455)	(251,199)
Total accounts receivable, net	334,894	320,516	323,587
Trade receivables, gross	615,123	602,579	538,423
Less: Allowance for expected credit losses	(313,610)	(312,455)	(251,199)
Trade receivables, net	301,513	290,124	287,224
Other receivables	9,887	9,850	17,875
Refundable deposits	20,619	20,542	18,488
Beginning balance	312,455	251,199	213,421
Charge for the year		35,616	32,318
Foreign exchange translation		25,640	5,460
Closing balance		$ 312,455	$ 251,199
Prepayments	$ 2,875

Fees Summary	Jun. 16, 2026 USD ($)
Fees Summary [Line Items]
Total Offering	$ 6,100,218.00
Previously Paid Amount	0.00
Total Fee Amount	842.44
Total Offset Amount	0.00
Net Fee	$ 842.44
Offering Table N/A
Offset Table N/A	N/A
Combined Prospectus Table N/A	N/A

Taxes

12 Months Ended

Dec. 31, 2025

Income Tax Disclosure [Abstract]

Taxes

17. Taxes

(Loss) income from continuing operations before taxes is comprised of the following components for the years ended December 31, 2025 and 2024 (in thousands):

	2025			2024
	Year Ended December 31,
	2025			2024
Domestic	$	(1,839	)	$	36
Foreign		(1,152	)		(12,030	)
Loss from continuing operations before taxes	$	(2,991	)	$	(11,994	)

The benefit (provision) for income taxes from continuing operations consists of the following (in thousands):

	2025			2024
	Year Ended December 31,
	2025			2024
Current – domestic	$	—		$	(21	)
Current – foreign		(7	)		803
Current – total		(7	)		782
Deferred – domestic		—			—
Income tax benefit	$	(7	)	$	782

The Company has incurred a taxable loss in each of the operating periods since incorporation. The income tax credits of $0 million and $0.8 million for the years ended December 31, 2025 and 2024, respectively, represent UK research and development (“R&D”) tax credits for expenditures in the United Kingdom.

	2025
	Year Ended December 31,
	2025
U.S. Federal Statutory Tax Rate	$	(609	)
State and local income taxes, net of federal income tax effect		(483	)
Foreign Tax Effects
UK
Statutory Tax Rate Difference		8,940
Change in Valuation Allowance		(55,877	)
Non-deductible expenses		47,251
Malaysia
Statutory Tax Rate Difference		(35	)
US
Change in Valuation Allowance		1,921
Non-deductible expenses		(1,039	)
Other adjustments		(62	)
Income tax benefit	$	7

	2024
	Year Ended December 31,
	2024
Loss from continuing operations before taxes	$	(11,994	)
Income tax expense computed at statutory federal tax rate		(2,527	)
Disallowed expenses and non-taxable income		35
Loss surrendered to generate R&D credit		—
Additional research and development tax relief		-
Stock Compensation		30
Change in valuation allowance		2,798
Foreign items, including change in tax rates, and other		(1,158	)
Change in Tax Rate		-
Section 382 Limitation		—
Other items		40
Income tax benefit	$	(782	)

Significant components of the Company’s deferred tax assets are shown below (in thousands):

Schedule of Deferred Tax Assets

	2025			2024
	Year Ended December 31,
	2025			2024
Net operating loss and tax credit carryforwards	$	3,203		$	59,417
Depreciation, amortization and impairment of property and equipment		—			39
Stock options		907			250
Research and development credits		—			—
Right of use asset		(3	)		(1	)
Lease liability		3			1
Other		—			114
Total deferred tax assets		4,110			59,820
Valuation allowance for deferred tax assets		(4,110	)		(59,820	)
Net deferred tax assets	$	—		$	—

A valuation allowance has been established, as realization of such assets is uncertain. The Company’s management evaluated the positive and negative evidence bearing upon the realizability of its deferred assets, and has determined that, at present, the Company may not be able to recognize the benefits of the deferred tax assets under the more likely than not criteria. Accordingly, a valuation allowance of approximately $4.1 million has been established at December 31, 2025. The valuation allowance has increased by approximately $55.7 million in 2025.

As specified in the Tax Reform Act of 1986, due to ownership changes, the Company’s ability to utilize its net operating loss (“NOL”) carryforwards may be limited. Utilization of the NOLs may be subject to a substantial annual limitation under Section 382 of the Internal Revenue Code of 1986 due to ownership change limitations that have occurred previously or that could occur in the future. These ownership changes may limit the amount of NOL and R&D credit carryforwards that can be utilized annually to offset future taxable income and tax, respectively. The Company completed a Section 382 study and has concluded that an ownership change occurred on March 4, 2015 and July 21, 2017. As a result of the ownership changes, the NOLs are limited.

As of December 31, 2025 and 2024, the Company has federal NOLs of $8.0 million and $3.5 million, respectively. The federal NOLs have an indefinite life. As of December 31, 2025 and 2024, the Company has state NOLs of $21.4 million and $16.8 million, respectively, which will begin to expire in 2028. As of December 31, 2025 and 2024, the Company had foreign NOLs of $0 million and $230.0 million, respectively. Following the liquidation and subsequent deconsolidation of the Company’s former UK subsidiary, the Company no longer has any foreign NOLs.

Management has evaluated all significant tax positions at December 31, 2025 and 2024 and concluded that there are no material uncertain tax positions. The Company would recognize both interest and penalties related to unrecognized benefits in income tax expense. The Company has not recorded any interest and penalties on any unrecognized tax benefits since its inception.

Tax years 2022 - 2024 remain open to examination by major taxing jurisdictions to which the Company is subject, which are primarily in the United States, as carryforward attributes generated in years past may still be adjusted upon examination by the Internal Revenue Service (“IRS”) or state tax authorities. The Company is currently not under examination by the IRS or any other jurisdictions for any tax years.

We have not provided a deferred tax liability on the cumulative amount of unremitted foreign earnings of international subsidiaries because it is our intent to permanently reinvest such earnings outside of the United States.

The Company has an aggregate deficit in foreign earnings and therefore has not provided any deferred tax liability on its outside book-tax basis difference in its foreign subsidiaries and because it is also our intent to permanently reinvest any earnings outside of the United States. We would recognize this deferred tax liability if we were to experience a change in circumstances producing a change in that intention. As a result of the repeal of Section 902 foreign tax credit under the Tax Act, future distributions would not be offset by a foreign tax credit.

Effective for tax years beginning after December 31, 2021, taxpayers are required to capitalize any expenses incurred that are considered incidental to research and experimentation (R&E) activities under IRC Section 174. While taxpayers historically had the option of deducting these expenses under IRC Section 174, the December 2017 Tax Cuts and Jobs Act mandates capitalization and amortization of R&E expenses for tax years tax years beginning after December 31, 2021. Expenses incurred in connection with R&E activities in the US must be amortized over a 5-year period if incurred, and R&E expenses incurred outside the US must be amortized over a 15-year period. R&E activities are broader in scope than qualified research activities that are considered under IRC Section 41 (relating to the research tax credit). For the year ended December 31, 2025, the Company performed an analysis based on available guidance and determined that the company does not have any R&E expenses in the US. The company will continue to monitor this issue for future developments, but it does not expect R&E capitalization and amortization to require it to pay cash taxes now or in the near future.

- Definition

The entire disclosure for income tax.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 740
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477617/942-740-50-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 740
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478822/944-740-50-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-12

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 231
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482663/740-10-55-231

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12C
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 270
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477891/740-270-50-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 6.I.5.Q1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480990/946-20-50-13

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h)(2))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/740/tableOfContent

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 14
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-14

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 21
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-21

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 17
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-17

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 11.C)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482603/740-30-50-2

+ Details

Stock Based Compensation

3 Months Ended

12 Months Ended

Mar. 31, 2026

Dec. 31, 2025

Share-Based Payment Arrangement [Abstract]

Stock Based Compensation

11. Stock Based Compensation

ASC 718 requires compensation expense associated with share-based awards to be recognized over the requisite service period which, for the Company, is the period between the grant date and the date the award vests or becomes exercisable. The Company recognizes all share-based awards under the straight-line attribution method, assuming that all granted awards will vest. Forfeitures are recognized in the periods when they occur.

Stock based compensation has been reported within expense line items on the consolidated statement of operations for the three months ended March 31, 2026 and 2025 as shown in the following table (in $000s):

	2026		2025
	Three Months Ended
	March 31,
	2026		2025
General and administrative	$	1	$	1,592
Research and development		—	$	74
Stock-based compensation costs	$	1	$	1,666

There were no stock options or restricted stock units granted during the three months ended March 31, 2026. During the three months ended March 31, 2025, a total of 24,818 stock options and 0 restricted stock units were granted.

15. Stock-Based Compensation Stock Based Compensation

Stock based compensation has been reported within expense line items on the consolidated statement of operations for the years ended 2025 and 2024 as shown in the following table (in thousands):

	2025		2024
	Year Ended
	December 31,
	2025		2024
General and administrative	$	2,297	$	498
Research and development		37		94
Stock-based compensation costs	$	2,334	$	592

2018 Plan

In May 2018, the Company’s stockholders approved the 2018 Equity Incentive Plan (the “2018 Plan”), under which the Company may make equity incentive grants to its officers, employees, directors and consultants. The 2018 Plan allows for various types of award grants, including stock options and restricted stock units.

On February 6, 2025, the Company’s stockholders approved an amendment to the 2018 Plan to reserve an additional 500,000 shares of Common Stock for issuance thereunder, which number would not be adjusted as a result of the Reverse Stock Split. On June 30, 2025, the Company’s stockholders approved another amendment to the 2028 Plan to reserve an additional 4,281,987 shares of Common Stock for issuance thereunder. As of December 31, 2025, the Company has reserved approximately 4,282,026 shares of the Company’s common stock under the 2018 Plan for future issuances.

Stock option awards granted under the Company’s equity incentive plans have a maximum life of 10 years and generally vest over a one to four-year period from the date of grant. Certain awards, though, vest immediately upon grant, including those granted in 2025, as discussed in further detail below.

2020 Inducement Equity Incentive Plan

In October 2020, the Inducement Equity Incentive Plan (the “Inducement Plan”), became effective. Under the Inducement Plan, the Company may make equity incentive grants to new senior level Employees (persons to whom the Company may issue securities without stockholder approval). The Inducement Plan allows for the issuance of up to 55 shares of the Company’s common stock (or the equivalent of such number). As of December 31, 2025, all 55 shares under the Inducement Plan are available for issuance.

Option Awards Granted Outside of the 2018 Plan and Inducement Plan

During February 2025, the Company issued stock option awards to employees and consultants outside of the 2018 Plan and the Inducement Plan. The shares underlying these options are not registered for resale. All of the options granted outside of the 2018 Plan and Inducement Plan vest immediately upon grant and can be exercised beginning three months from the recipient’s Termination Date through the expiry of the option awards, which is ten years from the grant date. The Termination Date is defined as the date on which an award recipient ceases to be an employee, director or consultant of the Company or of an Affiliate for any reason other than the death or disability, or termination of the recipient for cause.

Option Grants and Exercises

There were 24,812 options granted during the year ended December 31, 2025. Of these awards, 1,066 were issued under the 2018 Plan and the rest were issued outside of the 2018 Plan and the Inducement Plan. Options granted during the year ended December 31, 2025 had a grant date fair value ranging between $60.86 and $72.38 per option.

There were 52 options granted under the 2018 Plan during the year ended December 31, 2024. These options had a grant date fair value of $424.80 per option.

The fair value of the stock options granted is calculated using the Black-Scholes option-pricing model as prescribed by ASC 718 using the following assumptions:

	Year ended			Year ended
	December 31, 2025			December 31, 2024
Expected term (years)		5 - 10			6
Risk free interest rate		4.060% – 4.250%			3.995	%
Volatility		100% – 107%			93	%
Expected dividend yield over expected term		0.00	%		0.00	%
Resulting weighted average grant date fair value	$	70.79		$	424.80

There were no stock options exercised during each of the years ended December 31, 2025 and 2024, respectively. The Company does not expect to be able to benefit from the deduction for stock option exercises that may occur because the company has tax loss carryforwards from prior periods that would be expected to offset any potential taxable income.

As of December 31, 2025, the total remaining unrecognized compensation cost related to all outstanding awards with service conditions is less than $1,500 and will be amortized over an approximate remaining requisite service period of 0.50 years.

Outstanding Options

A summary of the share option activity and related information is as follows:

Schedule of Share Option Activity

				Weighted Average		Weighted Average Remaining
	Number of			Exercise		Contractual		Aggregate
	Options			Price Per		Term		Intrinsic
	Outstanding			Share		(Years)		Value ($000)

Options outstanding at December 31, 2023		595		$	12,048.00		7.96	$	—
Granted		52		$	547.20		—	$	—
Exercised		—		$	—		—	$	—
Cancelled/forfeited		(153	)	$	12,327.88		—	$	—
Options outstanding at December 31, 2024		494		$	10,658.14		7.20	$	—

Granted		24,812		$	78.92		—	$	—
Exercised		—		$	—		—	$	—
Cancelled/forfeited		(385	)	$	9,610.52		—	$	—
Options outstanding at December 31, 2025		24,921		$	103.04		9.13	$	—

Unvested at December 31, 2025		4		$	2,094.84		7.49	$	—
Vested and exercisable at December 31, 2025		24,917		$	102.72		9.13	$	—

Restricted Stock Units

The Company issued 500,178 restricted stock units during the year ended December 31, 2025. These restricted stock units vested immediately and were valued at $1.40 at the date of grant, which was equivalent to the market price of a share of the Company’s common stock on that date.

The Company issued 52 restricted stock units during the year ended December 31, 2024. These restricted stock units vested monthly over a six-month6 service period. These restricted stock units were valued at $547.20 at the date of grant, which was equivalent to the market price of a share of the Company’s common stock on that date.

Seventy-one71 restricted stock units were issued in January 2023. These units vest on the third anniversary of their date of grant, or earlier if certain defined clinical trial-related performance targets are met. A three-year 3vesting assumption was applied to these restricted stock units as satisfaction of the performance conditions is not probable at this time. Each restricted stock unit was valued at $3,240.00 at the date of grant, which was equivalent to the market price of a share of the Company’s common stock on that date. As of December 31, 2025, all but 2 of the original awards granted have been forfeited due to the recipient’s termination of service with the Company. In the year ended December 31, 2025, the Company reduced stock compensation cost, a component of selling general, and administrative expense, by approximately $92,000 as a result of forfeitures of these awards during that period.

The July 2025 Reverse Stock Split resulted in the effective cancellation of certain previously issued and outstanding restricted stock units. In the quarter ended June 30, 2025, the Company accelerated the recognition of any remaining unrecognized compensation expense upon the impending cancellation of those awards. This resulted in an approximately $1,000 charge during the year ended December 31, 2025.

Summarized information for restricted stock units as of December 31, 2025 and 2024 is as follows:

				Weighted Average
	Restricted			Grant Date
	Stock Units			Value Per
	Outstanding			Share

RSUs outstanding at Dec 31, 2023		144		$	3,902.40
Granted		52		$	547.20
Cancelled/forfeited		(32	)	$	3,675.17
RSUs outstanding at Dec 31, 2024		164		$	2,881.62

Granted		500,178		$	1.40
Vested and converted to Common Stock		(500,178	)	$	1.40
Cancelled/forfeited		(162	)	$	3,284.47
RSUs outstanding at December 31, 2025		2		$	3,240.00

Accounts Receivables

3 Months Ended

12 Months Ended

Mar. 31, 2026

Dec. 31, 2025

Accounts, Notes, Loans and Financing Receivable [Line Items]

Accounts Receivables

6. Accounts receivables

Accounts Receivables

Accounts receivables consisted of the following (in $000s):

Schedule of Accounts Receivables

	March 31,			December 31,
	2026			2025
Accounts receivables, gross		1,474			1,704
Allowance for doubtful debt		(286	)		(447	)
Total accounts receivable, net	$	1,188		$	1,257

Allowance for doubtful debt, which stood at $286,000 as at March 31, 2026 and $447,000 as at December 31, 2025 is determined based on expected credit losses. Losses are provided at the rate of 10% against balances greater than 120-149 days, 25% against balances greater than 150-179 days, 35% against balances greater than 180-364 days, and 50% against balances greater than 365 days.

Movement in provision for doubtful debt
Provision for doubtful debt as December 31, 2025		(447	)
Reduction in provision during the three months ended March 31, 2026		162
Foreign exchange translation adjustment		(1	)
Addition		-
Provision for doubtful debt as March 31, 2026	$	(286	)

7. Accounts receivable Accounts Receivables

The following is a summary of accounts receivable at December 31, 2025 and 2024 (in thousands):

Schedule of Accounts Receivables

	December 31,		December 31,
	2025		2024
Accounts receivables		1,257		—
Total accounts receivables	$	1,257	$	—

The above receivables are net of allowance for doubtful debt, which stood at $539,441 as at December 31, 2025, and is determined based on expected credit losses. Losses are provided at the rate of 10% against balances greater than 120-149 days, 25% against balances greater than 150-179 days, 35% against balances greater than 180-364 days, and 50% against balances greater than 365 days.

Future NRG Sdn. Bhd. [Member]

Accounts, Notes, Loans and Financing Receivable [Line Items]

Accounts Receivables

6. ACCOUNTS RECEIVABLE, NET

Schedule of Accounts Receivables

	Mar 31, 2026 (USD)
Trade receivables, gross		615,123
Less: Allowance for expected credit losses		(313,610	)
Trade receivables, net		301,513
Other receivables		9,887
Refundable deposits		20,619
Prepayments		2,875
Total accounts receivable, net		334,894

One customer accounted for approximately 75.7% of gross trade receivables at March 31, 2026 (December 31, 2025: approximately 75.7%).

Accounts Receivables

6.	ACCOUNTS RECEIVABLE, NET

Schedule of Accounts Receivables

	Note	2025			2024
		(USD)			(USD)
Trade receivables, gross			602,579			538,423
Less: Accumulated impairment			(312,455	)		(251,199	)
Trade receivables, net			290,124			287,224

Other receivables			9,850			17,875
Refundable deposits			20,542			18,488
Total accounts receivable, net			320,516			323,587

Movement in accumulated impairment:
Opening balance			251,199			213,421
Charge for the year			35,616			32,318
Foreign exchange translation			25,640			5,460
Closing balance			312,455			251,199

One customer represented approximately 75.72% and 86.35% of gross trade receivables as of December 31, 2025 and 2024, respectively. A prior customer entered winding-up proceedings and the related receivable was fully impaired since previous years.

Employee Benefit Plans

3 Months Ended

12 Months Ended

Mar. 31, 2026

Dec. 31, 2025

Defined Benefit Plan Disclosure [Line Items]

Employee Benefit Plans

16. Employee Benefit Plans

Pension Plan

The Company operates a defined contribution group personal pension plan for all of its UK based employees. Company contributions to the plan totaled approximately $500 and $51,000 for the years ended December 31, 2025 and 2024, respectively.

Schedule of Employee Benefit Plans

401(k) Plan

The 401(k) Plan provides for matching contributions by the Company in an amount equal to the lesser of 100% of the employee’s deferral or 6% of the U.S. employee’s qualifying compensation. The 401(k) Plan is intended to qualify under Section 401(k) of the Internal Revenue Code, so that contributions to the 401(k) Plan by employees or by the Company, and the investment earnings thereon, are not taxable to the employees until withdrawn. Company matching contributions are tax deductible by the Company when made. In 2025, Company employees could elect to reduce their current compensation by up to the statutorily prescribed annual limit of $23,500 if under 50 years old and $31,000 if over 50 years old and to have those funds contributed to the 401(k) Plan. The Company made contributions of approximately $333 and $40,000 to the 401(k) Plan for the years ended December 31, 2025 and 2024, respectively.

Future NRG Sdn. Bhd. [Member]

Defined Benefit Plan Disclosure [Line Items]

Employee Benefit Plans

16. EMPLOYEE BENEFIT PLANS

Employee Benefit Plans

Statutory defined contribution plans in Malaysia per the Employees Provident Fund Act 1991 (EPF), Social Security Organization Act 1969 (SOCSO), Employment Insurance System Act 2017 (EIS), and Human Resource Development Corporation Act 2001 (HRDC):

Schedule of Employee Benefit Plans

	Mar 31, 2026 (USD)
EPF contributions		7,083
SOCSO contributions		766
EIS contributions		88
HRDC contributions		550
Total statutory contribution expense		8,487

Employee Benefit Plans

15.

EMPLOYEE BENEFIT PLANS

Included in the compensation and benefits included in operating cost of USD 97,826 (FY 2024 : USD86,105) are statutory defined contribution of USD 11,706 (FY2024: USD10,619). The statutory defined contribution plans for its employees in Malaysia include contributions to the Employees Provident Fund (“EPF”), Social Security Organization (“SOCSO”), Employment Insurance System (“EIS”), and Human Resource Development Fund (“HRDF”) as follows:.

Schedule of Employee Benefit Plans

	Note	2025		2024
		(USD)		(USD)
Employee contributions:
EPF			9,345		5,176
SOCSO			1,013		650
EIS			116		74
HRDF			728		373
HRDC contributions			-		-
Total employee benefit plan expense			11,201		6,272

Director statutory contributions:
EPF			474		3,781
SOCSO			14		244
EIS			2		28
HRDF			15		295
HRDC contributions			-		-
Total director statutory contributions			505		4,347

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

+ Details

- Definition

The entire disclosure for retirement benefits.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (o)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (p)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (q)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 60
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480266/715-60-50-3

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480126/715-20-S99-2

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 70
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480794/715-70-50-1

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 17
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480482/715-20-55-17

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)(iv)(03)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)(i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (l)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-1

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/715/tableOfContent

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)(iii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-1

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (r)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-1

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (r)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-1

+ Details

Schedule of Effective Income Tax Rate Reconciliation (Details) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2026	Mar. 31, 2025	Dec. 31, 2025	Dec. 31, 2024
Income tax expense computed at statutory federal tax rate			$ (609)	$ (2,527)
Tax Jurisdiction of Domicile [Extensible Enumeration]			Income tax benefit
State and local income taxes, net of federal income tax effect			$ (483)
Foreign items, including change in tax rates, and other				(1,158)
Change in valuation allowance				2,798
Income tax benefit	$ 30		7	(782)
Loss from continuing operations before taxes	(167)	(4,206)	(2,991)	(11,994)
Disallowed expenses and non-taxable income				35
Loss surrendered to generate R&D credit
Additional research and development tax relief
Stock Compensation				30
Change in Tax Rate
Section 382 Limitation
Other items				40
Income tax benefit	$ 30		7	$ (782)
UNITED KINGDOM
Foreign items, including change in tax rates, and other			8,940
Change in valuation allowance			(55,877)
Non-deductible expenses			47,251
MALAYSIA
Foreign items, including change in tax rates, and other			(35)
UNITED STATES
Change in valuation allowance			1,921
Non-deductible expenses			(1,039)
Other adjustments			$ (62)

Consolidated Balance Sheets - USD ($)	Mar. 31, 2026	Dec. 31, 2025	Dec. 31, 2024
Current assets
Cash and cash equivalents	$ 3,339,000	$ 3,505,000	$ 3,137,000
Accounts receivable, net	1,188,000	1,257,000
Inventories	947,000	1,384,000
Prepaid expenses and other current assets	148,000	110,000	537,000
Total current assets	5,622,000	6,256,000	3,674,000
Non-current assets
Property and equipment, net	138,000	137,000	3,000
Right-of-use lease asset	10,000	12,000	5,000
Goodwill	1,570,000	1,570,000
Non-current deposits	224,000	210,000	412,000
Discontinued operations:
TOTAL ASSETS	7,564,000	8,185,000	4,094,000
Current liabilities
Accounts payable	256,000	617,000	4,599,000
Accrued and other current liabilities	540,000	715,000	1,669,000
Total current liabilities	796,000	1,332,000	6,268,000
Discontinued operations:
Lease liability		2,000
Other liabilities	8,000	9,000
Total liabilities	804,000	1,343,000	6,268,000
Stockholders’ equity
Common stock — 28,000,000 shares authorized, issued and outstanding	5,000	5,000
Additional paid-in capital	461,393,000	461,287,000	438,211,000
Accumulated other comprehensive income (loss)	(30,000)	(39,000)	(891,000)
Retained earnings / (Accumulated deficit)	(454,608,000)	(454,411,000)	(439,494,000)
Total stockholders’ equity	6,760,000	6,842,000	(2,174,000)
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	7,564,000	8,185,000	4,094,000
Future NRG Sdn. Bhd. [Member]
Current assets
Cash and cash equivalents	9,649	202,716	268,780
Accounts receivable, net	334,894	320,516	323,587
Inventories	68,776	65,076	82,920
Income taxes receivable	515	513	3,448
Other current assets
Total current assets	413,834	588,821	678,735
Non-current assets
Property and equipment, net	4,487,034	4,518,397	4,267,528
Total non-current assets — continuing operations	4,487,034	4,518,397	4,267,528
Discontinued operations:
Assets of discontinued operations held for sale		21,407,221	18,736,092
TOTAL ASSETS	4,900,868	26,514,439	23,682,355
Current liabilities
Accounts payable and accrued liabilities	477,406	5,113,187	3,440,900
Total current liabilities	477,406	5,113,187	3,440,900
Discontinued operations:
Liabilities of discontinued operations held for sale		16,941,462	18,454,470
Total liabilities	477,406	22,054,649	21,895,370
Stockholders’ equity
Common stock — 28,000,000 shares authorized, issued and outstanding	6,100,218	6,100,218	6,100,218
Accumulated other comprehensive income (loss)	216,636	207,074	24,679
Retained earnings / (Accumulated deficit)	(1,893,392)	(1,847,502)	(4,337,912)
Total stockholders’ equity	4,423,462	4,459,790	1,786,985
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	4,900,868	26,514,439	23,682,355
6% Convertible Exchangeable Preferred Stock [Member]
Stockholders’ equity
Preferred stock value
Series A Preferred Stock [Member]
Stockholders’ equity
Preferred stock value
Series B Preferred Stock [Member]
Stockholders’ equity
Preferred stock value

Schedule of Preliminary Allocation of Purchase Consideration (Details) (Parenthetical)	Sep. 11, 2025
Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]
Shares consideration percentage	19.99%

Schedule of Fair Value of Instruments Issued in Offering (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2025 USD ($)
Net proceeds	$ 6,290,213
Common Stock [Member]
Net proceeds	72,108
PreFunded Warrants [Member]
Net proceeds	2,398,831
Common Stock Warrants [Member]
Net proceeds	$ 3,819,274

Leases

3 Months Ended

Mar. 31, 2026

Lessee Disclosure [Abstract]

Leases

10. Leases

Following the acquisition of Fitters Sub on September 12, 2025, the Company utilizes three facilities in Malaysia, all on short term lease agreements. The Company terminated its lease agreement for its previous headquarters in Berkely Heights, New Jersey, effective January 31, 2025.

For the three months ended March 31, 2026, and 2025, the Company recognized operating lease expenses of $13,911 and $1,176 respectively. Cash payments made during the three months ended March 31, 2026, and 2025 totaled $13,911 and $0, respectively, and were presented within cash outflows from operating activities. The remaining lease term of the Company’s longest lease as of March 31, 2026, is approximately 0.9 years. The discount rate used by the Company in determining the lease liability was 12%.

Remaining lease payments for the facilities are as follows (in $000s):

Schedule of Remaining Lease Payments


2026	$	9
2027		2
Thereafter		—
Total future minimum lease obligation	$	11

Schedule of Inventory (Details) - USD ($)	Mar. 31, 2026	Dec. 31, 2025	Dec. 31, 2024
Inventory [Line Items]
Spare parts	$ 238,000	$ 242,000
Work in progress		134,000
Finished goods	709,000	1,008,000
Inventories — at lower of cost and NRV	947,000	1,384,000
Future NRG Sdn. Bhd. [Member]
Inventory [Line Items]
Spare parts	66,798
Consumables	1,977
Inventories — at lower of cost and NRV	$ 68,776	$ 65,076	$ 82,920

Stock Based Compensation (Tables)

3 Months Ended

12 Months Ended

Mar. 31, 2026

Dec. 31, 2025

Share-Based Payment Arrangement [Abstract]

Schedule of Stock Based Compensation Expense

	2026		2025
	Three Months Ended
	March 31,
	2026		2025
General and administrative	$	1	$	1,592
Research and development		—	$	74
Stock-based compensation costs	$	1	$	1,666

Stock based compensation has been reported within expense line items on the consolidated statement of operations for the years ended 2025 and 2024 as shown in the following table (in thousands):

	2025		2024
	Year Ended
	December 31,
	2025		2024
General and administrative	$	2,297	$	498
Research and development		37		94
Stock-based compensation costs	$	2,334	$	592

Schedule of Assumptions Used for Fair Value of the Stock Options Granted Using Black-Scholes Option-Pricing Model

The fair value of the stock options granted is calculated using the Black-Scholes option-pricing model as prescribed by ASC 718 using the following assumptions:

	Year ended			Year ended
	December 31, 2025			December 31, 2024
Expected term (years)		5 - 10			6
Risk free interest rate		4.060% – 4.250%			3.995	%
Volatility		100% – 107%			93	%
Expected dividend yield over expected term		0.00	%		0.00	%
Resulting weighted average grant date fair value	$	70.79		$	424.80

Schedule of Share Option Activity

A summary of the share option activity and related information is as follows:

Schedule of Share Option Activity

				Weighted Average		Weighted Average Remaining
	Number of			Exercise		Contractual		Aggregate
	Options			Price Per		Term		Intrinsic
	Outstanding			Share		(Years)		Value ($000)

Options outstanding at December 31, 2023		595		$	12,048.00		7.96	$	—
Granted		52		$	547.20		—	$	—
Exercised		—		$	—		—	$	—
Cancelled/forfeited		(153	)	$	12,327.88		—	$	—
Options outstanding at December 31, 2024		494		$	10,658.14		7.20	$	—

Granted		24,812		$	78.92		—	$	—
Exercised		—		$	—		—	$	—
Cancelled/forfeited		(385	)	$	9,610.52		—	$	—
Options outstanding at December 31, 2025		24,921		$	103.04		9.13	$	—

Unvested at December 31, 2025		4		$	2,094.84		7.49	$	—
Vested and exercisable at December 31, 2025		24,917		$	102.72		9.13	$	—

Schedule of Restricted Stock Units Activity

Summarized information for restricted stock units as of December 31, 2025 and 2024 is as follows:

				Weighted Average
	Restricted			Grant Date
	Stock Units			Value Per
	Outstanding			Share

RSUs outstanding at Dec 31, 2023		144		$	3,902.40
Granted		52		$	547.20
Cancelled/forfeited		(32	)	$	3,675.17
RSUs outstanding at Dec 31, 2024		164		$	2,881.62

Granted		500,178		$	1.40
Vested and converted to Common Stock		(500,178	)	$	1.40
Cancelled/forfeited		(162	)	$	3,284.47
RSUs outstanding at December 31, 2025		2		$	3,240.00

Revenue (Details Narrative) - USD ($)	3 Months Ended		12 Months Ended
Revenue (Details Narrative) - USD ($)	Mar. 31, 2026	Mar. 31, 2025	Dec. 31, 2025	Dec. 31, 2024
Revenue from Contract with Customer [Abstract]
Revenues	$ 743,000		$ 0	$ 43,000

- Definition

Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).

+ References

+ Details

Summary of Significant Accounting Policies (Details Narrative)			3 Months Ended		12 Months Ended
	Jul. 07, 2025	May 12, 2025	Mar. 31, 2026 USD ($) Segment Country $ / shares	Mar. 31, 2025 USD ($)	Dec. 31, 2025 USD ($) Country $ / shares	Dec. 31, 2025 USD ($) Country $ / shares	Dec. 31, 2025 USD ($) Segment Country $ / shares	Dec. 31, 2025 USD ($) Country $ / shares	Dec. 31, 2025 USD ($) Country Integer $ / shares	Dec. 31, 2024 USD ($) $ / shares	Mar. 31, 2026 RM / shares	Dec. 31, 2025 GBP (£) Country	Dec. 31, 2025 RM / shares	Jan. 24, 2025 USD ($)	Jan. 01, 2025 USD ($)	Dec. 31, 2024 RM / shares	Jan. 01, 2024 USD ($)
Cash and cash equivalents			$ 3,339,000		$ 3,505,000	$ 3,505,000	$ 3,505,000	$ 3,505,000	$ 3,505,000	$ 3,137,000
Cash exceeding balance insured by FDIC					$ 100,000	$ 100,000	$ 100,000	$ 100,000	$ 100,000
Cash balance insured by FSCS \| £												£ 85,000
Number of operating segment \| Segment			1				1
Number of reportable segments			1				1		1
Number of geographic areas for development operations \| Country			1		1	1	1	1	1			1
Revenue			$ 743,000			$ 0				43,000
Accounts receivable															$ 0		$ 0
Accounts receivable, before allowance for doubtful debt					$ 1,588,000	$ 1,588,000	$ 1,588,000	$ 1,588,000	$ 1,588,000
Reclassifications out of other comprehensive income (loss)			$ 0	0						$ 0
Reverse stock split	one-for-fifteen reverse stock split	one-for-sixteen reverse stock split
Common stock, par value \| $ / shares			$ 0.001		$ 0.001	$ 0.001	$ 0.001	$ 0.001	$ 0.001	$ 0.001
Tax on other comprehensive income (loss)			$ 0
Accumulated other comprehensive loss			(30,000)		$ (39,000)	$ (39,000)	$ (39,000)	$ (39,000)	$ (39,000)	$ (891,000)				$ 900,000
Operating cash flows from discontinued operations				$ 4,100,000
Accounts receivable, before allowance for doubtful debt			1,474,000		1,704,000	1,704,000	1,704,000	1,704,000	1,704,000
Accounts receivable, before allowance for doubtful debt			1,188,000		1,257,000	1,257,000	1,257,000	1,257,000	1,257,000
Future NRG Sdn. Bhd. [Member]
Cash and cash equivalents			9,649		$ 202,716	$ 202,716	$ 202,716	$ 202,716	$ 202,716	$ 268,780
Common stock, par value \| (per share)					$ 0.22	$ 0.22	$ 0.22	$ 0.22	$ 0.22	$ 0.22	RM 1.00		RM 1			RM 1
Accumulated other comprehensive loss			216,636		$ 207,074	$ 207,074	$ 207,074	$ 207,074	$ 207,074	$ 24,679
Accounts receivable, before allowance for doubtful debt			$ 334,894		$ 320,516	320,516	320,516	$ 320,516	320,516	$ 323,587
Payment terms					Payment terms are 30–60 days.
Future NRG Sdn. Bhd. [Member] \| Revenue Benchmark [Member] \| Customer Concentration Risk [Member] \| Customer One [Member]
Concentration risk percentage			68.00%					70.00%		71.00%
Maximum [Member]
Cash balances insured by FDIC					$ 250,000	$ 250,000	$ 250,000	$ 250,000	$ 250,000
Estimated useful life					5 years	5 years	5 years	5 years	5 years			5 years
Maximum [Member] \| Future NRG Sdn. Bhd. [Member]
Estimated useful life			50 years		50 years	50 years	50 years	50 years	50 years			50 years
Minimum [Member]
Estimated useful life					3 years	3 years	3 years	3 years	3 years			3 years
Minimum [Member] \| Future NRG Sdn. Bhd. [Member]
Estimated useful life			5 years		3 years	3 years	3 years	3 years	3 years			3 years

Schedule of Disposal Group of Financial Statements (Details) - Future NRG Sdn. Bhd. [Member] - USD ($)	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Mar. 31, 2026
Schedule of Equity Method Investments [Line Items]
Cash and cash equivalents	$ 3,135,050	$ 1,701,167
Total assets held for sale	21,407,221	18,736,092
Disposal Group, Not Discontinued Operations [Member]
Schedule of Equity Method Investments [Line Items]
Cash and cash equivalents	3,135,050	1,701,167	3,135,050
Trade and other receivables, net	795,614	579,260	795,614
Inventories	1,039,416	609,332	1,039,416
Income taxes receivable	(442)	13,880	(442)
Property and equipment, net	16,437,583	15,832,453	16,437,583
Total assets held for sale	21,407,221	18,736,092	21,407,221
Trade and other payables	2,819,424	1,941,697	2,819,424
Banker’s acceptance — short term	1,216,780	2,039,890	1,216,780
Hire purchase obligations	111,338	227,849	111,338
Amount due to ultimate holding company	12,793,920	14,245,034	12,793,920
Total liabilities held for sale	16,941,462	18,454,470	16,941,462
Net assets of the disposal	4,465,759	281,622	$ 4,465,759
Revenue	66,623,781	54,777,343
Cost of revenues	(62,151,255)	(52,197,437)
Gross profit	4,472,526	2,579,906
Operating expenses	(1,903,911)	(1,656,639)
Income before income taxes	2,568,615	923,267
Income tax expense	(11,065)	(2,148)
Net income from discontinued operations	$ 2,557,550	$ 921,119

Stockholders’ Equity (Details Narrative)										1 Months Ended	3 Months Ended		12 Months Ended
Stockholders’ Equity (Details Narrative)	Nov. 05, 2025 USD ($) shares	Sep. 11, 2025	Sep. 04, 2025 USD ($) shares	Jun. 30, 2025 shares	Jun. 20, 2025 USD ($) $ / shares shares	May 02, 2024 USD ($)	Apr. 30, 2024 $ / shares shares	Apr. 29, 2024 $ / shares shares	Jul. 31, 2017 $ / shares	Jul. 31, 2017 USD ($) $ / shares shares	Mar. 31, 2026 USD ($) $ / shares shares	Mar. 31, 2025 USD ($) shares	Dec. 31, 2025 USD ($) $ / shares shares	Dec. 31, 2024 USD ($) $ / shares shares	Mar. 31, 2026 RM / shares shares	Jan. 08, 2026 RM / shares	Dec. 31, 2025 RM / shares shares	Apr. 02, 2025 shares	Feb. 24, 2025 shares	Dec. 31, 2024 RM / shares shares	Nov. 13, 2024 $ / shares shares	Mar. 14, 2024	Oct. 30, 2023
Number of common stocks \| $ / shares											$ 0.001		$ 0.001	$ 0.001
Warrant term											5 years 6 months		18 months		5 years 6 months		18 months
Gross proceeds \| $						$ 8,000,000.0					$ 125,000	$ 3,894,000	$ 6,425,000	$ 6,209,000
Preferred stock, dividend rate											6.00%		6.00%	6.00%
Common stock, shares authorized											600,000,000		600,000,000	100,000,000	600,000,000		600,000,000			100,000,000
Future NRG Sdn. Bhd. [Member]
Number of common stocks \| (per share)													$ 0.22	$ 0.22	RM 1.00		RM 1			RM 1
Common stock, shares authorized											28,000,000		28,000,000	28,000,000	28,000,000		28,000,000			28,000,000
Roth Capital Partners Llc [Member]
Percentage of compensation raised																						7.00%
Ladenburg Thalmann Co.Inc [Member]
Percentage of compensation raised																							8.00%
Placement Agent Warrants [Member]
Warrants to purchase shares								1,242			1,242				1,242
Warrant exercise price \| $ / shares								$ 483.00			$ 124.512
Warrant term											5 years 6 months				5 years 6 months
Cash placement fee								7.00%
Management fee percentage								1.00%
Warrant outstanding term								five and a half years
Warrants exercise price \| $													$ 609,179
Common Stock [Member]
Conversion of shares														165
Issuance cost												758	1,698
Common Stock [Member] \| Future NRG Sdn. Bhd. [Member]
Share issue price per share \| RM / shares																RM 1.00
Common Stock Equity Offerings [Member]
Warrants to purchase shares	1,402,605
Issuance cost	1,402,605
Common Stock Equity Offerings [Member] \| Common Stock [Member]
Deemed dividend \| $	$ 9,540,000		$ 1,494,000
Common Stock Equity Offerings [Member] \| Investor [Member]
Warrants to purchase shares					218,000
Warrant exercise price \| $ / shares					$ 7.65
Common Stock Equity Offerings [Member] \| Investor [Member] \| Warrant [Member]
Number of share sold					1,962,000
April 2024 Securities Purchase Agreement [Member]
Issuance cost							604
April 2024 Securities Purchase Agreement [Member] \| PreFunded Warrants [Member]
Warrants to purchase shares							20,099				20,100				20,100
Warrant exercise price \| $ / shares							$ 0.024
April 2024 Securities Purchase Agreement [Member] \| Series A Warrants [Member]
Warrants to purchase shares							20,703				20,704				20,704
Warrant exercise price \| $ / shares											$ 326.40
April 2024 Securities Purchase Agreement [Member] \| Series B Warrants [Member]
Warrants to purchase shares							20,703				20,704				20,704
Warrant exercise price \| $ / shares											$ 326.40
April 2024 Securities Purchase Agreement [Member] \| PreFunded Warrants And Common Warrants [Member]
Warrants to purchase shares							386.38
April 2024 Securities Purchase Agreement [Member] \| Common Stock Warrants [Member]
Warrant exercise price \| $ / shares							$ 326.40				$ 0.24
Percentage of outstanding common stock							4.99%
Outstanding common stock at election of purchaser							9.99%
April 2024 Securities Purchase Agreement [Member] \| Common Stock [Member]
Warrants to purchase shares							386.40
June 2025 Warrants [Member] \| Series B Warrant [Member]
Warrants exercised													1,962,000	0			1,962,000			0
November 2024 Warrant Exercise And Reload Agreement [Member]
Warrants exercised													82,816				82,816
Cash payment \| $													$ 1,100,000
November 2024 Warrant Exercise And Reload Agreement [Member] \| Series C Warrants [Member]
Warrants to purchase shares													41,407				41,407				20,703
November 2024 Warrant Exercise And Reload Agreement [Member] \| Series D Warrants [Member]
Warrants to purchase shares													41,407				41,407
Warrant exercise price \| $ / shares													$ 99.60								$ 99.60
November 2024 Warrant Exercise And Reload Agreement [Member] \| Series C Warrants [Member]
Warrant term													5 years 6 months				5 years 6 months
April 2024 Warrants [Member]
Warrants to purchase shares											1,242				1,242
Warrants exercised											0	0	62,750		0		62,750
Warrant issued											62,750				62,750
April 2024 Warrants [Member] \| PreFunded Warrants [Member]
Warrants exercised														20,100
April 2024 Warrants [Member] \| Placement Agent Warrants [Member]
Warrant exercise price \| $ / shares													$ 124.512
Warrants exercised													1,242				1,242
Warrants exerciseable													1,242				1,242
April 2024 Warrants [Member] \| Series B Warrant [Member]
Warrants exercised													9,988	10,716
April 2024 Warrants [Member] \| Series A Warrant [Member]
Warrants exercised													20,704
April 2024 Warrants [Member] \| Placement Agent Warrants [Member]
Warrant term													5 years 6 months				5 years 6 months
December 2023 Private Placement [Member]
Warrants to purchase shares											1,750		1,750		1,750		1,750
Warrant exercise price \| $ / shares											$ 765.60		$ 765.60
Warrants exercised											0		0	0	0		0			0
Warrants exerciseable											1,651		1,651		1,651		1,651
December 2023 Private Placement [Member] \| Warrant [Member]
Warrants exerciseable											99		99		99		99
December 2023 Private Placement [Member] \| Placement Agent Warrants [Member]
Warrants exerciseable											33		33		33		33
December 2023 Placement Agency Agreement [Member]
Warrant exercise price \| $ / shares											$ 994.50		$ 994.50
Warrant term											5 years		5 years		5 years		5 years
December 2020 Warrant [Member]
Warrants to purchase shares													186				186
Warrant exercise price \| $ / shares													$ 14,868
Warrant term													5 years				5 years
Warrants exercised													0	0
April 2020 Warrants [Member]
Warrant exercise price \| $ / shares													$ 18,000
Warrants exercised													0				0
Warrants exercised														111
Series F Convertible Preferred Stock [Member] \| Common Stock Equity Offerings [Member]
Number of share sold					3,000,000
Series F Convertible Preferred Stock [Member] \| Common Stock Equity Offerings [Member] \| Investor [Member]
Number of share sold					3,000,000
Investment \| $					$ 3,000,000
Series F Preferred Stock [Member]
Number of share sold				3,000,000
Conversion of shares													654,000				654,000
Series F Preferred Stock [Member] \| Common Stock Equity Offerings [Member]
Share price \| $ / shares					$ 1.00
Gross proceeds \| $					$ 3,000,000
Conversion of shares					0.218
Number of common stocks \| $ / shares					$ 0.001
Series B Common Stock [Member] \| Common Stock Equity Offerings [Member] \| Investor [Member]
Warrants to purchase shares					218,000
Warrant exercise price \| $ / shares					$ 9.00
Series C Common Stock [Member]
Issuance cost			559,395
Series C Common Stock [Member] \| Common Stock Equity Offerings [Member]
Warrants to purchase shares			559,395
Series C Common Stock [Member] \| Common Stock Equity Offerings [Member] \| Investor [Member]
Warrants to purchase shares					218,000
Warrant exercise price \| $ / shares					$ 10.20
Series E Preferred Stock [Member]
Number of share sold													1,000,000
Gross proceeds \| $													$ 1,000,000.0
Conversion of shares											458,333		458,333		458,333		458,333
Preferred stock, dividend rate											1,000,000				1,000,000
Gross proceeds from issuance \| $											$ 1,000,000.0
Series C Preferred Stock [Member]
Number of share sold											1,000,000		1,000,000
Share issue price per share \| $ / shares											$ 0.011042		$ 0.011042
Series D Preferred Stock [Member]
Number of share sold											2,100,000		2,100,000
Share price \| $ / shares											$ 1.00		$ 1.00
Gross proceeds \| $											$ 3,100,000		$ 3,100,000
Conversion of shares											0.4583		0.4583
Number of common stocks \| $ / shares											$ 0.001		$ 0.001
Conversion of shares													0				0	354,738	1,745,262
Series C Convertible Preferred Stock [Member]
Number of share sold											1,000,000		1,000,000
Series A Common Stock Purchase Warrants [Member] \| Common Stock Equity Offerings [Member]
Warrants to purchase shares	654,000
Series B Common Stock Purchase Warrants [Member] \| Common Stock Equity Offerings [Member]
Warrants to purchase shares	654,000
Series C Common Stock Purchase Warrants [Member] \| Common Stock Equity Offerings [Member]
Warrants to purchase shares	94,605
Series B Preferred Stock [Member]
Number of share sold													237,745
Conversion of shares													0	165			0			165
Number of shares converted														119.00
Preferred stock, dividend rate													0	119,000			0			119,000
Series A Preferred Stock [Member]
Conversion of shares											2		2		2		2
Outstanding common stock at election of purchaser										4.99%	300.00%		300.00%
Stock value \| $										$ 1,000
Conversion price of convertible preferred stock \| $ / shares									$ 600.00
Conversion percentage										9.99%
Preferred stock, dividend rate											264		264	264	264		264			264
Conversion amount \| $											$ 500,000		$ 500,000
Conversion price of convertible preferred stock \| $ / shares									$ 144,000.00	$ 144,000.00
Series A Preferred Stock [Member] \| Underwritten Public Offering [Member]
Number of share sold										8,872
Convertible Preferred Stock [Member]
Conversion of shares													0.000000069				0.000000069
Share issue price per share \| $ / shares											$ 10.00		$ 10.00
Preferred stock, dividend rate											135,273		135,273		135,273		135,273
Conversion amount \| $											$ 213,192,000		$ 213,192,000
Preferred stock, dividend rate		6.00%									6.00%		6.00%	6.00%
Liquidation preference \| $ / shares											$ 10.00		$ 10.00
Conversion price (in dollars per share) \| $ / shares													$ 142,128,000
Shares reserved for future issuance upon conversion													6				6
Conversion price percentage											150.00%		150.00%
Trading days													20 days
Trading days period													30 days
Trading days prior													5 days
Redemption price per share \| $ / shares											$ 10.00		$ 10.00
Debt instrument, term											25 years		25 years

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) - shares	3 Months Ended		12 Months Ended
	Mar. 31, 2026	Mar. 31, 2025	Dec. 31, 2025	Dec. 31, 2024
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total shares excluded from calculation	28,009	748,218	28,111,000	117,842,000
Share-Based Payment Arrangement, Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total shares excluded from calculation	24,827	25,253	24,921,000	494,000
Restricted Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total shares excluded from calculation			10,000	164,000
Series A Convertible Preferred Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total shares excluded from calculation			2,000	2,000
Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total shares excluded from calculation			3,178,000	117,182,000

Taxes (Details Narrative) - USD ($)	12 Months Ended
Taxes (Details Narrative) - USD ($)	Dec. 31, 2025	Dec. 31, 2024
Operating Loss Carryforwards [Line Items]
Income tax credits	$ 0	$ 800,000
Valuation allowance for deferred tax assets	4,110,000	59,820,000
Increase in valuation allowance	55,700,000
Uncertain tax positions	0	0
Federal [Member]
Operating Loss Carryforwards [Line Items]
NOLs carryforward	8,000,000.0	3,500,000
State [Member]
Operating Loss Carryforwards [Line Items]
NOLs carryforward	21,400,000	16,800,000
Foreign [Member]
Operating Loss Carryforwards [Line Items]
NOLs carryforward	$ 0	$ 230,000,000.0

Schedule of Remaining Lease Payments (Details) - USD ($) $ in Thousands	Mar. 31, 2026	Dec. 31, 2025
Lessee Disclosure [Abstract]
2026	$ 9	$ 18
2027	2	2
Thereafter
Total future minimum lease obligation	$ 11	$ 20

Non-Current Assets

3 Months Ended

12 Months Ended

Mar. 31, 2026

Dec. 31, 2025

Non-current Assets

Non-Current Assets

8. Non-Current Assets

The Company had $0.2 million non-current assets as of March 31, 2026 and December 31, 2025. The balance relates to a 1.7 million Malaysian Ringgit (approximately $0.4M) loan to an unrelated customer. The loan is interest bearing at a rate of 8% per annum, and is recorded as a component of interest income.

10. Non-Current Assets

The Company had $0.2 million of non-current assets as of December 31, 2025 and $0.4 million as of December 31, 2024. The balance at December 31, 2025 relates to a 1.7 million Malaysian Ringgit (approximately $0.4M) loan to an unrelated customer. The loan is interest bearing at a rate of 8% per annum, and is recorded as a component of interest income.

The balance at December 31, 2024 primarily comprised of deposits held by a contract research organization in relation to the Company’s clinical trials.